<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="I worry there may be an error in the SoF Table (Day 7 soreness)" DOI="10.1002/14651858.CD000023.pub4" GROUP_ID="ARI" ID="972299090211411677" MERGED_FROM="" MODIFIED="2016-05-03 01:41:27 +0100" MODIFIED_BY="Justin Clark" REVIEW_NO="A017" REVMAN_SUB_VERSION="5.2.11 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="22.1">
<COVER_SHEET MODIFIED="2016-05-03 01:41:27 +0100" MODIFIED_BY="Justin Clark">
<TITLE>Antibiotics for sore throat</TITLE>
<CONTACT MODIFIED="2016-05-03 01:41:27 +0100" MODIFIED_BY="Justin Clark"><PERSON ID="18155" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Anneliese</FIRST_NAME><LAST_NAME>Spinks</LAST_NAME><SUFFIX>BSc (Hon) BA</SUFFIX><POSITION>Research Fellow</POSITION><EMAIL_1>anneliese.spinks@csiro.au</EMAIL_1><EMAIL_2>a.spinks@griffith.edu.au</EMAIL_2><ADDRESS><DEPARTMENT>School of Medicine</DEPARTMENT><ORGANISATION>Griffith University</ORGANISATION><ADDRESS_1>University Drive</ADDRESS_1><CITY>Meadowbrook</CITY><ZIP>4031</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 3382 1353</PHONE_1><FAX_1>+61 7 3382 1338</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-05-03 01:41:27 +0100" MODIFIED_BY="Justin Clark"><PERSON ID="18155" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Anneliese</FIRST_NAME><LAST_NAME>Spinks</LAST_NAME><SUFFIX>BSc (Hon) BA</SUFFIX><POSITION>Research Fellow</POSITION><EMAIL_1>anneliese.spinks@csiro.au</EMAIL_1><EMAIL_2>a.spinks@griffith.edu.au</EMAIL_2><ADDRESS><DEPARTMENT>School of Medicine</DEPARTMENT><ORGANISATION>Griffith University</ORGANISATION><ADDRESS_1>University Drive</ADDRESS_1><CITY>Meadowbrook</CITY><ZIP>4031</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 3382 1353</PHONE_1><FAX_1>+61 7 3382 1338</FAX_1></ADDRESS></PERSON><PERSON ID="4655" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Paul</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Glasziou</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>pglaszio@bond.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Centre for Research in Evidence-Based Practice (CREBP)</DEPARTMENT><ORGANISATION>Bond University</ORGANISATION><ADDRESS_1>University Drive</ADDRESS_1><CITY>Gold Coast</CITY><ZIP>4229</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 5595 4482</PHONE_1><FAX_1>+61 7 5595 1652</FAX_1></ADDRESS></PERSON><PERSON ID="12249" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Chris</FIRST_NAME><MIDDLE_INITIALS>B</MIDDLE_INITIALS><LAST_NAME>Del Mar</LAST_NAME><SUFFIX>MA MB BChir MD FRACGP FAFPHM</SUFFIX><POSITION>Professor</POSITION><EMAIL_1>cdelmar@bond.edu.au</EMAIL_1><URL>http://ari.cochrane.org</URL><MOBILE_PHONE>+61 403 220080</MOBILE_PHONE><ADDRESS><DEPARTMENT>Centre for Research in Evidence-Based Practice (CREBP)</DEPARTMENT><ORGANISATION>Bond University</ORGANISATION><ADDRESS_1>University Drive</ADDRESS_1><CITY>Gold Coast</CITY><ZIP>4229</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 7 5595 2504</PHONE_1><FAX_1>+61 7 5595 1652</FAX_1><FAX_2>+61 7 5595 1271</FAX_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-01-28 07:31:12 +1000" MODIFIED_BY="Liz Dooley">
<UP_TO_DATE>
<DATE DAY="11" MONTH="7" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="7" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="11" MONTH="7" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="11" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2014-01-28 07:32:23 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2014-01-28 07:32:23 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="1" YEAR="2014"/>
<DESCRIPTION>
<P>Feedback comment and author reply added to the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-01-28 07:31:45 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-01-28 07:31:45 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Our conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-01-28 07:31:42 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Searches conducted. We did not identify any new trials for inclusion but we excluded three new trials (<LINK REF="STD-Kapur-2011" TYPE="STUDY">Kapur 2011</LINK>; <LINK REF="STD-Kolobukhina-2011" TYPE="STUDY">Kolobukhina 2011</LINK>; <LINK REF="STD-Supajatura-2012" TYPE="STUDY">Supajatura 2012</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-08-15 20:06:30 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="5" YEAR="2011"/>
<DESCRIPTION>
<P>Searches conducted. No new studies were identified and our conclusions remain unchanged. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-05 12:00:57 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="17" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-02-18 09:39:18 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="21" MONTH="1" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-01-21 10:18:00 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="25" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Searches conducted. No new studies were identified and conclusions remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2009-05-06 09:56:27 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="27" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Typographical error in the Abstract corrected.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-10 08:37:24 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="12" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2009-05-06 09:56:29 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="18" MONTH="10" YEAR="2006"/>
<DESCRIPTION>
<P>Feedback added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-07-11 17:51:38 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="3" YEAR="2006"/>
<DESCRIPTION>
<P>In this 2006 update there is an addition of data from one new study by <LINK REF="STD-Zwart-2003" TYPE="STUDY">Zwart 2003</LINK>.<BR/>Additionally, reported statistics were changed from odds ratios to more clinically meaningful relative risks (using a random-effects model).<BR/>Since the update for this review was submitted to <I>The Cochrane Library</I> (Issue 4, 2006), we have been alerted to an error in the data extraction. This error involved switching the number of participants experiencing headache on day three between the intervention and placebo groups for the study by <LINK REF="STD-El_x002d_Daher-1991" TYPE="STUDY">El-Daher 1991</LINK>. We therefore incorrectly concluded that antibiotics conferred no benefit for the symptom of headache, whereas in fact the meta-analysis does show a significant protective effect (RR 0.47; 95% CI 0.38 to 0.58).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-07-14 09:02:33 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="22" MONTH="5" YEAR="2003"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-07-14 08:50:36 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="8" MONTH="5" YEAR="2000"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-07-14 08:49:23 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="30" MONTH="6" YEAR="1999"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-07-14 08:47:11 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="31" MONTH="3" YEAR="1996"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Bond University (2006 update)</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Oxford</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Griffith University</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>NHS support</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-10-25 14:56:46 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-10-25 10:48:57 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-01-28 08:39:38 +1000" MODIFIED_BY="Liz Dooley">Antibiotics for people with sore throats</TITLE>
<SUMMARY_BODY MODIFIED="2013-10-25 10:48:57 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Question</B>
</P>
<P>This review sought to determine whether antibiotics are effective for treating the symptoms and reducing the potential complications associated with sore throats.</P>
<P>
<B>Background</B>
</P>
<P>Sore throats are infections caused by bacteria or viruses. People usually recover quickly (usually after three or four days), although some develop complications. A serious but rare complication is rheumatic fever, which affects the heart and joints. Antibiotics reduce bacterial infections but they can cause diarrhea, rash and other adverse effects and communities build resistance to them.</P>
<P>
<B>Study characteristics</B>
</P>
<P>The review is current to July 2013 and included 27 trials with 12,835 cases of sore throat. All of the included studies were randomised, placebo-controlled trials which sought to determine if antibiotics helped reduce symptoms of either sore throat, fever and headache or the occurrence of more serious complications. Studies were conducted among both children and adults.</P>
<P>
<B>Key results</B>
</P>
<P>The review found that antibiotics shorten the duration of pain symptoms by an average of about one day and can reduce the chance of rheumatic fever by more than two-thirds in communities where this complication is common. Other complications associated with sore throat are also reduced through antibiotic use.</P>
<P>
<B>Quality of evidence</B>
</P>
<P>The quality of the included studies was moderate to high. However, there were very few recent trials included in the review (only three since 2000), hence it is unclear if changes in bacterial resistance in the community may have affected the effectiveness of antibiotics.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-10-23 12:09:17 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-03-11 14:01:26 +1000" MODIFIED_BY="[Empty name]">
<P>Sore throat is a common reason for people to present for medical care. Although it remits spontaneously, primary care doctors commonly prescribe antibiotics for it.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-05-18 08:19:13 +1000" MODIFIED_BY="Liz Dooley">
<P>To assess the benefits of antibiotics for sore throat for patients in primary care settings.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-09-11 21:18:09 +1000" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL 2013, Issue 6, MEDLINE (January 1966 to July week 1, 2013) and EMBASE (January 1990 to July 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-05-18 08:21:56 +1000" MODIFIED_BY="Liz Dooley">
<P>Randomised controlled trials (RCTs) or quasi-RCTs of antibiotics versus control assessing typical sore throat symptoms or complications.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-07-11 02:12:27 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently screened studies for inclusion and extracted data. We resolved differences in opinion by discussion. We contacted trial authors from three studies for additional information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-10-23 12:09:17 +1000" MODIFIED_BY="[Empty name]">
<P>We included 27 trials with 12,835 cases of sore throat. We did not identify any new trials in this 2013 update.</P>
<P>
<B>1. Symptoms</B>
<BR/>Throat soreness and fever were reduced by about half by using antibiotics. The greatest difference was seen at day three. The number needed to treat to benefit (NNTB) to prevent one sore throat at day three was less than six; at week one it was 21.</P>
<P>
<B>2. Non-suppurative complications</B>
<BR/>The trend was antibiotics protecting against acute glomerulonephritis but there were too few cases to be sure. Several studies found antibiotics reduced acute rheumatic fever by more than two-thirds within one month (risk ratio (RR) 0.27; 95% confidence interval (CI) 0.12 to 0.60).</P>
<P>
<B>3. Suppurative complications</B>
<BR/>Antibiotics reduced the incidence of acute otitis media within 14 days (RR 0.30; 95% CI 0.15 to 0.58); acute sinusitis within 14 days (RR 0.48; 95% CI 0.08 to 2.76); and quinsy within two months (RR 0.15; 95% CI 0.05 to 0.47) compared to those taking placebo.</P>
<P>
<B>4. Subgroup analyses of symptom reduction</B>
<BR/>Antibiotics were more effective against symptoms at day three (RR 0.58; 95% CI 0.48 to 0.71) if throat swabs were positive for <I>Streptococcus</I>, compared to RR 0.78; 95% CI 0.63 to 0.97 if negative. Similarly at week one the RR was 0.29 (95% CI 0.12 to 0.70) for positive and 0.73 (95% CI 0.50 to 1.07) for negative <I>Streptococcus </I>swabs.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-05-18 09:19:50 +1000" MODIFIED_BY="Liz Dooley">
<P>Antibiotics confer relative benefits in the treatment of sore throat. However, the absolute benefits are modest. Protecting sore throat sufferers against suppurative and non-suppurative complications in high-income countries requires treating many with antibiotics for one to benefit. This NNTB may be lower in low-income countries. Antibiotics shorten the duration of symptoms by about 16 hours overall.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-10-25 10:49:13 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2011-05-18 08:35:38 +1000" MODIFIED_BY="Liz Dooley">
<P>Sore throat is a very common reason for people to attend primary care settings (<LINK REF="REF-ABS-1985" TYPE="REFERENCE">ABS 1985</LINK>). Moreover, four to six times as many people suffering sore throat do not seek care (<LINK REF="REF-Goslings-1963" TYPE="REFERENCE">Goslings 1963</LINK>; <LINK REF="REF-Horder-1954" TYPE="REFERENCE">Horder 1954</LINK>). Sore throat is a disease that remits spontaneously, that is, 'cure' is not dependent on treatment (<LINK REF="REF-Del-Mar-1992c" TYPE="REFERENCE">Del Mar 1992c</LINK>). Nonetheless, primary care doctors commonly prescribe antibiotics for sore throat and other upper respiratory tract infections. There are large differences in clinical practice between countries (<LINK REF="REF-Froom-1990" TYPE="REFERENCE">Froom 1990</LINK>) and between primary care doctors (<LINK REF="REF-Howie-1971" TYPE="REFERENCE">Howie 1971</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>The administration of antibiotics is likely to shorten the time to the remittance of symptoms and reduce the likelihood of complications in patients whose sore throat has a bacteriological aetiology (<LINK REF="REF-van-Driel-2013" TYPE="REFERENCE">van Driel 2013</LINK>). However, their benefits may be limited in the treatment of sore throat more generally (<LINK REF="REF-Reveiz-2013" TYPE="REFERENCE">Reveiz 2013</LINK>). Traditionally, doctors have attempted to decide whether the cause of the infection is bacterial, especially when caused by the group A beta-haemolytic <I>Streptococcus</I> (GABHS) (which can cause acute rheumatic fever and acute glomerulonephritis). However, deciding the aetiological agent is difficult (<LINK REF="REF-Del-Mar-1992b" TYPE="REFERENCE">Del Mar 1992b</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2011-07-11 02:17:23 +1000" MODIFIED_BY="[Empty name]">
<P>Antibiotics target bacteria which are potentially responsible for sore throat symptoms and possible subsequent suppurative and non-suppurative sequelae. Successful eradication of bacteria may promote faster healing and prevention of secondary complications. However, not all sore throat cases are of bacteriologic origin and bacteria may resist antibiotic treatment which could limit the overall effectiveness of the intervention.</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-07-11 02:17:42 +1000" MODIFIED_BY="[Empty name]">
<P>Whether or not to prescribe antibiotics for sore throat is controversial. The issue is important because it is a very common disease and differences in prescribing result in large cost differences. Moreover, increased prescribing increases patient attendance rates (<LINK REF="REF-Howie-1978" TYPE="REFERENCE">Howie 1978</LINK>; <LINK REF="STD-Little-1997" TYPE="STUDY">Little 1997</LINK>). This review is built on an early meta-analysis (<LINK REF="REF-Del-Mar-1992a" TYPE="REFERENCE">Del Mar 1992a</LINK>) and is an update of previous Cochrane Reviews (<LINK REF="REF-Del-Mar-1997" TYPE="REFERENCE">Del Mar 1997</LINK>; <LINK REF="REF-Del-Mar-2000" TYPE="REFERENCE">Del Mar 2000</LINK>; <LINK REF="REF-Del-Mar-2004" TYPE="REFERENCE">Del Mar 2004</LINK>; <LINK REF="REF-Del-Mar-2006" TYPE="REFERENCE">Del Mar 2006</LINK>; <LINK REF="REF-Spinks-2009" TYPE="REFERENCE">Spinks 2009</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-08-21 10:52:37 +1000" MODIFIED_BY="Liz Dooley">
<P>To assess the benefits of antibiotics for sore throat for patients in primary care settings.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2011-05-18 08:39:29 +1000" MODIFIED_BY="Liz Dooley">
<P>Randomised controlled trials (RCTs) or quasi-RCTs.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-05-18 08:39:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Patients presenting to primary care facilities with symptoms of sore throat.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-05-18 08:40:01 +1000" MODIFIED_BY="Liz Dooley">
<P>Antibiotics or placebo control.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-07-11 02:17:52 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Symptoms of sore throat on day three.</LI>
<LI>Symptoms of sore throat at one week (days six to eight).</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Symptoms of fever at day three.</LI>
<LI>Symptoms of headache at day three.</LI>
<LI>Incidence of suppurative complications:</LI>
<OL>
<LI>quinsy;</LI>
<LI>acute otitis media;</LI>
<LI>acute sinusitis.</LI>
</OL>
<LI>Incidence of non-suppurative complications:</LI>
<OL>
<LI>incidence of acute rheumatic fever within two months;</LI>
<LI>acute glomerulonephritis within one month.</LI>
</OL>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-09-11 20:19:34 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-09-11 20:19:34 +1000" MODIFIED_BY="[Empty name]">
<P>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 6, part of <I>The Cochrane Library, </I>
<A HREF="http://www.thecochranelibrary.com">www.thecochranelibrary.com</A> (accessed 11 July 2013), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (May 2011 to July week 1, 2013) and EMBASE (May 2011 to July 2013). See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details of previous searches.</P>
<P>MEDLINE and CENTRAL were searched using the search strategy shown below. We combined the MEDLINE search string with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity and precision-maximising version (2008 revision) (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search string for EMBASE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>). There were no language or publication restrictions.</P>
<SUBSECTION>
<HEADING LEVEL="5">MEDLINE (Ovid)</HEADING>
<P>1 exp Pharyngitis/<BR/>2 pharyngit*.tw.<BR/>3 exp Nasopharyngitis/<BR/>4 (nasopharyngit* or rhinopharyngit*).tw.<BR/>5 exp Tonsillitis/<BR/>6 tonsillit*.tw.<BR/>7 (tonsil* adj2 (inflam* or infect*)).tw.<BR/>8 ((throat* or pharyn*) adj3 (infect* or inflam* or strep*)).tw.<BR/>9 (sore* adj2 throat*).tw.<BR/>10 or/1-9<BR/>11 exp Anti-Bacterial Agents/<BR/>12 antibiot*.tw,nm.<BR/>13 (azithromycin* or clarithromycin* or erythromycin* or roxithromycin* or macrolide* or cefamandole* or cefoperazone* or cefazolin* or cefonicid* or cefsulodin* or cephacetrile* or cefotaxime* or cephalothin* or cephapirin* or cephalexin* or cephaclor* or cephadroxil* or cephaloglycin* or cephradine* or cephaloridine* or ceftazidime* or cephamycin* or cefmetazole* or cefotetan* or cefoxitin* or cephalosporin* or cefpodoxime* or cefuroxime* or cefixime* or amoxicillin* or amoxycillin* or ampicillin* or sulbactum* or tetracyclin* or clindamycin* or lincomycin* or doxycyclin* or fluoroquinolone* or ciprofloxacin* or fleroxacin* or enoxacin* or norfloxacin* or ofloxacin* or pefloxacin* or moxifloxacin* or esparfloxacin* or clindamicin* or penicillin* or ticarcillin* or beta-lactam* or levofloxacin* or trimethoprim* or co-trimoxazole).tw,nm.<BR/>14 or/11-13<BR/>15 10 and 14</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-07-11 16:38:12 +1000" MODIFIED_BY="[Empty name]">
<P>We searched ClinicalTrials.gov and WHO ICTRP (11 July 2013) for completed and ongoing trials. We hand-checked references of selected studies and relevant reviews to find additional studies. </P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-08-21 11:25:36 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (AS, CD) independently screened abstracts of potential studies and retrieved full articles for those that were trials. Two review authors (AS, CD)<B> </B>examined the full articles and either selected for inclusion or rejected to the excluded studies list. We resolved differences in opinion by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-07-11 02:19:23 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (AS, CDM) independently extracted data from the included studies based on patient-relevant outcomes: namely the complications and symptoms listed above. Data extraction involved reading from tables, graphs and, in some cases, contacting trial authors for raw data (<LINK REF="STD-Dagnelie-1996" TYPE="STUDY">Dagnelie 1996</LINK>; <LINK REF="STD-Little-1997" TYPE="STUDY">Little 1997</LINK>; <LINK REF="STD-Zwart-2000" TYPE="STUDY">Zwart 2000</LINK>; <LINK REF="STD-Zwart-2003" TYPE="STUDY">Zwart 2003</LINK>).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-08-21 11:26:16 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed risk of bias according to the approach indicated in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We used the following six criteria: adequate sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other bias.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-07-11 02:19:32 +1000" MODIFIED_BY="[Empty name]">
<P>All treatment effect outcomes were dichotomous data, reported as risk ratios (RR). We reported occurrence of complications during the study period for suppurative and non-suppurative complications. We assessed the presence of symptoms (sore throat, fever, headache) when possible at day three and week one (days six to eight). We also calculated numbers needed to treat to benefit (NNTB) for the primary outcomes.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2011-06-02 10:00:06 +1000" MODIFIED_BY="Liz Dooley">
<P>We performed an intention-to treat (ITT) analysis for all outcomes.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>We assessed heterogeneity by using the Chi<SUP>2</SUP> test with the significance level set at 0.1. We determined the effect of heterogeneity by the I<SUP>2</SUP> statistic which indicates the proportion of total variability which can be explained by heterogeneity. We interpreted values of the I<SUP>2 </SUP>statistic greater than 50% as indicating substantial heterogeneity, in accordance with the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-05-18 09:23:39 +1000" MODIFIED_BY="Liz Dooley">
<P>We combined data where possible in order to perform meta-analyses to report RR for all relevant outcomes. We used a random-effects meta-analytical method (Mantel-Haenszel) in order to account for heterogeneity that was detected using the methods described above. Not all studies were able to contribute data to each of the meta-analyses performed.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>We performed a series of subgroup analyses to assess the differences in outcomes across various subgroups within the participant population:</P>
<OL>
<LI>treatment with penicillin (omitting other antibiotics);</LI>
<LI>children compared with adults;</LI>
<LI>positive throat swab versus negative throat swab versus untested and/or inseparable data for group A beta-haemolytic <I>Streptococcus</I> (GABHS).</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-05-18 09:24:37 +1000" MODIFIED_BY="Liz Dooley">
<P>We performed sensitivity analyses to assess the degree to which results were influenced by the following criteria:</P>
<OL>
<LI>early (pre-1975) versus later (post-1975) studies;</LI>
<LI>blinded versus unblinded studies;</LI>
<LI>antipyretics administered versus no antipyretics administered.</LI>
</OL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-10-25 10:49:13 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-10-25 10:49:13 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-08-29 14:29:10 +1000" MODIFIED_BY="[Empty name]">
<P>A total of 61 studies were considered for the review. Of these, there were 27 controlled studies that met the inclusion criteria and were included in the review. There were no new trials included in this 2013 update. However, three new trials were considered and subsequently excluded.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-10-25 10:49:13 +1000" MODIFIED_BY="[Empty name]">
<P>The included studies investigated a total of 12,835 cases of sore throat. The majority of studies were conducted in the 1950s, during which time the rates of serious complications (especially acute rheumatic fever) were much higher than today. Seven studies published in the last 15 years (between 1996 to 2003) were included. However, no new studies have been published since 2003.</P>
<P>The age of participants ranged from less than one year to older than 50 years. The participants of eight early studies were young male recruits from the United States Air Force (<LINK REF="STD-Brink-1951" TYPE="STUDY">Brink 1951</LINK>; <LINK REF="STD-Brumfitt-1957" TYPE="STUDY">Brumfitt 1957</LINK>; <LINK REF="STD-Catanzaro-1954" TYPE="STUDY">Catanzaro 1954</LINK>; <LINK REF="STD-Chamovitz-1954" TYPE="STUDY">Chamovitz 1954</LINK>; <LINK REF="STD-Denny-1950" TYPE="STUDY">Denny 1950</LINK>; <LINK REF="STD-Denny-1953" TYPE="STUDY">Denny 1953</LINK>; <LINK REF="STD-MacDonald-1951" TYPE="STUDY">MacDonald 1951</LINK>; <LINK REF="STD-Wannamaker-1951" TYPE="STUDY">Wannamaker 1951</LINK>). Seven of the remaining studies recruited children up to 18 years of age only (<LINK REF="STD-El_x002d_Daher-1991" TYPE="STUDY">El-Daher 1991</LINK>; <LINK REF="STD-Krober-1985" TYPE="STUDY">Krober 1985</LINK>; <LINK REF="STD-Nelson-1984" TYPE="STUDY">Nelson 1984</LINK>; <LINK REF="STD-Pichichero-1987" TYPE="STUDY">Pichichero 1987</LINK>; <LINK REF="STD-Siegel-1961" TYPE="STUDY">Siegel 1961</LINK>; <LINK REF="STD-Taylor-1977" TYPE="STUDY">Taylor 1977</LINK>; <LINK REF="STD-Zwart-2000" TYPE="STUDY">Zwart 2000</LINK>), three recruited only adults or adolescents aged 15 years or over (<LINK REF="STD-Howe-1997" TYPE="STUDY">Howe 1997</LINK>; <LINK REF="STD-Petersen-1997" TYPE="STUDY">Petersen 1997</LINK>; <LINK REF="STD-Zwart-2003" TYPE="STUDY">Zwart 2003</LINK>) and nine studies recruited both adults and children (<LINK REF="STD-Bennike-1951" TYPE="STUDY">Bennike 1951</LINK>; <LINK REF="STD-Chapple-1956" TYPE="STUDY">Chapple 1956</LINK>; <LINK REF="STD-Dagnelie-1996" TYPE="STUDY">Dagnelie 1996</LINK>; <LINK REF="STD-De-Meyere-1992" TYPE="STUDY">De Meyere 1992</LINK>; <LINK REF="STD-Landsman-1951" TYPE="STUDY">Landsman 1951</LINK>; <LINK REF="STD-Leelarasamee-2000" TYPE="STUDY">Leelarasamee 2000</LINK>; <LINK REF="STD-Little-1997" TYPE="STUDY">Little 1997</LINK>; <LINK REF="STD-Middleton-1988" TYPE="STUDY">Middleton 1988</LINK>; <LINK REF="STD-Whitfield-1981" TYPE="STUDY">Whitfield 1981</LINK>).</P>
<P>All studies recruited patients presenting with symptoms of sore throat. The majority of studies did not distinguish between bacterial and viral aetiology. However, seven studies included or analyzed results for group A beta haemolytic <I>Streptococcus</I> (GABHS) positive patients only (<LINK REF="STD-Catanzaro-1954" TYPE="STUDY">Catanzaro 1954</LINK>; <LINK REF="STD-De-Meyere-1992" TYPE="STUDY">De Meyere 1992</LINK>; <LINK REF="STD-El_x002d_Daher-1991" TYPE="STUDY">El-Daher 1991</LINK>; <LINK REF="STD-Krober-1985" TYPE="STUDY">Krober 1985</LINK>; <LINK REF="STD-Middleton-1988" TYPE="STUDY">Middleton 1988</LINK>; <LINK REF="STD-Nelson-1984" TYPE="STUDY">Nelson 1984</LINK>; <LINK REF="STD-Pichichero-1987" TYPE="STUDY">Pichichero 1987</LINK>), one study distinguished differences in outcomes between GABHS-positive and negative patients (<LINK REF="STD-Dagnelie-1996" TYPE="STUDY">Dagnelie 1996</LINK>) and two studies specifically excluded patients who were GABHS-positive (<LINK REF="STD-Petersen-1997" TYPE="STUDY">Petersen 1997</LINK>; <LINK REF="STD-Taylor-1977" TYPE="STUDY">Taylor 1977</LINK>).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-08-15 20:32:18 +1000" MODIFIED_BY="[Empty name]">
<P>The most common reason for exclusion was lack of appropriate control group (n = 13). Other reasons for exclusion were: irrelevant or non-patient centred outcomes (n = 6), main complaint other than acute sore throat (n = 6), inappropriate or no randomisation to treatment (n = 5), an intervention other than antibiotics was being tested (n = 2), the study tracked natural course of illness only (n = 1) or that the study reported previously published data already included (n = 1).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-09-11 21:36:55 +1000" MODIFIED_BY="[Empty name]">
<P>The overall risk of bias is presented graphically in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2011-06-02 11:30:32 +1000" MODIFIED_BY="Liz Dooley">
<P>In most early studies, participants were randomised to treatment and control groups by methods that could potentially introduce bias (for example, Air Force serial number, drawing a card from a deck, hospital bed number) or not randomised at all. Allocation methods were generally appropriate in the later studies.</P>
</ALLOCATION>
<BLINDING MODIFIED="2011-05-18 09:29:50 +1000" MODIFIED_BY="Liz Dooley">
<P>Eighteen of the studies were double-blinded and three were single-blinded.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-09-11 21:36:55 +1000" MODIFIED_BY="[Empty name]">
<P>Outcome data were complete for nearly all studies. For one study it was not clear how many participants maintained pain score diaries and some participants who were initially randomised were excluded due to being GABHS-positive (<LINK REF="STD-Petersen-1997" TYPE="STUDY">Petersen 1997</LINK>).</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>The use of antipyretic analgesics was not stated in nine studies, administered routinely in five studies and prohibited in four studies. The prohibition of analgesics might exaggerate any small symptomatic benefit of antibiotics over control if antipyretic analgesics are usually recommended in normal practice.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-09-11 21:28:12 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Symptoms of sore throat on day three</HEADING>
<P>At day three of the illness, antibiotics reduced symptoms of sore throat (risk ratio (RR) 0.68; 95% confidence interval (CI) 0.59 to 0.79) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Day three was the greatest time of benefit because the symptoms of only half the participants had settled.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Symptoms of sore throat at one week (days six to eight)</HEADING>
<P>At one week (six to eight days) the RR of experiencing sore throat was 0.49 (95% CI 0.32 to 0.76) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>), although 82% of controls were better by this time.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Symptoms of fever at day three</HEADING>
<P>At day three of the illness, antibiotics reduced symptoms of fever (RR 0.71; 95% CI 0.45 to 1.10) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Symptoms of headache at day three</HEADING>
<P>At day three of the illness, antibiotics reduced symptoms of headache (RR 0.44; 95% CI 0.27 to 0.71) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Incidence of suppurative complications</HEADING>
<P>Antibiotics reduced the incidence of acute otitis media to about one-third of that in the placebo group (RR 0.30; 95% CI 0.15 to 0.58) (<LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>) and reduced the incidence of acute sinusitis to about one-half of that in the placebo group (RR 0.48; 95% CI 0.08 to 2.76) (<LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>). Data indicate that the incidence of quinsy was also reduced in relation to the placebo group (RR 0.15; 95% CI 0.05 to 0.47) (<LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Incidence of non-suppurative complications</HEADING>
<P>Cases of acute glomerulonephritis only occurred in the control group which suggests protection by antibiotics. However, there were only two cases and only 10 studies reported on acute glomerulonephritis as an endpoint. Therefore, our estimate of the protection has a very wide 95% CI (RR 0.22; 95% CI 0.02 to 2.08) (<LINK REF="CMP-004.08" TYPE="ANALYSIS">Analysis 4.8</LINK>) which precludes us from definitively claiming that antibiotics protect sore throat sufferers from acute glomerulonephritis.</P>
<P>Several studies found benefit from antibiotics for acute rheumatic fever which reduced this complication to about one-quarter of that in the placebo group (RR 0.27; 95% CI 0.12 to 0.60) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). Few studies examined antibiotics other than penicillin. Confining the analysis to penicillin alone resulted in no difference in estimated protection (RR 0.27; 95% CI 0.14 to 0.50) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis of symptom reduction</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Blind versus unblinded studies</HEADING>
<P>There was no significant difference between blinded and unblinded studies for symptoms of sore throat at day three (RR 0.65; 95% CI 0.54 to 0.78 and RR 0.79; 95% CI 0.60 to 1.05, respectively) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) nor at one week (RR 0.62; 95% CI 0.38 to 1.03 and RR 0.30; 95% CI 0.08 to 1.15, respectively) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). Contrary to expectation, the trend was for a greater effect of antibiotics for blind studies at day three.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Antipyretics administered versus not administered</HEADING>
<P>Use of antipyretics led to no significant difference between studies in which antipyretics were offered and those in which they were not (RR 0.52; 95% CI 0.33 to 0.81 and RR 0.62; 95% CI 0.55 to 0.70, respectively) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Throat swabs positive for <I>Streptococcus</I> versus negative for <I>Streptococcus</I> versus not tested and/or inseparable combined data</HEADING>
<P>The probability of still experiencing pain on day three is slightly more than one-half (RR 0.58; 95% CI 0.48 to 0.71) for those participants who had positive throat swabs for GABHS, compared to three-quarters (RR 0.78; 95% CI 0.63 to 0.97) for those with negative swabs (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). There was a similar effect at one week (RR 0.29; 95% CI 0.12 to 0.70 and RR 0.73; 95% CI 0.50 to 1.07, respectively) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). That is, the effectiveness of antibiotics is increased in people with <I>Streptococci</I> growing in the throat.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Children versus adults</HEADING>
<P>There were few studies that included children (younger than 13 years of age): only 61 cases in total for when fever was evaluated at day three. There was overlap of the RR 95% CI, so that the trend for children to not experience benefits was not significantly different to adults who did (RR 1.27; 95% CI 0.76 to 2.13 and RR 0.29; 95% CI 0.06 to 1.51, respectively) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<P>Some of these results are summarised in <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<P>A trial from Thailand was included in the 2003 update (<LINK REF="STD-Leelarasamee-2000" TYPE="STUDY">Leelarasamee 2000</LINK>). It is especially important because it is one of the few trials from a non-Western industrial country. Unfortunately we were unable to enter its data into the meta-analysis because of different ways of collecting the data (in particular no data were collected mid-way through the illness). Nevertheless, the use of antibiotics conferred no benefit (nor harms) on symptoms or complications.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-10-25 10:49:13 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Natural history</HEADING>
<P>In the placebo groups, after three days symptoms of sore throat and fever had disappeared in about 40% and 85%, respectively. Eighty-two percent of participants were symptom-free by one week. This natural history was similar in <I>Streptococcus-</I>positive, negative and untested participants. About 1.7 per 100 placebo participants developed rheumatic fever. However, this complication occurred only in trials reporting before 1961. The background incidence of acute rheumatic fever has continued to decline in Western societies since then.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Benefits of treatment</HEADING>
<P>The absolute benefit of antibiotics for the duration of symptoms was modest. The reduction of illness time is greatest in the middle of the illness period when the mean absolute reduction is about one day at around day three. There are not enough data to draw conclusions about children. The absolute reduction averaged over the whole illness can only be estimated from these data. The difference in the area under the survival curves of sore throat symptoms for those treated with placebo as opposed to antibiotic is about 16 hours for the first week.</P>
<P>Estimates of the number of people with sore throat who must be treated to resolve the symptoms of one by day three (the number needed to treat to benefit (NNTB)) is about 3.7 for those with positive throat swabs for <I>Streptococcus</I>. It is 6.5 for those with a negative swab and 14.4 for those in whom no swab has been taken. The last result is difficult to understand. Intuitively one would expect the NNTB value to lie between both the swab-negative and swab-positive results. Perhaps participants with less severe throat infections were recruited into the three studies in which swabs were not taken.</P>
<P>Antibiotics are effective at reducing the relative complication rate of people suffering sore throat. However, the relative benefit exaggerates the absolute benefit because complication rates are low and the illness is short-lived. Interpretation of these data is aided by estimating the absolute benefit, which we attempt below.</P>
<P>In these trials, conducted mostly in the 1950s, for every 100 participants treated with antibiotics rather than placebo, there was one fewer case of acute rheumatic fever, two fewer cases of acute otitis media and three fewer cases of quinsy. These figures need to be adapted to current circumstances and individuals. For example, the complication rate of acute otitis media among those with sore throats before 1975 was 3%. A NNTB of about 50 to prevent one case of acute otitis media can be estimated from the data. After 1975, this complication rate fell to 0.7% and applying the odds of reducing the complication with antibiotics from the data table yields a NNTB of nearly 200 to prevent one case of acute otitis media. Clinicians will have to exercise judgement in applying these data to their patients.</P>
<P>In particular, in high-income countries (where absolute rates of complications are lower) the NNTB will rise above a rate at which it might be regarded as worthwhile to treat. In low-income countries where the absolute rate may be much higher, the lower NNTB will mean antibiotics are more likely to be effective.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse effects of treatment</HEADING>
<P>We were unable to present the adverse effects of antibiotic use because of inconsistencies in recording these symptoms. In other studies these were principally diarrhea, rashes and thrush (<LINK REF="REF-Venekamp-2013" TYPE="REFERENCE">Venekamp 2013</LINK>). Consideration of the side effects of antibiotics would have been useful in further defining their risk-benefits.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Special risk groups</HEADING>
<P>Acute rheumatic fever is common among people living in some parts of the world (Australian Aborigines living in low socio-economic conditions, for example) and antibiotics may be justified to reduce the complication of acute rheumatic fever in these settings. In other parts of the world the incidence of acute rheumatic fever is so low (one estimate is that it took 12 General Practitioners' working lifetimes to encounter one new case of acute rheumatic fever in Western Scotland in the 1980s (<LINK REF="REF-Howie-1985" TYPE="REFERENCE">Howie 1985</LINK>)) that the risks of serious complications arising from using antibiotics for sore throat might be of the same order as that of acute rheumatic fever.</P>
</SUBSECTION>
<SUMMARY_OF_RESULTS MODIFIED="2013-09-11 21:30:54 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Symptoms</HEADING>
<P>Throat soreness and fever were reduced by about half when using antibiotics. The greatest difference was seen at day three. The number needed to treat to benefit (NNTB) to prevent one sore throat at day three was less than six; at week one it was 21. Antibiotics were more effective against symptoms at day three and one week if throat swabs were positive for <I>Streptococcus</I> compared to negative throat swabs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Non-suppurative complications</HEADING>
<P>Antibiotics showed a trend for protecting against acute glomerulonephritis but there were too few cases for the results to reach statistical significance. Antibiotics reduced acute rheumatic fever by more than two-thirds.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Suppurative complications</HEADING>
<P>Antibiotics significantly reduced the incidence of acute otitis media by two-thirds, acute sinusitis by a half and quinsy by 85% compared to those taking placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Authors' conclusions  </HEADING>
<P>Antibiotics confer relative benefits in the treatment of sore throat. However, the absolute benefits are modest. Protecting sore throat sufferers against suppurative and non-suppurative complications in high-income countries requires treating many with antibiotics for one to benefit. This NNTB may be lower in low-income countries. Antibiotics shorten the duration of symptoms by about 16 hours overall.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2011-05-19 16:53:52 +1000" MODIFIED_BY="[Empty name]">
<P>The majority of trials included in this review were conducted prior to 1975, with only three trials published since 2000. The main reason for this is that very few antibiotic trials conducted recently include a placebo control arm. It is therefore unknown whether changes in bacterial resistance and population immunity over time may have altered the applicability of results.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2011-05-19 16:53:52 +1000" MODIFIED_BY="[Empty name]">
<P>The quality of the evidence is considered to be moderate to high. The greatest compromise to evidence quality arose from non-clarity in treatment allocation procedures.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>Non-reporting of anti-pyretic use in a high number of studies may have constituted a source of bias in the results. Publication bias may also be considered a potential threat to the validity of results, particularly for the earlier studies.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>A recent review analysing the risk-benefit profile of antimicrobial prescribing for children concluded that antibiotics show little benefit in preventing quinsy following sore throat (<LINK REF="REF-Keith-2010" TYPE="REFERENCE">Keith 2010</LINK>). A clinical evidence review of antibiotic treatment for streptococcal pharyngitis concluded that among patients with signs and symptoms of positive bacterial infection, a specific diagnosis should be determined by performing either a throat culture or rapid antigen-detection test, especially in children (<LINK REF="REF-Wessels-2011" TYPE="REFERENCE">Wessels 2011</LINK>). Antibiotic treatment with penicillin or a first-generation cephalosporin is then recommended in the case of positive bacteriologic assessment.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-05-18 09:58:52 +1000" MODIFIED_BY="Liz Dooley">
<P>Antibiotics have a beneficial effect on both suppurative and symptom reduction.</P>
<P>The effect on symptoms is small, so that clinicians must judge with individual cases whether it is clinically justifiable to employ antibiotics to produce this effect. In other words their use should be discretionary rather than either prohibited or mandatory. Since 90% of patients are symptom-free by one week (whether or not treated with antibiotics), the absolute benefit of antibiotics at this time and beyond is vanishingly small.</P>
<P>Acute rheumatic fever is common among people living in some parts of the world (Australian Aborigines living in low socio-economic conditions, for example) and antibiotics may be justified to reduce the incidence of this complication in these settings. For other settings where rheumatic fever is rare, there is a balance to be made between modest symptom reduction and the hazards of antimicrobial resistance.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>More trials are needed in low-income countries, in socio-economically deprived sections of high-income countries and also in children. In high-income countries, better prognostic studies are called for which can predict which patients may develop suppurative and non-suppurative complications. This will help to further define which patients benefit from antibiotics.</P>
<P>Studies which use patient-centred outcome measures compatible with those presented here would be greatly beneficial, in terms of easier comparison and analysis of results and ready inclusion into future updates of this review.</P>
<P>Few trials have attempted to measure the severity of symptoms. If antibiotics reduce the severity as well as the duration of symptoms, their benefit will have been underestimated in this meta-analysis.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-09-11 20:39:11 +1000" MODIFIED_BY="[Empty name]">
<P>A previous update was completed with the help of a Glaxo sponsored educational support grant from the Australasian Cochrane Centre. The 2006 update was supported by a grant from the UK NHS through the Acute Respiratory Infections Group, based in Australia (at Bond University).</P>
<P>Thanks to Prof Jim Dickinson for helpful suggestions about dividing the studies into early and late last century to examine the idea that the pathogenesis of this illness, and/or its sequelae, have changed with time. Thanks to Ian Thomas and Michael Thomas for research assistance. Thanks to Beth Clewer and Katie Farmer who in January 1999 drew our attention to mistakes in the data extraction by their careful checking of original studies as part of their medical student project at the University of Bristol Medical School. The authors wish to thank the following people for commenting on the 2006 draft of this updated review: Craig Mellis, Mark Jones and Tom Fahey.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-10-25 14:56:46 +1000" MODIFIED_BY="Liz Dooley">
<P>Paul Glasziou is on the board of Therapeutic Guidelines Limited and holds a research grant from the NHMRC on antibiotic resistance.</P>
<P>Chris Del Mar has received funding from the NHMRC for antibiotic resistance, funding the ARI Cochrane Group, and from some consultancies (GSK for advice about vaccines for otitis media; and a local pharmaceutical company contemplating analgesic ear drops for otitis media). </P>
<P>Anneliese Spinks does not have any interests to declare relevant to this review.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-07-11 02:25:31 +1000" MODIFIED_BY="[Empty name]">
<P>Chris Del Mar first conceived the review, presenting it as a meta-analysis in a journal (<LINK REF="REF-Del-Mar-1992a" TYPE="REFERENCE">Del Mar 1992a</LINK>; <LINK REF="REF-Del-Mar-1992b" TYPE="REFERENCE">Del Mar 1992b</LINK>). It was subsequently improved and modified for <I>The Cochrane Library</I> with Paul Glasziou (who improved the subgroup analyses) and Anneliese Spinks (who updated searches and completed the analyses).</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2013-08-21 11:40:54 +1000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-09-11 21:08:16 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-09-11 21:05:12 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-09-11 21:01:41 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bennike-1951" NAME="Bennike 1951" YEAR="1951">
<REFERENCE NOTES="&lt;p&gt;Bennike TBMK, Kjaer E, Skadhauge K, Trolle E. Penicillin therapy in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis. Acta Media Scand. 1951;139:253-274.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bennike TBMK, Kjaer E, Skadhauge K, Trolle E</AU>
<TI>Penicillin therapy in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1951</YR>
<VL>139</VL>
<PG>253-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brink-1951" NAME="Brink 1951" YEAR="1951">
<REFERENCE NOTES="&lt;p&gt;Brink WRR, Denny FW, Wannamaker LW. Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am J Med. 1951;10:300-308.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brink WRR, Denny FW, Wannamaker LW</AU>
<TI>Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis</TI>
<SO>American Journal of Medicine</SO>
<YR>1951</YR>
<VL>10</VL>
<PG>300-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brumfitt-1957" NAME="Brumfitt 1957" YEAR="1957">
<REFERENCE NOTES="&lt;p&gt;Brumfitt WS, Slater DH. Treatment of acute sore throat with penicillin: a controlled trial among young soldiers. Lancet 1957;1:8-11.&lt;br&gt;Brumfitt 1957 &lt;br&gt;Lancet 1957 272(6958):8-11&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brumfitt WS, Slater DH</AU>
<TI>Treatment of acute sore throat with penicillin: a controlled trial among young soldiers</TI>
<SO>Lancet</SO>
<YR>1957</YR>
<VL>272</VL>
<NO>6958</NO>
<PG>8-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Catanzaro-1954" NAME="Catanzaro 1954" YEAR="1954">
<REFERENCE NOTES="&lt;p&gt;Catanzaro 1954 (CHANGE TO TITLE AND ADDED ISSUE NO. AS PER PUBMED CITATION) &lt;br&gt;Catanzaro FJ, Morris AJ, Chamovitz R, Rammelkamp CH, Stolzer B, Perry WD. The role of Streptococcus in the pathogenesis of rheumatic fever. American Journal of Medicine 1954;17(6):749-56 &lt;/p&gt;&lt;p&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Catanzaro FJ, Morris AJ, Chamovitz R, Rammelkamp CH, Stolzer B, Perry WD</AU>
<TI>The role of Streptococcus in the pathogenesis of rheumatic fever</TI>
<SO>American Journal of Medicine</SO>
<YR>1954</YR>
<VL>17</VL>
<NO>6</NO>
<PG>749-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chamovitz-1954" NAME="Chamovitz 1954" YEAR="1954">
<REFERENCE NOTES="&lt;p&gt;Chamovitz R, Stetson CA, Rammelkamp CH. Prevention of rheumatic fever by treatment of previous streptococcal infections. N Engl J Med 1954;251:466-471.&lt;br&gt;Chamovitz 1954 &lt;br&gt;New England Journal of Medicine 1954;251(12):466-71&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chamovitz R, Stetson CA, Rammelkamp CH</AU>
<TI>Prevention of rheumatic fever by treatment of previous streptococcal infections</TI>
<SO>New England Journal of Medicine</SO>
<YR>1954</YR>
<VL>251</VL>
<NO>12</NO>
<PG>466-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chapple-1956" NAME="Chapple 1956" YEAR="1956">
<REFERENCE NOTES="&lt;p&gt;Chapple LM, Paulett JD, Tuckman E, Woodall JT, Tomlinson AJH, McDonald JC. Treatment of acute sore throat in general practice. BMJ. 1956; March: 705-708.&lt;br&gt;Chapple 1956 &lt;br&gt;British Medical Journal 1956 Mar 31;(4969):705-8&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chapple LM, Paulett JD, Tuckman E, Woodall JT, Tomlinson AJH, McDonald JC</AU>
<TI>Treatment of acute sore throat in general practice</TI>
<SO>British Medical Journal</SO>
<YR>1956</YR>
<VL>March</VL>
<NO>4969</NO>
<PG>705-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Dagnelie-1996" NAME="Dagnelie 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Dagnelie CF, van-der-Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin? A randomised double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract. 1996;46(411):589-93.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dagnelie CF, van-der-Graaf Y, De Melker RA</AU>
<TI>Do patients with sore throat benefit from penicillin? A randomised double-blind placebo-controlled clinical trial with penicillin V in general practice</TI>
<SO>British Journal of General Practice</SO>
<YR>1996</YR>
<VL>46</VL>
<NO>411</NO>
<PG>589-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Meyere-1992" NAME="De Meyere 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;De Meyere M, Mervielde Y, Verschraegen G, Bogaert M. Effect of penicillin on the clinical course of streptococcal pharngitis in general practice. Euro J Clin Pharmacol. 1992;43:581-585.&lt;br&gt;De Meyere 1992 &lt;br&gt;European Journal of Clinical Pharmacology 1992;43(6):581-5&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Meyere M, Mervielde Y, Verschraegen G, Bogaert M</AU>
<TI>Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1992</YR>
<VL>43</VL>
<NO>6</NO>
<PG>581-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denny-1950" NAME="Denny 1950" YEAR="1950">
<REFERENCE NOTES="&lt;p&gt;Denny LW, Brink WR, Rammelkamp CH, Custer EA. Prevention of rhuematic fever: treatment of the preceding streptococcal infection. JAMA. 1950;143:151-153.&lt;br&gt;Denny 1950 &lt;br&gt;Journal of the American Medical Association 1950;143(2):151-3.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Denny LW, Brink WR, Rammelkamp CH, Custer EA</AU>
<TI>Prevention of rheumatic fever: treatment of the preceding streptococcal infection</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1950</YR>
<VL>143</VL>
<NO>2</NO>
<PG>151-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denny-1953" MODIFIED="2009-01-07 14:17:18 +1000" MODIFIED_BY="[Empty name]" NAME="Denny 1953" YEAR="1953">
<REFERENCE MODIFIED="2009-01-07 14:17:18 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Denny LW, Hahn EO. Comparative effects of penicillin, aureomycin and terramycin on streptococcal tonsillitis and pharygitis. Pediatr. 1953;11:7- 14.&lt;br&gt;Denny 1953 &lt;br&gt;Pediatrics 1953;11(1):7-14 &lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-01-07 14:17:18 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Denny LW, Hahn EO</AU>
<TI>Comparative effects of penicillin, aureomycin and terramycin on streptococcal tonsillitis and pharyngitis</TI>
<SO>Pediatrics</SO>
<YR>1953</YR>
<VL>11</VL>
<NO>1</NO>
<PG>7-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Daher-1991" NAME="El-Daher 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Daher NT, Hijazi SS, Rawashdeh NM, Al-Khalil IA, Abu-Ektaish FM, Abdel-Latif DI</AU>
<TI>Immediate vs. delayed treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin V</TI>
<SO>Pediatric Infectious Diseases Journal</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>2</NO>
<PG>126-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Howe-1997" NAME="Howe 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Howe RW, Millar MR, Coast J, Whitfield M, Peters TJ, Brookes S. A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat. Br J Gen Practice. 1997;47(418):280-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howe RW, Millar MR, Coast J, Whitfield M, Peters TJ, Brookes S</AU>
<TI>A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat</TI>
<SO>British Journal of General Practice</SO>
<YR>1997</YR>
<VL>47</VL>
<NO>418</NO>
<PG>280-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krober-1985" MODIFIED="2011-07-11 02:33:57 +1000" MODIFIED_BY="[Empty name]" NAME="Krober 1985" YEAR="1985">
<REFERENCE MODIFIED="2011-07-11 02:33:57 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Krober JW, Michels GN. Streptococcal pharyngitis: placebo controlled double blind evaluation of clinical repsonse to penicillin therapy. JAMA. 1985;253:1271-1274.&lt;br&gt;Krober 1985 &lt;br&gt;Journal of the American Medical Association 1985;253(9):1271-4&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:33:57 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krober JW, Michels GN</AU>
<TI>Streptococcal pharyngitis: Placebo controlled double blind evaluation of clinical response to penicillin therapy</TI>
<SO>JAMA</SO>
<YR>1985</YR>
<VL>253</VL>
<NO>9</NO>
<PG>1271-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Landsman-1951" NAME="Landsman 1951" YEAR="1951">
<REFERENCE NOTES="&lt;p&gt;Landsman JB, Grist NR, Black R, McFarlane D, Blair W. Sore throat in general practice. BMJ. 1951;1:326-329.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Landsman JB, Grist NR, Black R, McFarlane D, Blair W</AU>
<TI>Sore throat in general practice</TI>
<SO>British Medical Journal</SO>
<YR>1951</YR>
<VL>1</VL>
<PG>326-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leelarasamee-2000" MODIFIED="2011-05-18 07:56:29 +1000" MODIFIED_BY="Liz Dooley" NAME="Leelarasamee 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-05-18 07:56:29 +1000" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;Leelarasamee 2000 &lt;br&gt;International Journal of Infectious Diseases 2000;4(2):70-4.&lt;/p&gt;" NOTES_MODIFIED="2011-05-18 07:56:29 +1000" NOTES_MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leelarasamee A, Leowattana W, Tobunluepop P, Chub-upakarn S, Artavetakan W, Jarupoonphol V, et al</AU>
<TI>Amoxycillin for fever and sore throat due to non-exudative pharyngotonsillitis: beneficial or harmful?</TI>
<SO>International Journal of Infectious Diseases</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>2</NO>
<PG>70-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Little-1997" MODIFIED="2011-05-25 10:02:32 +1000" MODIFIED_BY="[Empty name]" NAME="Little 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicaliseing efect of prescribing antibiotics. BMJ. 1997;315:350-2. Little 1997 &lt;br&gt;BMJ 1997;315(7104):350-2&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL</AU>
<TI>Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7104</NO>
<PG>350-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-05-25 10:02:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL</AU>
<TI>Open randomised trial of prescribing strategies in managing sore throat</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>314</VL>
<PG>722-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacDonald-1951" NAME="MacDonald 1951" YEAR="1951">
<REFERENCE NOTES="&lt;p&gt;MacDonald TC, Watson IH. Sulphonamides and acute tonsillitis: a controlled experiment in a Royal Airforce community. BMJ. 1951;1:323-326.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacDonald TC, Watson IH</AU>
<TI>Sulphonamides and acute tonsillitis: a controlled experiment in a Royal Airforce community</TI>
<SO>British Medical Journal</SO>
<YR>1951</YR>
<VL>1</VL>
<PG>323-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Middleton-1988" MODIFIED="2011-05-18 07:57:40 +1000" MODIFIED_BY="Liz Dooley" NAME="Middleton 1988" YEAR="1988">
<REFERENCE MODIFIED="2011-05-18 07:57:40 +1000" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;Middleton 1988 &lt;br&gt;The Journal of Pediatrics 1988;113(6):1089-94&lt;/p&gt;" NOTES_MODIFIED="2011-05-18 07:57:40 +1000" NOTES_MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Middleton DB, D'Amico F, Merenstein JH</AU>
<TI>Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis</TI>
<SO>Journal of Pediatrics</SO>
<YR>1988</YR>
<VL>113</VL>
<NO>6</NO>
<PG>1089-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nelson-1984" NAME="Nelson 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Ped Inf Dis. 1984;3:10-13.&lt;br&gt;Nelson 1984 &lt;br&gt;Pediatric Infectious Disease 1984;3(1):10-3&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nelson JD</AU>
<TI>The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1984</YR>
<VL>3</VL>
<NO>1</NO>
<PG>10-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petersen-1997" MODIFIED="2011-07-11 02:34:07 +1000" MODIFIED_BY="[Empty name]" NAME="Petersen 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-07-11 02:34:07 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Peterson K, Phillips RS, Soukup J, Komaroff AL, Aronson M. The effect of Erythromycin on resolution of symptoms among adults with pharyngitis not caused by Group A Atreptococcus. J Gen Intern Med. 1997;12:95-101.&lt;br&gt;Petersen 1997 &lt;br&gt;Journal of General Internal Medicine 1997;12(2):95-101&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:34:07 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson K, Phillips RS, Soukup J, Komaroff AL, Aronson M</AU>
<TI>The effect of erythromycin on resolution of symptoms among adults with pharyngitis not caused by Group A Streptococcus</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>2</NO>
<PG>95-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pichichero-1987" MODIFIED="2013-09-11 21:01:41 +1000" MODIFIED_BY="[Empty name]" NAME="Pichichero 1987" YEAR="1987">
<REFERENCE MODIFIED="2013-09-11 21:01:41 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Pichichero FA, Talpey WB, Green JL, Francis AB, Roghmann KJ, Hoekelman RA. Adverse and beneficial effects of immediate treatment of Group A Beta Haemolytic Streptococcal pharyngitis with penicillin. Ped Inf Dis. 1987;6:635-643.&lt;br&gt;Pichichero 1987 &lt;br&gt;Pediatric Infectious Disease 1987;6(7):635-43&lt;/p&gt;" NOTES_MODIFIED="2013-09-11 21:01:41 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pichichero FA, Talpey WB, Green JL, Francis AB, Roghmann KJ, Hoekelman RA</AU>
<TI>Adverse and beneficial effects of immediate treatment of group A beta haemolytic streptococcal pharyngitis with penicillin</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>7</NO>
<PG>635-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siegel-1961" NAME="Siegel 1961" YEAR="1961">
<REFERENCE NOTES="&lt;p&gt;Siegel EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. N Engl J Med. 1961;265:559- 565.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siegel EE, Stollerman GH</AU>
<TI>Controlled studies of streptococcal pharyngitis in a pediatric population</TI>
<SO>New England Journal of Medicine</SO>
<YR>1961</YR>
<VL>265</VL>
<PG>559-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-1977" MODIFIED="2011-07-11 02:34:17 +1000" MODIFIED_BY="[Empty name]" NAME="Taylor 1977" YEAR="1977">
<REFERENCE MODIFIED="2011-07-11 02:34:17 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Taylor GD, McKerr M, Fergusson DM. Amoxycillin and co- trimoxazole in presumed viral respiratory infections of childhood: placebo controlled trial. BMJ. 1977;2:552-554.&lt;br&gt;Taylor 1977 &lt;br&gt;British Medical Journal 1977;2(6086):552-4&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:34:17 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor B, Abbott GD, McKerr M, Fergusson DM</AU>
<TI>Amoxycillin and co-trimoxazole in presumed viral respiratory infections of childhood: placebo controlled trial</TI>
<SO>British Medical Journal</SO>
<YR>1977</YR>
<VL>2</VL>
<NO>6086</NO>
<PG>552-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wannamaker-1951" NAME="Wannamaker 1951" YEAR="1951">
<REFERENCE NOTES="&lt;p&gt;Wannamaker LW, Rammelkamp CH, Denny FW, Brink WR, Houser HB, Hahn EO. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10: 673-694.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wannamaker LW, Rammelkamp CH, Denny FW, Brink WR, Houser HB, Hahn EO</AU>
<TI>Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin</TI>
<SO>American Journal of Medicine</SO>
<YR>1951</YR>
<VL>10</VL>
<PG>673-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitfield-1981" NAME="Whitfield 1981" YEAR="1981">
<REFERENCE NOTES="&lt;p&gt;Whitfield AO. Penicillin in sore throat. Pract. 1981;225:234-239.&lt;br&gt;Whitfield 1981 &lt;br&gt;Penicillin in sore throat. Practitioner 1981;225(1352):234-9&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitfield MJ, Hughes AO</AU>
<TI>Penicillin in sore throat</TI>
<SO>Practitioner</SO>
<YR>1981</YR>
<VL>225</VL>
<NO>1352</NO>
<PG>234-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Zwart-2000" MODIFIED="2009-01-12 08:49:21 +1000" MODIFIED_BY="[Empty name]" NAME="Zwart 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-01-12 08:49:21 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Zwart 2000 &lt;br&gt;BMJ 2000;320(7228):150-4&lt;/p&gt;" NOTES_MODIFIED="2009-01-12 08:49:21 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zwart S, Sachs AP, Rujis GJ, Gubbels JW, Hoes AW, de Melker RA</AU>
<TI>Penicillin for acute sore throat: randomised double blind trial seven days versus three days treatment or placebo in adults</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>320</VL>
<NO>7228</NO>
<PG>150-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zwart-2003" NAME="Zwart 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;Zwart 2003 &lt;br&gt;BMJ 2003;327(7427):1324-8&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zwart S, Rovers MM, de Melker RA, Hoes AW</AU>
<TI>Penicillin for acute sore throat in children: randomised, double blind trial</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7427</NO>
<PG>1324-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-09-11 21:05:12 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Barwitz-1999" NAME="Barwitz 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barwitz HJK</AU>
<TI>Common cold - trial to rationalize management in general practice by recommendation</TI>
<TO>Erkaltung: eine Handlungsempfehlung</TO>
<SO>Zeitschrift fur Allgemeinmedizin</SO>
<YR>1999</YR>
<VL>75</VL>
<PG>932-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bass-1986" MODIFIED="2011-07-11 02:34:27 +1000" MODIFIED_BY="[Empty name]" NAME="Bass 1986" YEAR="1986">
<REFERENCE MODIFIED="2011-07-11 02:34:27 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Bass J. Treatment of streptococcal pharyngitis revisted. JAMA. 1986;256:740-743.&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:34:27 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bass J</AU>
<TI>Treatment of streptococcal pharyngitis revisited</TI>
<SO>JAMA</SO>
<YR>1986</YR>
<VL>256</VL>
<PG>740-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bishop-1952" NAME="Bishop 1952" YEAR="1952">
<REFERENCE NOTES="&lt;p&gt;Bishop JM, Peden AS, Prankerd TAJ, Cawley RH. Acute sore throat. Clinical features, aetiology and treatment. The Lancet, 1952;1:1183-1187.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bishop JM, Peden AS, Prankerd TAJ, Cawley RH</AU>
<TI>Acute sore throat. Clinical features, aetiology and treatment</TI>
<SO>Lancet</SO>
<YR>1952</YR>
<VL>1</VL>
<PG>1183-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Catanzaro-1958" NAME="Catanzaro 1958" YEAR="1958">
<REFERENCE NOTES="&lt;p&gt;Catanzaro FJ, Chamovitz R. Prevention of rheumatic fever by treatment of streptococcal infections: factors responsible for failures. N Engl J Med. 1958.259:51-57.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Catanzaro FJ, Chamovitz R</AU>
<TI>Prevention of rheumatic fever by treatment of streptococcal infections: factors responsible for failures</TI>
<SO>New England Journal of Medicine</SO>
<YR>1958</YR>
<VL>259</VL>
<PG>51-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cruickshank-1960" NAME="Cruickshank 1960" YEAR="1960">
<REFERENCE NOTES="&lt;p&gt;Cruickshank R. Sore throat: a controlled therapeutic trial in young adults. Controlled Clinical Trials: paper delivered at the conference convened by the Council for International Organisation of Medical Sciences. Oxford Blackwell. 1960:38-44.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Cruickshank R</AU>
<TI>Sore throat: a controlled therapeutic trial in young adults</TI>
<SO>Controlled Clinical Trials: paper delivered at the conference convened by the Council for International Organisation of Medical Sciences</SO>
<YR>1960</YR>
<PG>38-44</PG>
<PB>Blackwell</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dowell-2001" NAME="Dowell 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dowell J, Pitkethly M, Bain J, Martin S</AU>
<TI>A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care</TI>
<SO>British Journal of General Practice</SO>
<YR>2001</YR>
<VL>51</VL>
<PG>200-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerber-1985" NAME="Gerber 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerber MA, Spadaccini LJ, Wright LL, Deutsch L, Kaplan EL</AU>
<TI>Twice-daily penicillin in the treatment of streptococcal pharyngitis</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1985</YR>
<VL>139</VL>
<PG>1145-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerber-1989" NAME="Gerber 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Gerber MA, Randolph MF. Failure of once-daily penicillin v therapy for streptococcal pharyngitis. Am J Dis Child. 1989;143:153-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerber MA, Randolph MF</AU>
<TI>Failure of once-daily penicillin V therapy for streptococcal pharyngitis</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1989</YR>
<VL>143</VL>
<PG>153-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ginsburg-1980" MODIFIED="2009-01-12 08:49:44 +1000" MODIFIED_BY="[Empty name]" NAME="Ginsburg 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-01-12 08:49:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ginsburg CM, McCracken GH, Crow SD, Steinberg JB, Cope F</AU>
<TI>A controlled comparative study of penicillin V and cefadroxil therapy on Group A streptococcal tonsillopharyngitis</TI>
<SO>Journal of International Medical Research</SO>
<YR>1980</YR>
<VL>8</VL>
<NO>Suppl 1</NO>
<PG>82-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guthrie-1988" MODIFIED="2011-07-11 02:34:39 +1000" MODIFIED_BY="[Empty name]" NAME="Guthrie 1988" YEAR="1988">
<REFERENCE MODIFIED="2011-07-11 02:34:39 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Guthrie RR, Rofman BA. Aetiology of acute pharyngitis and clinical response to empirical therapy with erythromycin versus amoxicillin. Fam Pract. 1988;5:29-35.&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:34:39 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guthrie RM, Ruoff GE, Rofman BA, Ginsberg D, Karp RR, Brown SM, et al</AU>
<TI>Aetiology of acute pharyngitis and clinical response to empirical therapy with erythromycin versus amoxicillin</TI>
<SO>Family Practice</SO>
<YR>1988</YR>
<VL>5</VL>
<PG>29-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haverkorn-1971" NAME="Haverkorn 1971" YEAR="1971">
<REFERENCE NOTES="&lt;p&gt;Haverkorn MV, Goslings WRO. Streptococcal pharyngitis in the general population. A controlled study of streptococcal pharyngitis and its complications in the Netherlands. J Infect Dis. 1971;124:339-347.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haverkorn MV, Goslings WRO</AU>
<TI>Streptococcal pharyngitis in the general population. A controlled study of streptococcal pharyngitis and its complications in the Netherlands</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1971</YR>
<VL>124</VL>
<PG>339-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herz-1988" NAME="Herz 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Herz MJ. Antibiotics and the adult sore throat - an unnecessary ceremony. Family Pract. 1988;5:196-199.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herz MJ</AU>
<TI>Antibiotics and the adult sore throat - an unnecessary ceremony</TI>
<SO>Family Practice</SO>
<YR>1988</YR>
<VL>5</VL>
<PG>196-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Howie-1970" NAME="Howie 1970" YEAR="1970">
<REFERENCE NOTES="&lt;p&gt;Howie JGR, Clark GA. Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice The Lancet. 1970; Nov 28:1099-1102.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howie JGR, Clark GA</AU>
<TI>Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice</TI>
<SO>Lancet</SO>
<YR>1970</YR>
<VL>Nov 28</VL>
<PG>1099-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-1991" NAME="Jensen 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jensen JH, Larsen SB</AU>
<TI>Treatment of recurrent acute tonsillitis with clindamycin. An alternative to tonsillectomy?</TI>
<SO>Clinical Otolaryngology</SO>
<YR>1991</YR>
<VL>16</VL>
<PG>498-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kapur-2011" MODIFIED="2013-08-08 11:14:14 +1000" MODIFIED_BY="[Empty name]" NAME="Kapur 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-08-08 11:14:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kapur A, Hannay D, Baxter G, Mitra A</AU>
<TI>A randomized prospective study to evaluate the natural history of acute upper respiratory infections in children and provide guidance for health professionals</TI>
<SO>American Journal of Respiratory and Clinical Care Medicine</SO>
<YR>2011</YR>
<VL>183</VL>
<PG>A4934</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kolobukhina-2011" MODIFIED="2013-09-11 21:03:30 +1000" MODIFIED_BY="[Empty name]" NAME="Kolobukhina 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-09-11 21:03:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kolobukhina LV, Merkulova LN, Schelkanov MY, Isaeva EI, Kruzhkova IS, Malikov VE, et al</AU>
<TI>The efficacy of Ingavirin in the combined treatment of ARVI complicated by tonsillitis</TI>
<SO>Vestnik Otorinolaringologii</SO>
<YR>2011</YR>
<VL>6</VL>
<PG>91-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marlow-1989" NAME="Marlow 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Marlow RA, Torrez AJ, Haxby D. The treatment of non streptococcal pharyngitis with erythromycin: a preliminary study. Fam-Med. 1989;21:425-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marlow RA, Torrez AJ, Haxby D</AU>
<TI>The treatment of non streptococcal pharyngitis with erythromycin: a preliminary study</TI>
<SO>Family Medicine</SO>
<YR>1989</YR>
<VL>21</VL>
<PG>425-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massell-1951" NAME="Massell 1951" YEAR="1951">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massell BF, Sturgis GP, Knobloch JD, Streeper RB, Hall TN, Norcross P</AU>
<TI>Prevention of rheumatic fever by prompt penicillin therapy of hemolytic streptococcic respiratory infections</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1951</YR>
<VL>146</VL>
<NO>16</NO>
<PG>1469-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McDonald-1985" NAME="McDonald 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;McDonald CJ, Tierny WM, Hui SL, French MLV, Leland DS, Jones RB. A controlled trial of erythromicin in adults with nonstreptococcal pharyngitis. J Infec Dis. 1985;152:1093-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDonald CJ, Tierny WM, Hui SL, French MLV, Leland DS, Jones RB</AU>
<TI>A controlled trial of erythromycin in adults with nonstreptococcal pharyngitis</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1985</YR>
<VL>152</VL>
<PG>1093-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Merenstein-1974" MODIFIED="2011-07-11 02:35:16 +1000" MODIFIED_BY="[Empty name]" NAME="Merenstein 1974" YEAR="1974">
<REFERENCE MODIFIED="2011-07-11 02:35:16 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Merenstein JH, Rogers KD. Streptococcal pharyngitis. JAMA. 1974;227:1278-1282.&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:35:16 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Merenstein JH, Rogers KD</AU>
<TI>Early treatment and management by nurse practitioners</TI>
<SO>JAMA</SO>
<YR>1974</YR>
<VL>227</VL>
<PG>1278-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morris-1956" NAME="Morris 1956" YEAR="1956">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morris AJ, Chamovitz R, Catanzaro FJ, Rammelkamp CH</AU>
<TI>Prevention of rheumatic fever by treatment of previous streptococcic infections; effect of sulfadiazine</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1956</YR>
<VL>160</VL>
<NO>2</NO>
<PG>114-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nasonova-1999" MODIFIED="2011-07-11 02:36:25 +1000" MODIFIED_BY="[Empty name]" NAME="Nasonova 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-07-11 02:36:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nasonova VA, Belov BS, Strachunsky LS, Sudilovskaya EI, Bogdanovich TM, Krechikova OI, et al</AU>
<TI>Antibacterial therapy of Streptococcus tonsillitis (quinsy and pharyngitis)</TI>
<SO>Antibiotiki i Khimioterapiia</SO>
<YR>1999</YR>
<VL>44</VL>
<PG>19-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pandraud-2002" NAME="Pandraud 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pandraud L</AU>
<TI>Therapeutic efficacy and clinical acceptability of fusafungine in follicular pharyngitis</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2002</YR>
<VL>18</VL>
<PG>381-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Randolph-1985" MODIFIED="2013-09-11 21:04:25 +1000" MODIFIED_BY="Liz Dooley" NAME="Randolph 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-09-11 21:04:25 +1000" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;Randolph MFGMA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. Pediatr. 1985;106:870- 875.&lt;/p&gt;" NOTES_MODIFIED="2013-09-11 21:04:25 +1000" NOTES_MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Randolph MF, Gerber MA, DeMeo KK, Wright L</AU>
<TI>Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis</TI>
<SO>Journal of Pediatrics</SO>
<YR>1985</YR>
<VL>106</VL>
<PG>870-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schalen-1985" NAME="Schalen 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;Schalen L, Christenses P, Elisson I, Fex S, Kamme S, Schalen C. Inefficacy of penicillin V in acute laryngitis in adults evaluation from results of double-blind study. Ann otol Rhinol Laryngol. 1985;94:14-17.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schalen L, Christenses P, Elisson I, Fex S, Kamme S, Schalen C</AU>
<TI>Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double-blind study</TI>
<SO>Annals of Otology Rhinology and Laryngology</SO>
<YR>1985</YR>
<VL>94</VL>
<PG>14-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schalen-1993" NAME="Schalen 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Schalen L, Eliasson I, Kamme C, Schalen C. Erythromicin in acute laryngitis in adults. Ann Otol Rhinol Laryngol. 1993;102:209-214.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schalen L, Eliasson I, Kamme C, Schalen C</AU>
<TI>Erythromycin in acute laryngitis in adults</TI>
<SO>Annals of Otology Rhinology and Laryngology</SO>
<YR>1993</YR>
<VL>102</VL>
<PG>209-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-1981" MODIFIED="2011-07-11 02:36:39 +1000" MODIFIED_BY="[Empty name]" NAME="Schwartz 1981" YEAR="1981">
<REFERENCE MODIFIED="2011-07-11 02:36:39 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Schwartz R, Wientzen RL, Pedeira F. Penicillin V for Group A Streptococcal pharyngotonsillitis. A randomised trial of seven vs ten days therapy. JAMA . 1981;246:1790-1795.&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:36:39 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz R, Wientzen RL, Pedeira F</AU>
<TI>Penicillin V for Group A Streptococcal pharyngotonsillitis. A randomised trial of seven vs ten days therapy</TI>
<SO>JAMA</SO>
<YR>1981</YR>
<VL>246</VL>
<PG>1790-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shevrygin-2000" NAME="Shevrygin 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shevrygin BV, Manuilov BM</AU>
<TI>Therapeutic efficacy of new drug Pharingal at acute inflammatory diseases of pharynx and tonsils in pediatrics</TI>
<TO>Terapevticheskaia effektivnost' novogo perparata Faringal pri ostrykh vospalitel'nykh zabolevaniiakh glotki i mindalin u detei</TO>
<SO>Antibiotiki i Khimioterapiia</SO>
<YR>2000</YR>
<VL>45</VL>
<PG>34-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shvartzman-1993" NAME="Shvartzman 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Shvartzman PH, Tabenkin. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ. 1993;306:1170-1172.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F</AU>
<TI>Treatment of streptococcal pharyngitis with amoxycillin once a day</TI>
<SO>BMJ</SO>
<YR>1993</YR>
<VL>306</VL>
<PG>1170-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stillerman-1986" NAME="Stillerman 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stillerman M</AU>
<TI>Comparison of oral cephalosporins with penicillin for Group A streptococcal pharyngitis</TI>
<SO>Pediatric Infectious Diseases Journal</SO>
<YR>1986</YR>
<VL>5</VL>
<PG>648-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stromberg-1988" MODIFIED="2013-09-11 21:05:12 +1000" MODIFIED_BY="[Empty name]" NAME="Stromberg 1988" YEAR="1988">
<REFERENCE MODIFIED="2013-09-11 21:05:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stromberg A, Schwan A, Cars O</AU>
<TI>Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomised controlled clinical trial with phenoxymethylpenicillin and cefadroxil</TI>
<SO>Scandinavian Journal of Infectious Disease</SO>
<YR>1988</YR>
<VL>20</VL>
<PG>36-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Supajatura-2012" MODIFIED="2013-08-08 11:21:41 +1000" MODIFIED_BY="[Empty name]" NAME="Supajatura 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-08-08 11:21:19 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Supajatura V, Pongbaibul Y, Tharavichitkul P</AU>
<TI>Mangosteen spray for efficacious treatment of streptococcal pharyngitis</TI>
<SO>International Journal of Infectious Diseases</SO>
<YR>2012</YR>
<VL>16S</VL>
<PG>e441</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Todd-1984" NAME="Todd 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Todd JK, Todd N, Damato J, Todd WA. Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation. Ped Infec Dis. 1984;3:226-231.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Todd JK, Todd N, Damato J, Todd WA</AU>
<TI>Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation</TI>
<SO>Pediatric Infectious Disease</SO>
<YR>1984</YR>
<VL>3</VL>
<PG>226-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valkenburg-1971" NAME="Valkenburg 1971" YEAR="1971">
<REFERENCE NOTES="&lt;p&gt;Valkenburg HHMJ, Goslings WRO. Streptococcal pharyngitis in the general population. The attack rate if not treated with penicillin. J Infect Dis. 1971;124:783-786.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valkenburg HHMJ, Goslings WRO</AU>
<TI>Streptococcal pharyngitis in the general population. The attack rate if not treated with penicillin</TI>
<SO>Journal of Infectious Diseases</SO>
<YR>1971</YR>
<VL>124</VL>
<PG>783-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-09-11 21:08:16 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-09-11 21:08:16 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-ABS-1985" MODIFIED="2011-07-11 02:42:55 +1000" MODIFIED_BY="[Empty name]" NAME="ABS 1985" NOTES="&lt;p&gt;Australian Bureau of Statistics. Australian Helath Survey .Canberra: AGPS: 11-52 (Cat No 4311.0) 1985.&lt;/p&gt;" NOTES_MODIFIED="2011-07-11 02:42:55 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Australian Bureau of Statistics</AU>
<TI>Australian Health Survey</TI>
<SO>Canberra: AGPS: (Cat No 4311.0)</SO>
<YR>1985</YR>
<PG>11-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-1992a" NAME="Del Mar 1992a" NOTES="&lt;p&gt;Del Mar C. Managing sore throat: a literature review. I. Making the diagnosis. Med J Aust . 1992;156: 572-575.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Del Mar C</AU>
<TI>Managing sore throat: a literature review. I. Making the diagnosis</TI>
<SO>Medical Journal of Australia</SO>
<YR>1992</YR>
<VL>156</VL>
<PG>572-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-1992b" NAME="Del Mar 1992b" NOTES="&lt;p&gt;Del Mar C. Managing sore throats: a literature review. II. Do antibiotics confer benefit? Med J Aust. 1992; 156: 644-649.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Del Mar C</AU>
<TI>Managing sore throats: a literature review. II. Do antibiotics confer benefit?</TI>
<SO>Medical Journal of Australia</SO>
<YR>1992</YR>
<VL>156</VL>
<PG>644-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-1992c" NAME="Del Mar 1992c" NOTES="&lt;p&gt;Del Mar C. Spontaneously remitting disease, principles of management. Med J Aust. 1992;157:101-107.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Del Mar C</AU>
<TI>Spontaneously remitting disease, principles of management</TI>
<SO>Medical Journal of Australia</SO>
<YR>1992</YR>
<VL>157</VL>
<PG>101-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Froom-1990" MODIFIED="2011-07-11 02:34:56 +1000" MODIFIED_BY="[Empty name]" NAME="Froom 1990" TYPE="JOURNAL_ARTICLE">
<AU>Froom J, Culpepper L, Grob P, Bartelds A, Bowers P, Bridges-Webb C, et al</AU>
<TI>Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network</TI>
<SO>BMJ</SO>
<YR>1990</YR>
<VL>300</VL>
<PG>582-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goslings-1963" MODIFIED="2009-05-06 09:59:53 +1000" MODIFIED_BY="Liz Dooley" NAME="Goslings 1963" NOTES="&lt;p&gt;Goslings WRO, Valkenberg HA, Bots AW, Lorrier JC. Attack rates of streptococcal pharyngitis, rheumatic fever and glomerulnephritis in the general population. A controlled pilot study of controlled streptococcal pharyngitis in one village. N Engl J Med. 1963;268: 687-694.&lt;/p&gt;" NOTES_MODIFIED="2009-05-06 09:59:53 +1000" NOTES_MODIFIED_BY="Liz Dooley" TYPE="JOURNAL_ARTICLE">
<AU>Goslings WRO, Valkenberg HA, Bots AW, Lorrier JC</AU>
<TI>Attack rates of streptococcal pharyngitis, rheumatic fever and glomerulonephritis in the general population. A controlled pilot study of controlled streptococcal pharyngitis in one village</TI>
<SO>New England Journal of Medicine</SO>
<YR>1963</YR>
<VL>268</VL>
<PG>687-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-09-11 21:06:55 +1000" MODIFIED_BY="Liz Dooley" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horder-1954" NAME="Horder 1954" NOTES="&lt;p&gt;Horder J, Horder E. Illness in general pracice. Pract. 1954;173: 177-187.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Horder J, Horder E</AU>
<TI>Illness in general practice</TI>
<SO>Practitioner</SO>
<YR>1954</YR>
<VL>173</VL>
<PG>177-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howie-1971" NAME="Howie 1971" NOTES="&lt;p&gt;Howie JGR, Gill G, Durno D. Respiratory illness and antibiotic use in general practice. J Roy Coll Gen Pract. 1971;21: 657-661.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Howie JGR, Gill G, Durno D</AU>
<TI>Respiratory illness and antibiotic use in general practice</TI>
<SO>Journal of the Royal College of General Practitioners</SO>
<YR>1971</YR>
<VL>21</VL>
<PG>657-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howie-1978" NAME="Howie 1978" NOTES="&lt;p&gt;Howie JGR. Antibiotics and respiratory illness in general practice: prescribing policy and workload. BMJ. 1978;2:1342-1346.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Howie JGR</AU>
<TI>Antibiotics and respiratory illness in general practice: prescribing policy and workload</TI>
<SO>British Medical Journal</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>1342-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howie-1985" NAME="Howie 1985" NOTES="&lt;p&gt;Howie JGR, Froggo B. Antibiotics, sore throats and rheumatic fever. J R Coll Gen Pract. 1985; 35:223-224.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Howie JGR, Foggo B</AU>
<TI>Antibiotics, sore throats and rheumatic fever</TI>
<SO>Journal of the Royal College of General Practitioners</SO>
<YR>1985</YR>
<VL>35</VL>
<PG>223-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keith-2010" MODIFIED="2011-05-24 09:25:49 +1000" MODIFIED_BY="[Empty name]" NAME="Keith 2010" TYPE="JOURNAL_ARTICLE">
<AU>Keith T, Saxena S, Murray J, Sharland M</AU>
<TI>Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know?</TI>
<SO>Current Opinion in Infectious Disease</SO>
<YR>2010</YR>
<VL>23</VL>
<PG>242-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2013-09-11 21:08:16 +1000" MODIFIED_BY="Liz Dooley" NAME="Lefebvre 2011" TYPE="BOOK_SECTION">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<ED>Higgins JPT, Green S</ED>
<PB>Wiley-Blackwell</PB>
<CY>Chichester</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reveiz-2013" MODIFIED="2013-08-21 10:29:56 +1000" MODIFIED_BY="Liz Dooley" NAME="Reveiz 2013" TYPE="COCHRANE_REVIEW">
<AU>Reveiz L, Cardona AF</AU>
<TI>Antibiotics for acute laryngitis in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-08-21 10:29:56 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-08-21 10:29:56 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD004783.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-van-Driel-2013" MODIFIED="2013-08-29 14:34:45 +1000" MODIFIED_BY="Liz Dooley" NAME="van Driel 2013" TYPE="COCHRANE_REVIEW">
<AU>van Driel ML, De Sutter AI, Keber N, Habraken H, Christiaens T</AU>
<TI>Different antibiotic treatments for group A streptococcal pharyngitis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-08-29 14:34:45 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-08-29 14:34:45 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD004406.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Venekamp-2013" MODIFIED="2013-08-21 10:31:52 +1000" MODIFIED_BY="Liz Dooley" NAME="Venekamp 2013" NOTES="&lt;p&gt;Glasziou P, Hayman M, Del Mar C. Antibiotics versus placebo for acute otitis media in children (Cochrane Review). In: The Cochrane Library, Issue 1, 1997. Oxford: Update Software.&lt;/p&gt;" NOTES_MODIFIED="2013-08-21 10:31:52 +1000" NOTES_MODIFIED_BY="Liz Dooley" TYPE="COCHRANE_REVIEW">
<AU>Venekamp RP, Sanders S, Glasziou PP, Del Mar CB, Rovers MM</AU>
<TI>Antibiotics for acute otitis media in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-08-21 10:31:52 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-08-21 10:31:52 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000219.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wessels-2011" MODIFIED="2011-07-11 02:37:05 +1000" MODIFIED_BY="[Empty name]" NAME="Wessels 2011" TYPE="JOURNAL_ARTICLE">
<AU>Wessels MR</AU>
<TI>Streptococcal pharyngitis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2011</YR>
<VL>364</VL>
<PG>648-55</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-08-21 10:34:00 +1000" MODIFIED_BY="Liz Dooley">
<REFERENCE ID="REF-Del-Mar-1997" MODIFIED="2009-01-28 08:22:51 +1000" MODIFIED_BY="Liz Dooley" NAME="Del Mar 1997" TYPE="COCHRANE_REVIEW">
<AU>Del Mar CB, Glasziou PP, Hayem M</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1997</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2009-01-28 08:22:51 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2009-01-28 08:22:51 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-2000" MODIFIED="2011-05-18 08:06:07 +1000" MODIFIED_BY="Liz Dooley" NAME="Del Mar 2000" TYPE="COCHRANE_REVIEW">
<AU>Del Mar CB, Glasziou PP, Spinks AB</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-01-28 08:23:20 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2009-01-28 08:23:20 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-2004" MODIFIED="2011-05-18 08:06:18 +1000" MODIFIED_BY="Liz Dooley" NAME="Del Mar 2004" TYPE="COCHRANE_REVIEW">
<AU>Del Mar CB, Glasziou PP, Spinks AB</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2009-01-28 08:23:29 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2009-01-28 08:23:29 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Del-Mar-2006" MODIFIED="2011-05-18 08:06:34 +1000" MODIFIED_BY="Liz Dooley" NAME="Del Mar 2006" TYPE="COCHRANE_REVIEW">
<AU>Del Mar CB, Glasziou PP, Spinks AB</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-01-28 08:23:36 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2009-01-28 08:23:36 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Spinks-2009" MODIFIED="2011-05-18 08:07:32 +1000" MODIFIED_BY="Liz Dooley" NAME="Spinks 2009" TYPE="COCHRANE_REVIEW">
<AU>Spinks AB, Glasziou PP, Del Mar CB</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Spinks-2011" MODIFIED="2013-08-21 10:34:00 +1000" MODIFIED_BY="Liz Dooley" NAME="Spinks 2011" TYPE="COCHRANE_REVIEW">
<AU>Spinks AB, Glasziou PP, Del Mar CB</AU>
<TI>Antibiotics for sore throat</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2013-08-21 10:33:57 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2013-08-21 10:33:57 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD000023.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-10-25 10:46:38 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-10-25 10:46:38 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-05-18 08:49:05 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Bennike-1951">
<CHAR_METHODS MODIFIED="2009-01-28 09:50:17 +1000" MODIFIED_BY="Liz Dooley">
<P>Open study, quasi-randomised</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 08:48:33 +1000" MODIFIED_BY="Liz Dooley">
<P>669 patients aged from less than 1 year to older than 50 years of age. Research was divided into 3 studies: ordinary tonsillitis, "phlegmonous" tonsillitis and "ulcerative" tonsillitis. Participants were excluded if they had a complication of tonsillitis on admission or if they had previous antibiotic treatment for the present sore throat</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 08:48:52 +1000" MODIFIED_BY="Liz Dooley">
<P>Age-adjusted intramuscular penicillin twice daily for 6 days or no treatment as a control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever, otitis media, quinsy, sinusitis and symptoms of sore throat and headache</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 08:49:05 +1000" MODIFIED_BY="Liz Dooley">
<P>No antipyretics were administered to the control group. The use of antipyretics to participants in the treatment group was unstated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Brink-1951">
<CHAR_METHODS MODIFIED="2009-01-07 12:34:56 +1000" MODIFIED_BY="[Empty name]">
<P>Open study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:30:34 +1000" MODIFIED_BY="Liz Dooley">
<P>395 young adult males recruited into United States Air Force</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Intramuscular penicillin over 4 days, chlortetracycline for 3 days or no treatment as control group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 08:49:44 +1000" MODIFIED_BY="Liz Dooley">
<P>Incidence of rheumatic fever, otitis media and symptoms of sore throat, fever and headache</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No antipyretics were administered</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:31:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brumfitt-1957">
<CHAR_METHODS MODIFIED="2009-01-07 12:35:41 +1000" MODIFIED_BY="[Empty name]">
<P>Open study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:23:24 +1000" MODIFIED_BY="Liz Dooley">
<P>121 young adult men, aged 18 to 21 years, recruited into United States Air Force. Participants were excluded from study if their temperature was below 99.3 degrees F, if they had sore throat for more than 72 hours prior to presentation, or if they had some other generalised illness</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:31:02 +1000" MODIFIED_BY="[Empty name]">
<P>Intramuscular penicillin twice-daily for 4 days or no treatment as a control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever and symptoms of sore throat and fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:31:04 +1000" MODIFIED_BY="[Empty name]">
<P>Aspirin gargles were given 6-hourly. Whether participants were permitted to swallow the aspirin was not documented<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Catanzaro-1954">
<CHAR_METHODS MODIFIED="2011-05-18 08:51:33 +1000" MODIFIED_BY="Liz Dooley">
<P>Single-blind, participants were unaware of treatment type, placebo-controlled trial. The outcome of treatment was not determined blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:23:33 +1000" MODIFIED_BY="Liz Dooley">
<P>640 young adult males recruited into United States Air Force. Missing data were not explained<BR/>Data from participants who produced a GABHS-negative throat swab were excluded. Participants were excluded if they presented with a suppurative complication at the time of admission</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Intramuscular penicillin administered for 5 days, sulphonamide administered for 5 days or no treatment as a control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chamovitz-1954">
<CHAR_METHODS MODIFIED="2011-05-18 08:52:13 +1000" MODIFIED_BY="Liz Dooley">
<P>Single-blind placebo study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>366 young adult males recruited into United States Air Force. Participants were excluded if they had previously developed rheumatic fever, had previous penicillin reaction or if they had a suppurative complication at the time of admission</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intramuscular penicillin</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-11 02:26:01 +1000" MODIFIED_BY="[Empty name]">
<P>Incidence of rheumatic fever, otitis media and sinusitis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:26:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chapple-1956">
<CHAR_METHODS MODIFIED="2011-07-11 02:26:09 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 08:53:22 +1000" MODIFIED_BY="Liz Dooley">
<P>308 participants older than 2 years. Data from 283 participants included in analyses</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:26:15 +1000" MODIFIED_BY="[Empty name]">
<P>Age-adjusted oral penicillin, sulphadimidine or barium sulphate (placebo) administered for 5 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 08:53:34 +1000" MODIFIED_BY="Liz Dooley">
<P>Incidence of rheumatic fever, otitis media and symptom of sore throat</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:13:26 +1000" MODIFIED_BY="[Empty name]">
<P>All groups received controlled doses of antipyretics twice daily for 3 days<BR/>Data from only 200 participants presenting with sore throat on day 1 included in sore throat analysis<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:26:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dagnelie-1996">
<CHAR_METHODS MODIFIED="2011-05-18 08:54:07 +1000" MODIFIED_BY="Liz Dooley">
<P>Randomised, double-blind, placebo-controlled trial of penicillin V on the course and bacteriological response in patients with sore throat in general practice</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 08:54:21 +1000" MODIFIED_BY="Liz Dooley">
<P>239 patients aged 4 to 60, presenting with sore throat to 37 General Practices in the Netherlands, who were clinically suspected of GABHS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:26:26 +1000" MODIFIED_BY="[Empty name]">
<P>Treatment with either penicillin V or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-11 02:26:31 +1000" MODIFIED_BY="[Empty name]">
<P>Resolution of sore throat, fever and return to daily activities (assessed by doctor and by diary for 7 days)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:13:27 +1000" MODIFIED_BY="[Empty name]">
<P>* Need raw data to make this study comparable to the meta-analysis, however data are available for sore throat on day 3 and quinsy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Meyere-1992">
<CHAR_METHODS MODIFIED="2011-07-11 02:26:40 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-09-11 20:47:19 +1000" MODIFIED_BY="[Empty name]">
<P>173 participants aged 5 to 50 years, from the Gent region of Belgium<BR/>Data were obtained from 173 participants on days 1 and 3<BR/>Data were obtained from 131 participants on days 2, 4, 5, 6 and 7<BR/>Participants excluded if they: produced a GABHS-negative throat swab, had a sore throat for greater than 5 days, had a previous history of acute rheumatic fever, had an allergy to beta-lactam antibiotics, had received any antibiotics within the past 14 days, were in any high-risk situation as determined by the physician</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 08:56:32 +1000" MODIFIED_BY="Liz Dooley">
<P>Oral penicillin or oral placebo 3 times a day</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Symptom of sore throat<BR/>All data obtained, except from days 1 and 3, were self reported from a diary</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:26:51 +1000" MODIFIED_BY="[Empty name]">
<P>Antipyretics were used as required by participants. Use of antipyretics and other symptom-relieving methods was documented in a diary<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Denny-1950">
<CHAR_METHODS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Single-blind study. The outcome was determined blind on follow-up by physicians who did not know what treatment type each participant had received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:30:35 +1000" MODIFIED_BY="Liz Dooley">
<P>1602 young adult males recruited into United States Air Force</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 08:57:12 +1000" MODIFIED_BY="Liz Dooley">
<P>Intramuscular penicillin for 4 days or no treatment as a control group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever only</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:27:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Denny-1953">
<CHAR_METHODS MODIFIED="2011-07-11 02:27:05 +1000" MODIFIED_BY="[Empty name]">
<P>Single-blind, randomised, placebo-controlled trial. Outcome determined blind by physicians who did not know treatment type</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:30:35 +1000" MODIFIED_BY="Liz Dooley">
<P>103 young adult males recruited in the United States Air Force. Participants were excluded if they had no exudate on their tonsils or larynx, if they had a leukocyte count of less than 10,000; or if they had experienced symptoms of sore throat for more than 31 hours</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 08:57:56 +1000" MODIFIED_BY="Liz Dooley">
<P>Intramuscular penicillin daily for 5 days, oral aureomycin or oral terramycin administered every 6 hours for 3 days or oral lactose placebo for 3 days as a control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-11 02:27:19 +1000" MODIFIED_BY="[Empty name]">
<P>Incidence of acute rheumatic fever, otitis media, quinsy, sinusitis and symptoms of sore throat and headache</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No antipyretics were administered<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:13:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Daher-1991">
<CHAR_METHODS MODIFIED="2011-06-02 11:30:51 +1000" MODIFIED_BY="Liz Dooley">
<P>Double-blinded, randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>229 children with positive culture for GABHS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Early treatment with oral penicillin for 10 days versus oral placebo for 2 days followed by oral penicillin for 8 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptoms of sore throat and headache on day 3</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:13:29 +1000" MODIFIED_BY="[Empty name]">
<P>Examination of participants was done on day 3 before administering penicillin to placebo group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:27:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Howe-1997">
<CHAR_METHODS>
<P>22 GPs in one region of the UK recruited</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-11 02:27:33 +1000" MODIFIED_BY="[Empty name]">
<P>154 patients aged 16 to 60 years presenting to their GP with sore throat and for whom the GP would normally prescribe an antibiotic</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:27:37 +1000" MODIFIED_BY="[Empty name]">
<P>Therapy with either penicillin V (250 mg 4 times a day), cefixime (200 mg daily) or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Resolution of a composite "symptom score" with time; eradication of GABHS. A diary was kept of symptom resolution over 7 days</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-01-07 13:25:19 +1000" MODIFIED_BY="[Empty name]">
<P>*Symptom results were bundled into a composite "symptom score". The raw data on sore throat, cough and fever resolution has been requested from the authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:27:50 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krober-1985">
<CHAR_METHODS MODIFIED="2011-05-18 08:59:23 +1000" MODIFIED_BY="Liz Dooley">
<P>Double-blind placebo trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-11 02:27:50 +1000" MODIFIED_BY="[Empty name]">
<P>44 children presenting to a paediatric clinic. 26 of these participants yielded GABHS-positive throat swabs<BR/>Participants were excluded if: the duration of symptoms was greater than 72 hours; they had received oral antibiotics within the past 72 hours or intramuscular antibiotics within the past 30 days; they had history of penicillin allergy; they had a rash suggestive of scarlet fever; they had a concurrent infection that required antibiotics other than penicillin; or if they had severe illness requiring immediate penicillin treatment<BR/>Participants who produced GABHS-negative throat swabs were excluded from the study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 09:00:29 +1000" MODIFIED_BY="Liz Dooley">
<P>Oral penicillin or similar looking and tasting oral placebo for the control condition, 3 times a day for 3 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptom of fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:27:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Landsman-1951">
<CHAR_METHODS MODIFIED="2011-07-11 02:27:57 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:00:51 +1000" MODIFIED_BY="Liz Dooley">
<P>95 participants who presented to general practice complaining of sore throat<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Oral sulphonamide or similar looking and tasting oral placebo, for the control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of sinusitis or quinsy or symptoms of sore throat or fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:28:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leelarasamee-2000">
<CHAR_METHODS MODIFIED="2011-07-11 02:28:06 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:01:18 +1000" MODIFIED_BY="Liz Dooley">
<P>1217 patients aged over 5 years presenting to 4 community-based medical centres with complaints of fever or sore throat of less than 10 days duration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-02 11:30:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants were randomised to receive either amoxycillin or placebo for 7 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 09:01:40 +1000" MODIFIED_BY="Liz Dooley">
<P>Duration of sore throat and fever. Incidence of complications and adverse reactions</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretics were given if deemed necessary by physicians</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:28:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Little-1997">
<CHAR_METHODS MODIFIED="2011-06-02 11:30:56 +1000" MODIFIED_BY="Liz Dooley">
<P>Unblinded randomised trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-11 02:28:16 +1000" MODIFIED_BY="[Empty name]">
<P>716 patients aged 4 years and over, presenting to their GP with a sore throat, with an abnormal physical finding localised to the throat (e.g. inflamed tonsils or pharynx, etc.)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-02 11:30:57 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants were randomised to 3 groups. Participants in the first group were given an antibiotic for 10 days; those in the second group were given no prescription; and in the third group were given an offer of antibiotic prescription if the symptoms were not starting to settle after 3 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 09:02:36 +1000" MODIFIED_BY="Liz Dooley">
<P>Main outcomes - duration of symptoms, satisfaction and compliance with and perceived efficacy of antibiotics, time off school or work. Participants given a daily diary in which to record symptoms and temperature. Participants who did not return diaries were followed up over the phone</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:28:20 +1000" MODIFIED_BY="[Empty name]">
<P>Participants randomised, but neither participants nor doctors blinded to the therapy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-18 10:26:28 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-MacDonald-1951">
<CHAR_METHODS MODIFIED="2011-05-18 09:02:55 +1000" MODIFIED_BY="Liz Dooley">
<P>Outcome determined blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:26:28 +1000" MODIFIED_BY="Liz Dooley">
<P>82 young adult males recruited into the United States Air Force<BR/>41 in treatment group; 41 in control group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 09:03:03 +1000" MODIFIED_BY="Liz Dooley">
<P>Oral sulphatriad or identical oral lactose placebo, administered to the control condition, taken every 4 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptom of sore throat</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 09:03:15 +1000" MODIFIED_BY="Liz Dooley">
<P>Antipyretics were administered to 1 participant in the treatment group and 2 participants in the control group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:13:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Middleton-1988">
<CHAR_METHODS MODIFIED="2011-06-02 11:31:01 +1000" MODIFIED_BY="Liz Dooley">
<P>Multicentre, double-blind, randomised, placebo-controlled</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:03:58 +1000" MODIFIED_BY="Liz Dooley">
<P>178 participants aged 4 to 29 years with streptococcal pharyngitis. Participants had symptom duration of less than 4 days. Results reported for 57 participants with severe illness only</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-27 11:42:37 +1000" MODIFIED_BY="[Empty name]">
<P>8 individual doses of penicillin or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptoms of sore throat and fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:13:30 +1000" MODIFIED_BY="[Empty name]">
<P>Phone report after 48 hours used to measure outcome at day 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:28:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nelson-1984">
<CHAR_METHODS MODIFIED="2011-07-11 02:28:39 +1000" MODIFIED_BY="[Empty name]">
<P>An oral placebo was used to single-blind participants, however outcome was not determined blind<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-11 02:28:44 +1000" MODIFIED_BY="[Empty name]">
<P>51 children aged 5 to 11 years. Sixteen participants were excluded because they did not produce GABHS-positive throat swabs, leaving 35 participants. Children with history of penicillin hypersensitivity were also excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intramuscular penicillin or oral syrup placebo as a control group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptoms of sore throat and fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No antipyretics were administered<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petersen-1997">
<CHAR_METHODS MODIFIED="2011-07-11 02:29:01 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised placebo-controlled trial of participants' culture-negative for GABHS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-27 08:01:35 +1000" MODIFIED_BY="[Empty name]">
<P>186 adults (aged 18 to 50) presenting to an ambulatory setting, whose chief complaint was sore throat and whose GABHS culture was subsequently found to be negative</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>Treatment with either erythromycin (333 mg, 3 times daily) or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-11 02:29:23 +1000" MODIFIED_BY="[Empty name]">
<P>Main outcomes - time to improvement in sore throat, cough, activity level and sense of well-being. Participants completed a daily questionnaire on the progress of outcome measures. Follow-up visits were arranged 2 to 3 weeks after enrolment to repeat cultures, collect diaries and assess compliance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-16 09:27:03 +1000" MODIFIED_BY="[Empty name]">
<P>It is not clear how many participants kept diaries for the sore throat data in each group. Authors excluded GABHS-positive patients (15 out of 212 initially randomised)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:31:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pichichero-1987">
<CHAR_METHODS MODIFIED="2011-07-11 02:30:46 +1000" MODIFIED_BY="[Empty name]">
<P>Single-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:06:35 +1000" MODIFIED_BY="Liz Dooley">
<P>114 GABHS-positive children aged 4 to 18 years. Children were excluded from the study if: a throat swab was negative for GABHS; were allergic to penicillin; had received penicillin in past 7 days; had another acute illness within 7 days, had a GABHS-positive swab in past month, or had another concurrent infection that required antibiotics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:30:41 +1000" MODIFIED_BY="[Empty name]">
<P>Oral penicillin for 48 hours or an identical-looking and tasting oral placebo used for the control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-11 02:31:21 +1000" MODIFIED_BY="[Empty name]">
<P>Incidence of otitis media, quinsy or sinusitis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-11 02:30:50 +1000" MODIFIED_BY="[Empty name]">
<P>Antipyretics administered 4-hourly</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-24 09:54:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siegel-1961">
<CHAR_METHODS MODIFIED="2009-01-07 13:54:19 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-24 09:54:44 +1000" MODIFIED_BY="[Empty name]">
<P>1213 children aged 3 to 16 years. Suppurative complications occurring in participants in the control condition were treated with sulphonamides. Participants were excluded if they had a complication on admission</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intramuscular penicillin or no treatment for the controls</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-01-07 13:38:34 +1000" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:31:42 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taylor-1977">
<CHAR_METHODS MODIFIED="2011-07-11 02:31:35 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-11 02:31:38 +1000" MODIFIED_BY="[Empty name]">
<P>122 children aged 2 to 10 years. Children with positive <I>Streptococcus</I> throat swabs were excluded<BR/>9 children were excluded during trial because of pre-existing suppurative complications</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:31:42 +1000" MODIFIED_BY="[Empty name]">
<P>Oral amoxycillin, oral cotrimoxazole or an oral placebo was administered by parents 3 times a day for 5 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of otitis media and sinusitis and symptoms of sore throat and fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-01-07 13:54:54 +1000" MODIFIED_BY="[Empty name]">
<P>Antipyretic use was not documented</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-06-02 10:34:13 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Wannamaker-1951">
<CHAR_METHODS MODIFIED="2011-06-02 10:34:13 +1000" MODIFIED_BY="Liz Dooley">
<P>Single-blind study. The intervention outcomes were determined by physicians who were unaware of participant treatment allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 10:30:12 +1000" MODIFIED_BY="Liz Dooley">
<P>1974 young adult males recruited into the United States Air Force</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 09:09:00 +1000" MODIFIED_BY="Liz Dooley">
<P>Intramuscular penicillin over 1 to 3 days or no treatment for the control condition</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incidence of rheumatic fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:31:59 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Whitfield-1981">
<CHAR_METHODS MODIFIED="2011-07-11 02:31:54 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:10:36 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants were people who presented to the General Practitioner with sore throat, aged more than 10 years. 745 participants were commenced on the study. Only 528 returned questionnaires. Participants were excluded if the General Practitioner thought the participant would demonstrate poor compliance; if they had previous reaction to penicillin; or a previous episode of rheumatic fever or acute nephritis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-11 02:31:59 +1000" MODIFIED_BY="[Empty name]">
<P>Oral penicillin 4 times a day for 5 days or identical-looking and tasting oral lactose placebo 4 times a day for 5 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Symptom of fever</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Antipyretic use was not documented</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:32:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zwart-2000">
<CHAR_METHODS MODIFIED="2011-07-11 02:32:07 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:11:26 +1000" MODIFIED_BY="Liz Dooley">
<P>561 participants aged 15 to 60 years presenting with sore throat of less than 7 days duration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 09:11:32 +1000" MODIFIED_BY="Liz Dooley">
<P>Penicillin V for 7 days, penicillin V for 3 days followed by 4 days of placebo or placebo or 7 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Resolution of symptoms and recurrence of sore throat</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Author was contacted for data that could be used in the meta-analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-11 02:32:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zwart-2003">
<CHAR_METHODS MODIFIED="2011-07-11 02:32:11 +1000" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomised, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 09:11:50 +1000" MODIFIED_BY="Liz Dooley">
<P>156 children aged 4 to 15 years presenting with sore throat of less than 7 days duration with at least 2 of 4 Centor criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 09:11:57 +1000" MODIFIED_BY="Liz Dooley">
<P>Penicillin V for 7 days, penicillin V for 3 days followed by 4 days of placebo or placebo or 7 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Duration of symptoms of sore throat, occurrence of streptococcal sequelae</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Author was contacted for data that could be used in the meta-analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>F: Farenheit<BR/>GABHS: group A beta haemolytic <I>Streptococcus</I>
<BR/>GP: general practitioner<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-09-11 21:34:27 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-06-02 11:31:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Barwitz-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-06-02 11:31:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants were randomised to 2 GPs for subsequent treatment with different management protocols</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bass-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study used a Likert scale to measure severity and duration of symptoms. No raw scores are available for entry into meta-analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bishop-1952">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-randomised allocation to treatment groups. (Quote) "Where an exceptionally severe case fell in the control group and it was felt unjustifiable to withhold specific treatment, the case was transferred to one of the other groups and the next case was placed in the control group." This bias was not quantified</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Catanzaro-1958">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study compared sulphonamides with other antibiotics. No control condition was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 02:32:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cruickshank-1960">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 02:32:28 +1000" MODIFIED_BY="[Empty name]">
<P>Study is another report of the data previously published by <LINK REF="STD-Brumfitt-1957" TYPE="STUDY">Brumfitt 1957</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dowell-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Cough was the main complaint for patients, not sore throat</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:46:16 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Gerber-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:46:16 +1000" MODIFIED_BY="Liz Dooley">
<P>Study compared 2 different regimens of penicillin. No placebo control group was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:46:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Gerber-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:46:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Assessed 2 regimes of penicillin. No control group used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ginsburg-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study compared penicillin V with cefadroxil. No placebo control group was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guthrie-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study did not use control condition</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:12:57 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Haverkorn-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:12:57 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants not treated with antibiotics given antipyretics. Participants receiving antibiotics received no antipyretics. No control condition</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 18:07:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herz-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 18:07:49 +1000" MODIFIED_BY="[Empty name]">
<P>No participant-centred outcomes, except return visits for URIs<BR/>Poor randomisation - out of a series of 202, the first and last 50 were assigned to antibiotics, with the middle 102 assigned to control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Howie-1970">
<CHAR_REASON_FOR_EXCLUSION>
<P>Illness was "cold or flu-like illness", not acute pharyngitis (exclusively). Soreness of throat not an outcome measure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:45:35 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Jensen-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:45:35 +1000" MODIFIED_BY="Liz Dooley">
<P>Participants were not randomly allocated to treatment groups and were not blinded to treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-11 20:55:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kapur-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-11 20:55:26 +1000" MODIFIED_BY="[Empty name]">
<P>No intervention was provided to participants. Study tracked natural course of illness only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kolobukhina-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>Study investigated the combination of Ingavirin (antiviral medication) with an antibacterial agent in adults with viral respiratory infections. No comparison of antibiotics alone against placebo</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 18:08:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marlow-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 18:08:07 +1000" MODIFIED_BY="[Empty name]">
<P>Participant population highly selected (non-pregnant, negative rapid strep. test, negative throat culture, no other infection present, not allergic to erythromycin, aged older than 12) and participant-centred outcomes not compatible with those in this meta-analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 10:29:06 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Massell-1951">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 10:29:06 +1000" MODIFIED_BY="Liz Dooley">
<P>Study examined effect of penicillin on haemolytic streptococci infections in rheumatic patients only, without randomisation to control condition. Infections that were not treated with penicillin for 'various reasons' were treated as controls. These reasons were not given</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McDonald-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data suitable for this meta-analysis were described although symptoms were recorded. The author was approached for these data, but no reply was received</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 02:32:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Merenstein-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 02:32:46 +1000" MODIFIED_BY="[Empty name]">
<P>No data on suppurative or non-suppurative complications<BR/>No data on day 3 for soreness of throat, fever or headache</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 10:22:50 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Morris-1956">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 10:22:50 +1000" MODIFIED_BY="Liz Dooley">
<P>Study observed effect of sulfadiazine on prevention of rheumatic fever only. No control condition was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Nasonova-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="Liz Dooley">
<P>Study a controlled clinical trial without randomisation of participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 18:09:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pandraud-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 18:09:18 +1000" MODIFIED_BY="[Empty name]">
<P>Investigation of effect of fusafungine on chronic conditions of follicular pharyngitis. Not relevant for this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 02:32:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Randolph-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 02:32:53 +1000" MODIFIED_BY="[Empty name]">
<P>No data on suppurative or non-suppurative complications<BR/>No data on day 3 or 7 for soreness of throat, fever or headache</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 02:32:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schalen-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 02:32:57 +1000" MODIFIED_BY="[Empty name]">
<P>Primary complaint hoarseness, not sore throat. No patient-centred outcomes apart from hoarseness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schalen-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Patients presented for laryngitis and hoarseness, not pharyngitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:44:49 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Schwartz-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:44:49 +1000" MODIFIED_BY="Liz Dooley">
<P>Study compared 7 versus 10 days of treatment with penicillin. No control group was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shevrygin-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study was a clinical trial without a control condition</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shvartzman-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study compared efficacy of amoxycillin against penicillin, no control condition was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-11 02:33:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stillerman-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-11 02:33:11 +1000" MODIFIED_BY="[Empty name]">
<P>Study compared penicillin with cephalosporins, no control group was used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stromberg-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>No placebo control group was used. Study compared different antibiotic regimens</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-08-08 11:23:43 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Supajatura-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-08-08 11:23:43 +1000" MODIFIED_BY="[Empty name]">
<P>Antibiotics were not offered as an intervention. Study investigated the efficacy of Mangosteen spray against placebo only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Todd-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primary complaint not sore throat - purulent nasopharyngitis instead</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 09:13:16 +1000" MODIFIED_BY="Liz Dooley" STUDY_ID="STD-Valkenburg-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 09:13:16 +1000" MODIFIED_BY="Liz Dooley">
<P>Study did not involve any control measures. Data only given for participants not treated with antibiotics</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>GP: general practitioner<BR/>URIs: upper respiratory infections</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-10-25 10:46:38 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-06-02 11:31:12 +1000" MODIFIED_BY="Liz Dooley" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 08:49:10 +1000" MODIFIED_BY="Liz Dooley" RESULT="NO" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION>
<P>Participants allocated to alternate conditions on alternate days</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:37 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Brink-1951">
<DESCRIPTION>
<P>Participants randomised by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:41 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION>
<P>Participants randomised by hospital bed number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:44 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION>
<P>Participants randomised by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:47 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION>
<P>Participants randomised by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:48 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION>
<P>Participants randomised by random bottle dispensing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:32:01 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:37:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION>
<P>Randomisation method not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:49 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1950">
<DESCRIPTION>
<P>Participants randomised by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 08:58:28 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1953">
<DESCRIPTION>
<P>Participants were randomly allocated to treatment groups by drawing a card from a deck</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:23:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-25 10:05:22 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Howe-1997">
<DESCRIPTION>
<P>Block randomisation scheme (performed in blocks of 6)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:30:52 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Krober-1985">
<DESCRIPTION>
<P>Participants were randomised by table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:27:03 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION>
<P>Randomised by random numbering of bottles</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:33:00 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:28:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Little-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:31:00 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION>
<P>Participants randomised by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:31:27 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:31:02 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION>
<P>Participants randomised to conditions by hospital number allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:34:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:33:57 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:31:07 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION>
<P>Participants randomised by bed chart number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:37:23 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION>
<P>The method of randomisation to groups was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 11:31:12 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION>
<P>Participants randomised to groups by Air Force serial number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:34:25 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION>
<P>Randomised by pre-determined random order</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:34:31 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-02 10:34:40 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-10-23 12:25:32 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:25:32 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION>
<P>No concealment of allocation present</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-25 10:04:54 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brink-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:48:22 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:35:46 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:37:31 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:37:27 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:37:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 12:33:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:30:26 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Denny-1950">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:23:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1953">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:23:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:25:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Howe-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:25:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krober-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:27:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:27:38 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:29:28 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Little-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:30:59 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:31:32 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:32:34 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:34:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:35:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:36:54 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:37:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:55:27 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:56:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:57:11 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:57:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-10-25 10:46:38 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 12:26:26 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION>
<P>No blinding of participants or assessments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 12:22:29 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brink-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 12:23:03 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 12:24:18 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-05-18 08:52:42 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION>
<P>Participants did not know treatment type they were receiving. The outcome of treatment was not determined blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 12:26:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-02 10:32:04 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:45:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 12:32:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1950">
<DESCRIPTION>
<P>Single blind study - assessment was conducted by physicians who were unaware of treatment condition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:45:41 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1953">
<DESCRIPTION>
<P>Single-blind study - assessment was conducted by physicians who were unaware of treatment condition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-02 10:32:41 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 13:58:17 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Howe-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:45:53 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krober-1985">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:46:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-02 10:33:03 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-05-27 11:44:47 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Little-1997">
<DESCRIPTION>
<P>No blinding of participants or assessors was performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-24 11:39:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION>
<P>Outcomes were determined blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-02 10:33:35 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION>
<P>Double-blind study design used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-05-18 09:04:38 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION>
<P>An oral placebo was used to single-blind participants. However outcome was not determined blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 13:35:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-11 02:31:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION>
<P>Single-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 13:36:59 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:46:31 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-23 12:37:29 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION>
<P>Single-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-25 10:46:38 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-02 10:34:34 +1000" MODIFIED_BY="Liz Dooley" RESULT="YES" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION>
<P>Double-blind study design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-01-07 13:57:36 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-10-23 12:27:02 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-23 12:27:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 12:22:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brink-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 12:23:54 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 12:24:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 12:25:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:49:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-27 11:55:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION>
<P>No attrition of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 12:28:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:22:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denny-1950">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:23:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denny-1953">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-27 11:52:16 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION>
<P>No attrition of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:58:18 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Howe-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:26:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krober-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:27:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-09-11 21:17:20 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION>
<P>Some loss to follow-up occurred</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-27 11:47:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Little-1997">
<DESCRIPTION>
<P>No attrition of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:31:15 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-27 11:44:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION>
<P>No attrition of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:32:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-06-02 11:31:05 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION>
<P>It is not clear how many participants kept diaries for the sore throat data in each group. Authors excluded GABHS-positive participants (15 out of 212 initially randomised)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-27 11:41:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION>
<P>No participant attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:37:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:38:15 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:56:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:56:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:57:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-01-07 13:57:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-10-23 12:24:28 +1000" MODIFIED_BY="Liz Dooley" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 08:49:24 +1000" MODIFIED_BY="Liz Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION>
<P>No antipyretics were administered to the control group. The use of antipyretics to participants in the treatment group was unstated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:24:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brink-1951">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:24:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:48:40 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:48:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:24:14 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:24:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:24:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:50:25 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Denny-1950">
<DESCRIPTION>
<P>Antipyretic use was not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Denny-1953">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Howe-1997">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:51:04 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Krober-1985">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:51:32 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:31 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:25 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Little-1997">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:13 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:23:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:22:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:38:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:38:26 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:56:04 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-07 13:56:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION>
<P>Antipyretic use was not documented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:22:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-23 12:22:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION>
<P>All relevant outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-02-23 10:29:46 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bennike-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Brink-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Brumfitt-1957">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Catanzaro-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chamovitz-1954">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chapple-1956">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dagnelie-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-De-Meyere-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Denny-1950">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Denny-1953">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Daher-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Howe-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Krober-1985">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Landsman-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Leelarasamee-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Little-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-MacDonald-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Middleton-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nelson-1984">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Petersen-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pichichero-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Siegel-1961">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Taylor-1977">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wannamaker-1951">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Whitfield-1981">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zwart-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zwart-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-10-25 10:47:45 +1000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-10-25 10:47:45 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-05-18 09:42:04 +1000" MODIFIED_BY="Liz Dooley">Summary of findings</TITLE>
<TABLE COLS="7" ROWS="13">
<TR>
<TD COLSPAN="7">
<P>
<B>Antibiotics compared with placebo for sore throat</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>patients presenting with sore throat</P>
<P>
<B>Settings: </B>community</P>
<P>
<B>Intervention: </B>antibiotics</P>
<P>
<B>Comparison: </B>placebo</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ROWSPAN="3" VALIGN="BOTTOM">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH VALIGN="BOTTOM">
<P>Antibiotics</P>
</TH>
<TH VALIGN="BOTTOM">
<P>Placebo</P>
</TH>
</TR>
<TR>
<TD>
<P>Sore throat: day 3</P>
</TD>
<TD>
<P>0.66</P>
</TD>
<TD>
<P>0.72</P>
</TD>
<TD>
<P>0.68 to 0.76</P>
</TD>
<TD>
<P>3621 (15)</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sore throat: day 7</P>
</TD>
<TD>
<P>0.18</P>
</TD>
<TD>
<P>0.65</P>
</TD>
<TD>
<P>0.55 to 0.76</P>
</TD>
<TD>
<P>2974 (13)</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Rheumatic fever</P>
</TD>
<TD>
<P>0.017</P>
</TD>
<TD>
<P>0.29</P>
</TD>
<TD>
<P>0.18 to 0.44</P>
</TD>
<TD>
<P>10,101 (16)</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P>Based largely on risk in pre-1960 trials</P>
</TD>
</TR>
<TR>
<TD>
<P>Glomerulonephritis</P>
</TD>
<TD>
<P>0.001</P>
</TD>
<TD>
<P>0.22</P>
</TD>
<TD>
<P>0.07 to 1.32</P>
</TD>
<TD>
<P>5147 (10)</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD>
<P>Sparse data: 2 cases only</P>
</TD>
</TR>
<TR>
<TD>
<P>Quinsy</P>
</TD>
<TD>
<P>0.023</P>
</TD>
<TD>
<P>0.14</P>
</TD>
<TD>
<P>0.05 to 0.39</P>
</TD>
<TD>
<P>2433 (8)</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Otitis media</P>
</TD>
<TD>
<P>0.02</P>
</TD>
<TD>
<P>0.28</P>
</TD>
<TD>
<P>0.15 to 0.52</P>
</TD>
<TD>
<P>3760 (11)</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2009-01-12 09:07:29 +1000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-09-11 21:12:18 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-09-11 21:12:18 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Antibiotics versus placebo for the treatment of sore throats: symptom of sore throat</NAME>
<DICH_OUTCOME CHI2="85.8934971113238" CI_END="0.7930110723571225" CI_START="0.5895886991303211" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6837765472337998" ESTIMABLE="YES" EVENTS_1="1009" EVENTS_2="1031" I2="83.70074514272594" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.10072074883620512" LOG_CI_START="-0.22945084935588722" LOG_EFFECT_SIZE="-0.16508579909604618" METHOD="MH" MODIFIED="2011-07-11 02:38:04 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.250977182427505E-12" P_Q="1.0" P_Z="4.982481461166904E-7" Q="0.0" RANDOM="YES" SCALE="45.69" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.059731301081404224" TOTALS="YES" TOTAL_1="2066" TOTAL_2="1555" WEIGHT="100.0" Z="5.026986218157962">
<NAME>Symptom of sore throat on day 3</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.781326884954097" CI_START="0.5564838644124426" EFFECT_SIZE="0.6593904793888002" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="129" LOG_CI_END="-0.10716723164034482" LOG_CI_START="-0.2545474237789265" LOG_EFFECT_SIZE="-0.18085732770963567" ORDER="16630" O_E="0.0" SE="0.08657185440591988" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.007494685975279789" WEIGHT="8.505468357593305"/>
<DICH_DATA CI_END="1.1230192216466712" CI_START="0.5268974608143697" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" LOG_CI_END="0.05038718972863577" LOG_CI_START="-0.2782738943423093" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="16631" O_E="0.0" SE="0.19305714768187754" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="0.03727106227106227" WEIGHT="5.894583244750027"/>
<DICH_DATA CI_END="0.7277436015157603" CI_START="0.37230366810320353" EFFECT_SIZE="0.5205205205205206" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="37" LOG_CI_END="-0.1380216042864224" LOG_CI_START="-0.42910268489594383" LOG_EFFECT_SIZE="-0.2835621445911831" ORDER="16632" O_E="0.0" SE="0.17098246762462002" STUDY_ID="STD-Chapple-1956" TOTAL_1="135" TOTAL_2="65" VAR="0.029235004235004233" WEIGHT="6.427023171132471"/>
<DICH_DATA CI_END="0.8778871165762538" CI_START="0.4543772874975945" EFFECT_SIZE="0.631578947368421" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="57" LOG_CI_END="-0.05656132441260133" LOG_CI_START="-0.34258338539780697" LOG_EFFECT_SIZE="-0.19957235490520417" ORDER="16633" O_E="0.0" SE="0.16801077445474588" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="117" TOTAL_2="117" VAR="0.02822762033288349" WEIGHT="6.500631164239401"/>
<DICH_DATA CI_END="0.523220657203175" CI_START="0.219084263940608" EFFECT_SIZE="0.3385696568830095" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="59" LOG_CI_END="-0.28131511802428877" LOG_CI_START="-0.6593888151786337" LOG_EFFECT_SIZE="-0.4703519666014612" ORDER="16634" O_E="0.0" SE="0.22208236120344615" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="82" TOTAL_2="91" VAR="0.04932057515769793" WEIGHT="5.24327068399012"/>
<DICH_DATA CI_END="0.6846721275309944" CI_START="0.5092787953016872" EFFECT_SIZE="0.5904989384288747" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="48" LOG_CI_END="-0.1645173515629025" LOG_CI_START="-0.29304440604487625" LOG_EFFECT_SIZE="-0.2287808788038894" ORDER="16635" O_E="0.0" SE="0.0754974280218919" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.005699861637920748" WEIGHT="8.738779534934451"/>
<DICH_DATA CI_END="0.5387173596354544" CI_START="0.32933958720699136" EFFECT_SIZE="0.42121366649668535" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="106" LOG_CI_END="-0.2686390295173217" LOG_CI_START="-0.482356063177482" LOG_EFFECT_SIZE="-0.37549754634740184" ORDER="16636" O_E="0.0" SE="0.1255384434883566" STUDY_ID="STD-El_x002d_Daher-1991" TOTAL_1="111" TOTAL_2="118" VAR="0.015759900793479303" WEIGHT="7.574240328909656"/>
<DICH_DATA CI_END="1.951561348526883" CI_START="0.25742720209073794" EFFECT_SIZE="0.7087912087912088" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.2903822081450252" LOG_CI_START="-0.5893455635166768" LOG_EFFECT_SIZE="-0.14948167768582582" ORDER="16637" O_E="0.0" SE="0.5167564477967855" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.26703722633955196" WEIGHT="1.7498273479134738"/>
<DICH_DATA CI_END="1.1145658243200058" CI_START="0.8310907461170167" EFFECT_SIZE="0.9624475791078917" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="122" LOG_CI_END="0.04710572225078644" LOG_CI_START="-0.08035155336848343" LOG_EFFECT_SIZE="-0.01662291555884849" ORDER="16638" O_E="0.0" SE="0.07486903462244884" STUDY_ID="STD-Little-1997" TOTAL_1="215" TOTAL_2="187" VAR="0.005605372345297443" WEIGHT="8.751417477047823"/>
<DICH_DATA CI_END="1.0047930928022244" CI_START="0.4423243428206223" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="27" LOG_CI_END="0.0020766409550338496" LOG_CI_START="-0.3542591590663963" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="16639" O_E="0.0" SE="0.20931341282324586" STUDY_ID="STD-MacDonald-1951" TOTAL_1="41" TOTAL_2="41" VAR="0.043812104787714544" WEIGHT="5.522210718482226"/>
<DICH_DATA CI_END="1.277549563743161" CI_START="0.05731127398694374" EFFECT_SIZE="0.27058823529411763" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.10637775799861376" LOG_CI_START="-1.2417599373920136" LOG_EFFECT_SIZE="-0.5676910896966999" ORDER="16640" O_E="0.0" SE="0.7919027556616737" STUDY_ID="STD-Middleton-1988" TOTAL_1="34" TOTAL_2="23" VAR="0.6271099744245524" WEIGHT="0.8324900178682465"/>
<DICH_DATA CI_END="0.9752310608327314" CI_START="0.689344860355195" EFFECT_SIZE="0.8199210446401458" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="74" LOG_CI_END="-0.010892475013303357" LOG_CI_START="-0.16156345809253755" LOG_EFFECT_SIZE="-0.08622796655292045" ORDER="16641" O_E="0.0" SE="0.08850488129413707" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.007833114012889294" WEIGHT="8.462864733167745"/>
<DICH_DATA CI_END="0.9696597926337156" CI_START="0.7116230747112225" EFFECT_SIZE="0.8306818181818182" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="165" LOG_CI_END="-0.013380612226636397" LOG_CI_START="-0.14774997815798" LOG_EFFECT_SIZE="-0.08056529519230816" ORDER="16642" O_E="0.0" SE="0.07892923068715982" STUDY_ID="STD-Whitfield-1981" TOTAL_1="256" TOTAL_2="272" VAR="0.006229823456866891" WEIGHT="8.668568186505786"/>
<DICH_DATA CI_END="0.8427845139978163" CI_START="0.6707171703182121" EFFECT_SIZE="0.7518444283338309" ESTIMABLE="YES" EVENTS_1="215" EVENTS_2="131" LOG_CI_END="-0.07428345306759725" LOG_CI_START="-0.17346057560507358" LOG_EFFECT_SIZE="-0.12387201433633538" ORDER="16643" O_E="0.0" SE="0.058257132713187866" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0033938935119619835" WEIGHT="9.058007811332624"/>
<DICH_DATA CI_END="1.4314603058499842" CI_START="0.9468555600496903" EFFECT_SIZE="1.1642105263157896" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="38" LOG_CI_END="0.15577930961271344" LOG_CI_START="-0.02371626625305" LOG_EFFECT_SIZE="0.06603152167983173" ORDER="16644" O_E="0.0" SE="0.1054365897809798" STUDY_ID="STD-Zwart-2003" TOTAL_1="100" TOTAL_2="56" VAR="0.011116874464642615" WEIGHT="8.070617222132654"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="85.89349711132378" CI_END="0.7930110723571225" CI_START="0.5895886991303211" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6837765472337998" ESTIMABLE="YES" EVENTS_1="1009" EVENTS_2="1031" I2="83.70074514272594" I2_Q="23.37233265846059" ID="CMP-001.02" LOG_CI_END="-0.10072074883620512" LOG_CI_START="-0.22945084935588722" LOG_EFFECT_SIZE="-0.16508579909604618" METHOD="MH" MODIFIED="2013-09-11 21:09:36 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="2.2503110486127298E-12" P_Q="0.2532999343178899" P_Z="4.982481461166904E-7" Q="1.3050116683610775" RANDOM="YES" SCALE="39.78" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.059731301081404224" TOTALS="YES" TOTAL_1="2066" TOTAL_2="1555" WEIGHT="99.99999999999997" Z="5.026986218157962">
<NAME>Symptom of sore throat on day 3: blind versus unblinded studies</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="70.92738065702075" CI_END="0.779774651448396" CI_START="0.5443958807786947" DF="11" EFFECT_SIZE="0.6515413326751798" ESTIMABLE="YES" EVENTS_1="734" EVENTS_2="754" I2="84.49117971352695" ID="CMP-001.02.01" LOG_CI_END="-0.10803088676154599" LOG_CI_START="-0.26408516958525463" LOG_EFFECT_SIZE="-0.18605802817340025" MODIFIED="2013-09-11 21:09:25 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="8.138034690574614E-11" P_Z="2.959768385972493E-6" STUDIES="12" TAU2="0.06971091506541473" TOTAL_1="1532" TOTAL_2="1130" WEIGHT="76.84853092060882" Z="4.673592132890838">
<NAME>Symptom of sore throat on day 3: blinded studies</NAME>
<DICH_DATA CI_END="0.7277436015157603" CI_START="0.37230366810320353" EFFECT_SIZE="0.5205205205205206" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="37" LOG_CI_END="-0.1380216042864224" LOG_CI_START="-0.42910268489594383" LOG_EFFECT_SIZE="-0.2835621445911831" ORDER="16645" O_E="0.0" SE="0.17098246762462002" STUDY_ID="STD-Chapple-1956" TOTAL_1="135" TOTAL_2="65" VAR="0.029235004235004233" WEIGHT="6.42702317113247"/>
<DICH_DATA CI_END="0.8778871165762538" CI_START="0.4543772874975945" EFFECT_SIZE="0.631578947368421" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="57" LOG_CI_END="-0.05656132441260133" LOG_CI_START="-0.34258338539780697" LOG_EFFECT_SIZE="-0.19957235490520417" ORDER="16646" O_E="0.0" SE="0.16801077445474588" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="117" TOTAL_2="117" VAR="0.02822762033288349" WEIGHT="6.500631164239399"/>
<DICH_DATA CI_END="0.523220657203175" CI_START="0.219084263940608" EFFECT_SIZE="0.3385696568830095" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="59" LOG_CI_END="-0.28131511802428877" LOG_CI_START="-0.6593888151786337" LOG_EFFECT_SIZE="-0.4703519666014612" ORDER="16647" O_E="0.0" SE="0.22208236120344615" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="82" TOTAL_2="91" VAR="0.04932057515769793" WEIGHT="5.243270683990119"/>
<DICH_DATA CI_END="0.6846721275309944" CI_START="0.5092787953016872" EFFECT_SIZE="0.5904989384288747" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="48" LOG_CI_END="-0.1645173515629025" LOG_CI_START="-0.29304440604487625" LOG_EFFECT_SIZE="-0.2287808788038894" ORDER="16648" O_E="0.0" SE="0.0754974280218919" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.005699861637920748" WEIGHT="8.73877953493445"/>
<DICH_DATA CI_END="0.5387173596354544" CI_START="0.32933958720699136" EFFECT_SIZE="0.42121366649668535" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="106" LOG_CI_END="-0.2686390295173217" LOG_CI_START="-0.482356063177482" LOG_EFFECT_SIZE="-0.37549754634740184" ORDER="16649" O_E="0.0" SE="0.1255384434883566" STUDY_ID="STD-El_x002d_Daher-1991" TOTAL_1="111" TOTAL_2="118" VAR="0.015759900793479303" WEIGHT="7.574240328909655"/>
<DICH_DATA CI_END="1.951561348526883" CI_START="0.25742720209073794" EFFECT_SIZE="0.7087912087912088" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.2903822081450252" LOG_CI_START="-0.5893455635166768" LOG_EFFECT_SIZE="-0.14948167768582582" ORDER="16650" O_E="0.0" SE="0.5167564477967855" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.26703722633955196" WEIGHT="1.7498273479134736"/>
<DICH_DATA CI_END="1.0047930928022244" CI_START="0.4423243428206223" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="27" LOG_CI_END="0.0020766409550338496" LOG_CI_START="-0.3542591590663963" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="16651" O_E="0.0" SE="0.20931341282324586" STUDY_ID="STD-MacDonald-1951" TOTAL_1="41" TOTAL_2="41" VAR="0.043812104787714544" WEIGHT="5.522210718482224"/>
<DICH_DATA CI_END="1.277549563743161" CI_START="0.05731127398694374" EFFECT_SIZE="0.27058823529411763" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.10637775799861376" LOG_CI_START="-1.2417599373920136" LOG_EFFECT_SIZE="-0.5676910896966999" ORDER="16652" O_E="0.0" SE="0.7919027556616737" STUDY_ID="STD-Middleton-1988" TOTAL_1="34" TOTAL_2="23" VAR="0.6271099744245524" WEIGHT="0.8324900178682464"/>
<DICH_DATA CI_END="0.9752310608327314" CI_START="0.689344860355195" EFFECT_SIZE="0.8199210446401458" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="74" LOG_CI_END="-0.010892475013303357" LOG_CI_START="-0.16156345809253755" LOG_EFFECT_SIZE="-0.08622796655292045" ORDER="16653" O_E="0.0" SE="0.08850488129413707" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.007833114012889294" WEIGHT="8.462864733167743"/>
<DICH_DATA CI_END="0.9696597926337156" CI_START="0.7116230747112225" EFFECT_SIZE="0.8306818181818182" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="165" LOG_CI_END="-0.013380612226636397" LOG_CI_START="-0.14774997815798" LOG_EFFECT_SIZE="-0.08056529519230816" ORDER="16654" O_E="0.0" SE="0.07892923068715982" STUDY_ID="STD-Whitfield-1981" TOTAL_1="256" TOTAL_2="272" VAR="0.006229823456866891" WEIGHT="8.668568186505784"/>
<DICH_DATA CI_END="0.8427845139978163" CI_START="0.6707171703182121" EFFECT_SIZE="0.7518444283338309" ESTIMABLE="YES" EVENTS_1="215" EVENTS_2="131" LOG_CI_END="-0.07428345306759725" LOG_CI_START="-0.17346057560507358" LOG_EFFECT_SIZE="-0.12387201433633538" ORDER="16655" O_E="0.0" SE="0.058257132713187866" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0033938935119619835" WEIGHT="9.058007811332622"/>
<DICH_DATA CI_END="1.4314603058499842" CI_START="0.9468555600496903" EFFECT_SIZE="1.1642105263157896" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="38" LOG_CI_END="0.15577930961271344" LOG_CI_START="-0.02371626625305" LOG_EFFECT_SIZE="0.06603152167983173" ORDER="16656" O_E="0.0" SE="0.1054365897809798" STUDY_ID="STD-Zwart-2003" TOTAL_1="100" TOTAL_2="56" VAR="0.011116874464642615" WEIGHT="8.070617222132652"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.165746963243418" CI_END="1.0501308082931322" CI_START="0.5970967483973693" DF="2" EFFECT_SIZE="0.7918520638501426" ESTIMABLE="YES" EVENTS_1="275" EVENTS_2="277" I2="82.08807698594809" ID="CMP-001.02.02" LOG_CI_END="0.021243399814276125" LOG_CI_START="-0.22395529384405324" LOG_EFFECT_SIZE="-0.10135594701488856" MODIFIED="2013-09-11 21:09:36 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0037617472230083715" P_Z="0.10515684405323374" STUDIES="3" TAU2="0.048244528589001676" TOTAL_1="534" TOTAL_2="425" WEIGHT="23.151469079391152" Z="1.6203512572130154">
<NAME>Symptom of sore throat on day 3: unblinded studies</NAME>
<DICH_DATA CI_END="0.781326884954097" CI_START="0.5564838644124426" EFFECT_SIZE="0.6593904793888002" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="129" LOG_CI_END="-0.10716723164034482" LOG_CI_START="-0.2545474237789265" LOG_EFFECT_SIZE="-0.18085732770963567" ORDER="16657" O_E="0.0" SE="0.08657185440591988" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.007494685975279789" WEIGHT="8.505468357593305"/>
<DICH_DATA CI_END="1.1230192216466712" CI_START="0.5268974608143697" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" LOG_CI_END="0.05038718972863577" LOG_CI_START="-0.2782738943423093" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="16658" O_E="0.0" SE="0.19305714768187754" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="0.03727106227106227" WEIGHT="5.894583244750026"/>
<DICH_DATA CI_END="1.1145658243200058" CI_START="0.8310907461170167" EFFECT_SIZE="0.9624475791078917" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="122" LOG_CI_END="0.04710572225078644" LOG_CI_START="-0.08035155336848343" LOG_EFFECT_SIZE="-0.01662291555884849" ORDER="16659" O_E="0.0" SE="0.07486903462244884" STUDY_ID="STD-Little-1997" TOTAL_1="215" TOTAL_2="187" VAR="0.005605372345297443" WEIGHT="8.751417477047822"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.519027988577237" CI_END="0.6974430643094324" CI_START="0.4807833084947394" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5790673397329521" ESTIMABLE="YES" EVENTS_1="287" EVENTS_2="299" I2="61.97367281136948" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.15649124019127747" LOG_CI_START="-0.3180506182816507" LOG_EFFECT_SIZE="-0.2372709292364641" METHOD="MH" MODIFIED="2013-09-11 21:09:48 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.03253593474081795" P_Q="0.452013681727095" P_Z="8.566079563503702E-9" Q="0.5655977690228615" RANDOM="YES" SCALE="20.03" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.02509529126001107" TOTALS="YES" TOTAL_1="693" TOTAL_2="444" WEIGHT="100.0" Z="5.756923322912093">
<NAME>Symptom of sore throat on day 3: antipyretics versus no antipyretics</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.256648759693197" CI_END="0.8117422926044301" CI_START="0.3318656394803453" DF="2" EFFECT_SIZE="0.5190273355310014" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="122" I2="75.77709724357565" ID="CMP-001.03.01" LOG_CI_END="-0.09058182625632719" LOG_CI_START="-0.47903771100380277" LOG_EFFECT_SIZE="-0.284809768630065" MODIFIED="2013-09-11 21:09:43 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.01610993353457779" P_Z="0.0040527075789650565" STUDIES="3" TAU2="0.11802081933552787" TOTAL_1="259" TOTAL_2="196" WEIGHT="43.119878689373486" Z="2.874029772121972">
<NAME>Symptom of sore throat on day 3: antipyretics administered</NAME>
<DICH_DATA CI_END="1.1230192216466712" CI_START="0.5268974608143697" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" LOG_CI_END="0.05038718972863577" LOG_CI_START="-0.2782738943423093" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="16660" O_E="0.0" SE="0.19305714768187754" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="0.03727106227106227" WEIGHT="14.440731636866019"/>
<DICH_DATA CI_END="0.7277436015157603" CI_START="0.37230366810320353" EFFECT_SIZE="0.5205205205205206" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="37" LOG_CI_END="-0.1380216042864224" LOG_CI_START="-0.42910268489594383" LOG_EFFECT_SIZE="-0.2835621445911831" ORDER="16661" O_E="0.0" SE="0.17098246762462002" STUDY_ID="STD-Chapple-1956" TOTAL_1="135" TOTAL_2="65" VAR="0.029235004235004233" WEIGHT="16.576677271979335"/>
<DICH_DATA CI_END="0.523220657203175" CI_START="0.219084263940608" EFFECT_SIZE="0.3385696568830095" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="59" LOG_CI_END="-0.28131511802428877" LOG_CI_START="-0.6593888151786337" LOG_EFFECT_SIZE="-0.4703519666014612" ORDER="16662" O_E="0.0" SE="0.22208236120344615" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="82" TOTAL_2="91" VAR="0.04932057515769793" WEIGHT="12.102469780528134"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1652376294405702" CI_END="0.6995120992218091" CI_START="0.5495055134719742" DF="1" EFFECT_SIZE="0.6199885122022333" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="177" I2="14.180595036215975" ID="CMP-001.03.02" LOG_CI_END="-0.15520476926390048" LOG_CI_START="-0.2600279457183032" LOG_EFFECT_SIZE="-0.20761635749110186" MODIFIED="2013-09-11 21:09:48 +1000" MODIFIED_BY="Liz Dooley" NO="2" P_CHI2="0.2803819951659057" P_Z="8.232891315488162E-15" STUDIES="2" TAU2="0.0010901178845729952" TOTAL_1="434" TOTAL_2="248" WEIGHT="56.880121310626514" Z="7.76394299520125">
<NAME>Symptom of sore throat on day 3: no antipyretics administered</NAME>
<DICH_DATA CI_END="0.781326884954097" CI_START="0.5564838644124426" EFFECT_SIZE="0.6593904793888002" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="129" LOG_CI_END="-0.10716723164034482" LOG_CI_START="-0.2545474237789265" LOG_EFFECT_SIZE="-0.18085732770963567" ORDER="16663" O_E="0.0" SE="0.08657185440591988" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.007494685975279789" WEIGHT="27.634746965606578"/>
<DICH_DATA CI_END="0.6846721275309944" CI_START="0.5092787953016872" EFFECT_SIZE="0.5904989384288747" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="48" LOG_CI_END="-0.1645173515629025" LOG_CI_START="-0.29304440604487625" LOG_EFFECT_SIZE="-0.2287808788038894" ORDER="16664" O_E="0.0" SE="0.0754974280218919" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.005699861637920748" WEIGHT="29.245374345019936"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="103.16148436835148" CI_END="0.7772254996147162" CI_START="0.5862285858543921" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6750050411138486" ESTIMABLE="YES" EVENTS_1="1003" EVENTS_2="1040" I2="81.58227354294552" I2_Q="85.56370791503596" ID="CMP-001.04" LOG_CI_END="-0.10945295928134727" LOG_CI_START="-0.23193300818326412" LOG_EFFECT_SIZE="-0.17069298373230568" METHOD="MH" MODIFIED="2013-09-11 21:12:18 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.4355183708403274E-13" P_Q="9.809584506433877E-4" P_Z="4.682473638783072E-8" Q="13.853972946994332" RANDOM="YES" SCALE="35.5" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.06791603062321944" TOTALS="YES" TOTAL_1="2054" TOTAL_2="1546" WEIGHT="100.0" Z="5.462964842493046">
<NAME>Symptom of sore throat on day 3: GABHS-positive throat swab, negative swab, untested/inseparable</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="51.308656801809185" CI_END="0.7098408245802578" CI_START="0.47678617526262146" DF="10" EFFECT_SIZE="0.5817579323025055" ESTIMABLE="YES" EVENTS_1="471" EVENTS_2="544" I2="80.510111502963" ID="CMP-001.04.01" LOG_CI_END="-0.14883902699451393" LOG_CI_START="-0.32167634574726955" LOG_EFFECT_SIZE="-0.2352576863708917" MODIFIED="2013-09-11 21:11:28 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.531685366318314E-7" P_Z="9.52218795049323E-8" STUDIES="11" TAU2="0.07571709035952709" TOTAL_1="1073" TOTAL_2="766" WEIGHT="54.45084920807346" Z="5.3356138095704635">
<NAME>Symptom of sore throat on day 3: GABHS-positive throat swab</NAME>
<DICH_DATA CI_END="0.781326884954097" CI_START="0.5564838644124426" EFFECT_SIZE="0.6593904793888002" ESTIMABLE="YES" EVENTS_1="119" EVENTS_2="129" LOG_CI_END="-0.10716723164034482" LOG_CI_START="-0.2545474237789265" LOG_EFFECT_SIZE="-0.18085732770963567" ORDER="16665" O_E="0.0" SE="0.08657185440591988" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.007494685975279789" WEIGHT="6.863929883761983"/>
<DICH_DATA CI_END="1.1230192216466712" CI_START="0.5268974608143697" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" LOG_CI_END="0.05038718972863577" LOG_CI_START="-0.2782738943423093" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="16666" O_E="0.0" SE="0.19305714768187754" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="0.03727106227106227" WEIGHT="4.920887696141317"/>
<DICH_DATA CI_END="0.6272488861836192" CI_START="0.20237242331678715" EFFECT_SIZE="0.35628342245989303" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="22" LOG_CI_END="-0.20256010119667195" LOG_CI_START="-0.6938486678070687" LOG_EFFECT_SIZE="-0.44820438450187033" ORDER="16667" O_E="0.0" SE="0.2885853359445732" STUDY_ID="STD-Chapple-1956" TOTAL_1="68" TOTAL_2="41" VAR="0.08328149612224217" WEIGHT="3.4234281628676277"/>
<DICH_DATA CI_END="0.6027771105477862" CI_START="0.21633408483178204" EFFECT_SIZE="0.3611111111111111" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="36" LOG_CI_END="-0.21984324765058727" LOG_CI_START="-0.6648750492703137" LOG_EFFECT_SIZE="-0.4423591484604505" ORDER="16668" O_E="0.0" SE="0.2614138832143739" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="55" TOTAL_2="55" VAR="0.06833721833721834" WEIGHT="3.798910302437177"/>
<DICH_DATA CI_END="0.523220657203175" CI_START="0.219084263940608" EFFECT_SIZE="0.3385696568830095" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="59" LOG_CI_END="-0.28131511802428877" LOG_CI_START="-0.6593888151786337" LOG_EFFECT_SIZE="-0.4703519666014612" ORDER="16669" O_E="0.0" SE="0.22208236120344615" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="82" TOTAL_2="91" VAR="0.04932057515769793" WEIGHT="4.415121606161313"/>
<DICH_DATA CI_END="0.6846721275309944" CI_START="0.5092787953016872" EFFECT_SIZE="0.5904989384288747" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="48" LOG_CI_END="-0.1645173515629025" LOG_CI_START="-0.29304440604487625" LOG_EFFECT_SIZE="-0.2287808788038894" ORDER="16670" O_E="0.0" SE="0.0754974280218919" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.005699861637920748" WEIGHT="7.031278917060397"/>
<DICH_DATA CI_END="0.5387173596354544" CI_START="0.32933958720699136" EFFECT_SIZE="0.42121366649668535" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="106" LOG_CI_END="-0.2686390295173217" LOG_CI_START="-0.482356063177482" LOG_EFFECT_SIZE="-0.37549754634740184" ORDER="16671" O_E="0.0" SE="0.1255384434883566" STUDY_ID="STD-El_x002d_Daher-1991" TOTAL_1="111" TOTAL_2="118" VAR="0.015759900793479303" WEIGHT="6.1859349809764685"/>
<DICH_DATA CI_END="1.1206652334405662" CI_START="0.4446197502389077" EFFECT_SIZE="0.7058823529411765" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.04947589896209008" LOG_CI_START="-0.35201124962338814" LOG_EFFECT_SIZE="-0.15126767533064908" ORDER="16672" O_E="0.0" SE="0.23583553847254768" STUDY_ID="STD-MacDonald-1951" TOTAL_1="26" TOTAL_2="24" VAR="0.05561840120663652" WEIGHT="4.19003725155149"/>
<DICH_DATA CI_END="1.782488164493459" CI_START="0.0824378233592382" EFFECT_SIZE="0.38333333333333336" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.25102665487046916" LOG_CI_START="-1.0838734836025705" LOG_EFFECT_SIZE="-0.41642341436605074" ORDER="16673" O_E="0.0" SE="0.7841269492013192" STUDY_ID="STD-Middleton-1988" TOTAL_1="24" TOTAL_2="23" VAR="0.6148550724637681" WEIGHT="0.7581074665815178"/>
<DICH_DATA CI_END="0.8225571217701414" CI_START="0.5947475084891312" EFFECT_SIZE="0.699438202247191" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="68" LOG_CI_END="-0.0848339331248873" LOG_CI_START="-0.22566736862939038" LOG_EFFECT_SIZE="-0.15525065087713885" ORDER="16674" O_E="0.0" SE="0.08272625715209411" STUDY_ID="STD-Zwart-2000" TOTAL_1="178" TOTAL_2="83" VAR="0.006843633622394402" WEIGHT="6.9237051348409855"/>
<DICH_DATA CI_END="1.48300304864832" CI_START="0.861105334175912" EFFECT_SIZE="1.1300539083557952" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="28" LOG_CI_END="0.17114204381987344" LOG_CI_START="-0.06494372049371851" LOG_EFFECT_SIZE="0.053099161663077495" ORDER="16675" O_E="0.0" SE="0.1386779466011849" STUDY_ID="STD-Zwart-2003" TOTAL_1="53" TOTAL_2="43" VAR="0.01923157287352109" WEIGHT="5.93950780569318"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="15.650881170837582" CI_END="0.9739431915805744" CI_START="0.6292596622701521" DF="5" EFFECT_SIZE="0.7828557745870603" ESTIMABLE="YES" EVENTS_1="262" EVENTS_2="202" I2="68.05291698644712" ID="CMP-001.04.02" LOG_CI_END="-0.01146637402753801" LOG_CI_START="-0.2011701071448874" LOG_EFFECT_SIZE="-0.10631824058621271" MODIFIED="2013-09-11 21:11:39 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.007914847946749681" P_Z="0.028027696702364845" STUDIES="6" TAU2="0.04260371459233951" TOTAL_1="458" TOTAL_2="278" WEIGHT="29.982481218306827" Z="2.1968984903395574">
<NAME>Symptom of sore throat on day 3: GABHS-negative throat swab</NAME>
<DICH_DATA CI_END="0.5602678324903668" CI_START="0.17743861603888733" EFFECT_SIZE="0.31529850746268656" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="-0.2516043116266097" LOG_CI_START="-0.7509518585315832" LOG_EFFECT_SIZE="-0.5012780850790964" ORDER="16676" O_E="0.0" SE="0.29331922086220347" STUDY_ID="STD-Chapple-1956" TOTAL_1="67" TOTAL_2="26" VAR="0.0860361653272101" WEIGHT="3.3621727057599693"/>
<DICH_DATA CI_END="1.2792530580026267" CI_START="0.6453700090883394" EFFECT_SIZE="0.9086206896551724" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="29" LOG_CI_END="0.10695646380876624" LOG_CI_START="-0.19019122050954756" LOG_EFFECT_SIZE="-0.041617378350390685" ORDER="16677" O_E="0.0" SE="0.17454602067333738" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="60" TOTAL_2="51" VAR="0.03046631333289712" WEIGHT="5.261247601980557"/>
<DICH_DATA CI_END="1.285025523719709" CI_START="0.24988695180279716" EFFECT_SIZE="0.5666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.10891175389341524" LOG_CI_START="-0.6022564205761922" LOG_EFFECT_SIZE="-0.24667233334138852" ORDER="16678" O_E="0.0" SE="0.41774370602268646" STUDY_ID="STD-MacDonald-1951" TOTAL_1="15" TOTAL_2="17" VAR="0.17450980392156867" WEIGHT="2.13514319622035"/>
<DICH_DATA CI_END="0.9752310608327314" CI_START="0.689344860355195" EFFECT_SIZE="0.8199210446401458" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="74" LOG_CI_END="-0.010892475013303357" LOG_CI_START="-0.16156345809253755" LOG_EFFECT_SIZE="-0.08622796655292045" ORDER="16679" O_E="0.0" SE="0.08850488129413707" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.007833114012889294" WEIGHT="6.83326357944911"/>
<DICH_DATA CI_END="0.9489696701203235" CI_START="0.6865125539303392" EFFECT_SIZE="0.8071428571428572" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="63" LOG_CI_END="-0.022747667772785102" LOG_CI_START="-0.16335151661685146" LOG_EFFECT_SIZE="-0.09304959219481829" ORDER="16680" O_E="0.0" SE="0.08259139681128132" STUDY_ID="STD-Zwart-2000" TOTAL_1="180" TOTAL_2="81" VAR="0.006821338827238531" WEIGHT="6.9257705351733225"/>
<DICH_DATA CI_END="1.524944489412762" CI_START="0.8027067897273119" EFFECT_SIZE="1.1063829787234043" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="10" LOG_CI_END="0.18325403490870332" LOG_CI_START="-0.09544306351053988" LOG_EFFECT_SIZE="0.04390548569908171" ORDER="16681" O_E="0.0" SE="0.1637080551843501" STUDY_ID="STD-Zwart-2003" TOTAL_1="47" TOTAL_2="13" VAR="0.02680032733224222" WEIGHT="5.464883599723518"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.082219420276092" CI_END="0.9989175327489137" CI_START="0.8016688505629352" DF="2" EFFECT_SIZE="0.8948748908568085" ESTIMABLE="YES" EVENTS_1="270" EVENTS_2="294" I2="3.948643427078885" ID="CMP-001.04.03" LOG_CI_END="-4.703641768499244E-4" LOG_CI_START="-0.0960049909085978" LOG_EFFECT_SIZE="-0.04823767754272385" MODIFIED="2013-09-11 21:12:18 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3530628279061089" P_Z="0.04778632127128171" STUDIES="3" TAU2="4.710406792782553E-4" TOTAL_1="523" TOTAL_2="502" WEIGHT="15.566669573619718" Z="1.9792637270058357">
<NAME>Symptom of sore throat on day 3: untested for GABHS culture or combined inseparable data</NAME>
<DICH_DATA CI_END="1.951561348526883" CI_START="0.25742720209073794" EFFECT_SIZE="0.7087912087912088" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.2903822081450252" LOG_CI_START="-0.5893455635166768" LOG_EFFECT_SIZE="-0.14948167768582582" ORDER="16682" O_E="0.0" SE="0.5167564477967855" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.26703722633955196" WEIGHT="1.545331655855119"/>
<DICH_DATA CI_END="1.1145658243200058" CI_START="0.8310907461170167" EFFECT_SIZE="0.9624475791078917" ESTIMABLE="YES" EVENTS_1="135" EVENTS_2="122" LOG_CI_END="0.04710572225078644" LOG_CI_START="-0.08035155336848343" LOG_EFFECT_SIZE="-0.01662291555884849" ORDER="16683" O_E="0.0" SE="0.07486903462244884" STUDY_ID="STD-Little-1997" TOTAL_1="215" TOTAL_2="187" VAR="0.005605372345297443" WEIGHT="7.040315477086254"/>
<DICH_DATA CI_END="0.9696597926337156" CI_START="0.7116230747112225" EFFECT_SIZE="0.8306818181818182" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="165" LOG_CI_END="-0.013380612226636397" LOG_CI_START="-0.14774997815798" LOG_EFFECT_SIZE="-0.08056529519230816" ORDER="16684" O_E="0.0" SE="0.07892923068715982" STUDY_ID="STD-Whitfield-1981" TOTAL_1="256" TOTAL_2="272" VAR="0.006229823456866891" WEIGHT="6.981022440678345"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="38.59334146363069" CI_END="0.760588129727169" CI_START="0.3187646177544653" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4923906827317763" ESTIMABLE="YES" EVENTS_1="246" EVENTS_2="206" I2="71.49767399548418" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.11885045677641734" LOG_CI_START="-0.4965298904339454" LOG_EFFECT_SIZE="-0.30769017360518136" METHOD="MH" MODIFIED="2011-07-11 02:38:37 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="6.20964887668718E-5" P_Q="1.0" P_Z="0.0014055412247004646" Q="0.0" RANDOM="YES" SCALE="134.01" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.295203940480954" TOTALS="YES" TOTAL_1="1839" TOTAL_2="1135" WEIGHT="100.0" Z="3.193510712631899">
<NAME>Symptom of sore throat at one week (6 to 8 days)</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1403397977957725" CI_START="0.003820678133937854" EFFECT_SIZE="0.066006600660066" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.057034281440619186" LOG_CI_START="-2.417859547117267" LOG_EFFECT_SIZE="-1.1804126328383238" ORDER="16685" O_E="0.0" SE="1.453764885816934" STUDY_ID="STD-Bennike-1951" TOTAL_1="100" TOTAL_2="99" VAR="2.1134323432343236" WEIGHT="2.043387122524366"/>
<DICH_DATA CI_END="0.5656613172102819" CI_START="0.06423205642886788" EFFECT_SIZE="0.19061371841155234" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.24744351950341473" LOG_CI_START="-1.192248173557858" LOG_EFFECT_SIZE="-0.7198458465306363" ORDER="16686" O_E="0.0" SE="0.5549829306500449" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.30800605331291253" WEIGHT="8.159308392809303"/>
<DICH_DATA CI_END="3.853594541260966" CI_START="0.009436800535005082" EFFECT_SIZE="0.19069767441860466" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5858660181148893" LOG_CI_START="-2.025175224506629" LOG_EFFECT_SIZE="-0.7196546031958698" ORDER="16687" O_E="0.0" SE="1.5337385507784802" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="2.3523539421440725" WEIGHT="1.8589872566294385"/>
<DICH_DATA CI_END="0.6490930510836854" CI_START="0.061624446499956353" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="15" LOG_CI_END="-0.1876930402174583" LOG_CI_START="-1.2102469684545791" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="16688" O_E="0.0" SE="0.6006532391700641" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="51" TOTAL_2="51" VAR="0.3607843137254902" WEIGHT="7.502842213147043"/>
<DICH_DATA CI_END="1.1940423123914907" CI_START="0.09925655614140866" EFFECT_SIZE="0.3442622950819672" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.07701971683736007" LOG_CI_START="-1.0032407973910558" LOG_EFFECT_SIZE="-0.4631105402768478" ORDER="16689" O_E="0.0" SE="0.6345503734335582" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="61" TOTAL_2="70" VAR="0.4026541764246682" WEIGHT="7.05268914376525"/>
<DICH_DATA CI_END="0.2886844122510116" CI_START="0.049406023985461955" EFFECT_SIZE="0.11942675159235669" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.5395766655690013" LOG_CI_START="-1.306220095121991" LOG_EFFECT_SIZE="-0.9228983803454961" ORDER="16690" O_E="0.0" SE="0.4503301454656065" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.2027972399150743" WEIGHT="9.883061644702872"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16691" O_E="0.0" SE="0.0" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2951384689399066" CI_START="0.6174585006199147" EFFECT_SIZE="0.8942562592047129" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="35" LOG_CI_END="0.1123162032293819" LOG_CI_START="-0.2093922260155373" LOG_EFFECT_SIZE="-0.04853801139307772" ORDER="16692" O_E="0.0" SE="0.18897312382087353" STUDY_ID="STD-Little-1997" TOTAL_1="388" TOTAL_2="184" VAR="0.0357108415266192" WEIGHT="14.873244208462422"/>
<DICH_DATA CI_END="7.950938032119094" CI_START="0.013974591508858441" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9004183686742379" LOG_CI_START="-1.8546608781135625" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16693" O_E="0.0" SE="1.618347187425374" STUDY_ID="STD-MacDonald-1951" TOTAL_1="41" TOTAL_2="41" VAR="2.619047619047619" WEIGHT="1.6888646242278822"/>
<DICH_DATA CI_END="1.0575221452956358" CI_START="0.41644165890132645" EFFECT_SIZE="0.663623595505618" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" LOG_CI_END="0.024289470589864283" LOG_CI_START="-0.3804458321730134" LOG_EFFECT_SIZE="-0.17807818079157461" ORDER="16694" O_E="0.0" SE="0.2377435203149746" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.05652198145175673" WEIGHT="13.993214767748439"/>
<DICH_DATA CI_END="3.532864908484046" CI_START="0.23684136916078635" EFFECT_SIZE="0.9147286821705426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.5481270309752831" LOG_CI_START="-0.6255424369615302" LOG_EFFECT_SIZE="-0.0387077029931236" ORDER="16695" O_E="0.0" SE="0.6894192552236491" STUDY_ID="STD-Taylor-1977" TOTAL_1="129" TOTAL_2="59" VAR="0.47529890947313097" WEIGHT="6.387745827652728"/>
<DICH_DATA CI_END="1.0336438164399022" CI_START="0.6386689878083188" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="117" EVENTS_2="63" LOG_CI_END="0.01437091090133125" LOG_CI_START="-0.19472417159950725" LOG_EFFECT_SIZE="-0.09017663034908802" ORDER="16696" O_E="0.0" SE="0.12282348649834376" STUDY_ID="STD-Zwart-2000" TOTAL_1="352" TOTAL_2="154" VAR="0.015085608835608834" WEIGHT="15.861882476639458"/>
<DICH_DATA CI_END="3.5471510612904984" CI_START="0.7217059425342434" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="7" LOG_CI_END="0.5498796840140692" LOG_CI_START="-0.14163971870221945" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="16697" O_E="0.0" SE="0.406201920231798" STUDY_ID="STD-Zwart-2003" TOTAL_1="100" TOTAL_2="56" VAR="0.16499999999999998" WEIGHT="10.694772321690792"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="33.276064624897444" CI_END="0.855055220423708" CI_START="0.3763357130138791" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5672634450098082" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="194" I2="66.94320640377137" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.06800583714212179" LOG_CI_START="-0.4244245666152556" LOG_EFFECT_SIZE="-0.2462152018786887" METHOD="MH" MODIFIED="2011-07-11 02:39:14 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="4.746051661231876E-4" P_Q="0.32143992421032364" P_Z="0.006771066217089183" Q="0.983079534726631" RANDOM="YES" SCALE="219.58" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.24120247474667394" TOTALS="YES" TOTAL_1="1825" TOTAL_2="1119" WEIGHT="100.0" Z="2.7078988180101464">
<NAME>Symptom of sore throat at one week (6 to 8 days): blind versus unblinded studies</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="22.268554935483337" CI_END="1.0345661078694726" CI_START="0.37740810590554263" DF="7" EFFECT_SIZE="0.6248628931254335" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="135" I2="68.56553997203471" ID="CMP-001.06.01" LOG_CI_END="0.014758246925989057" LOG_CI_START="-0.42318877636970165" LOG_EFFECT_SIZE="-0.2042152647218563" MODIFIED="2011-07-11 02:39:08 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0022831975569072016" P_Z="0.0675694406527355" STUDIES="9" TAU2="0.2782547568779959" TOTAL_1="1018" TOTAL_2="598" WEIGHT="72.63841378681707" Z="1.8278674938174417">
<NAME>Symptom of sore throat at 1 week (6 to 8 days): blinded studies</NAME>
<DICH_DATA CI_END="4.155537441932651" CI_START="0.23724149183916263" EFFECT_SIZE="0.9929078014184397" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6186271997137602" LOG_CI_START="-0.6248093536680439" LOG_EFFECT_SIZE="-0.0030910769771418803" ORDER="16698" O_E="0.0" SE="0.7304007865666793" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="47" TOTAL_2="35" VAR="0.5334853090172238" WEIGHT="5.658085840418271"/>
<DICH_DATA CI_END="1.4210819316348458" CI_START="0.11931062469799061" EFFECT_SIZE="0.4117647058823529" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.1526191176397459" LOG_CI_START="-0.92332088036778" LOG_EFFECT_SIZE="-0.38535088136401713" ORDER="16699" O_E="0.0" SE="0.6320124808185074" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="51" TOTAL_2="70" VAR="0.39943977591036417" WEIGHT="6.841962070975011"/>
<DICH_DATA CI_END="0.2886844122510116" CI_START="0.049406023985461955" EFFECT_SIZE="0.11942675159235669" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.5395766655690013" LOG_CI_START="-1.306220095121991" LOG_EFFECT_SIZE="-0.9228983803454961" ORDER="16700" O_E="0.0" SE="0.4503301454656065" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.2027972399150743" WEIGHT="9.872190984173958"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16701" O_E="0.0" SE="0.0" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.950938032119094" CI_START="0.013974591508858441" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9004183686742379" LOG_CI_START="-1.8546608781135625" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16702" O_E="0.0" SE="1.618347187425374" STUDY_ID="STD-MacDonald-1951" TOTAL_1="41" TOTAL_2="41" VAR="2.619047619047619" WEIGHT="1.532470880630189"/>
<DICH_DATA CI_END="1.0575221452956358" CI_START="0.41644165890132645" EFFECT_SIZE="0.663623595505618" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" LOG_CI_END="0.024289470589864283" LOG_CI_START="-0.3804458321730134" LOG_EFFECT_SIZE="-0.17807818079157461" ORDER="16703" O_E="0.0" SE="0.2377435203149746" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.05652198145175673" WEIGHT="14.722505621567493"/>
<DICH_DATA CI_END="3.532864908484046" CI_START="0.23684136916078635" EFFECT_SIZE="0.9147286821705426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.5481270309752831" LOG_CI_START="-0.6255424369615302" LOG_EFFECT_SIZE="-0.0387077029931236" ORDER="16704" O_E="0.0" SE="0.6894192552236491" STUDY_ID="STD-Taylor-1977" TOTAL_1="129" TOTAL_2="59" VAR="0.47529890947313097" WEIGHT="6.117573638510722"/>
<DICH_DATA CI_END="1.0336438164399022" CI_START="0.6386689878083188" EFFECT_SIZE="0.8125" ESTIMABLE="YES" EVENTS_1="117" EVENTS_2="63" LOG_CI_END="0.01437091090133125" LOG_CI_START="-0.19472417159950725" LOG_EFFECT_SIZE="-0.09017663034908802" ORDER="16705" O_E="0.0" SE="0.12282348649834376" STUDY_ID="STD-Zwart-2000" TOTAL_1="352" TOTAL_2="154" VAR="0.015085608835608834" WEIGHT="17.10282397367981"/>
<DICH_DATA CI_END="3.5471510612904984" CI_START="0.7217059425342434" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="7" LOG_CI_END="0.5498796840140692" LOG_CI_START="-0.14163971870221945" LOG_EFFECT_SIZE="0.2041199826559248" ORDER="16706" O_E="0.0" SE="0.406201920231798" STUDY_ID="STD-Zwart-2003" TOTAL_1="100" TOTAL_2="56" VAR="0.16499999999999998" WEIGHT="10.79080077686162"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.1899900485209" CI_END="1.1480779144275663" CI_START="0.08096195359054528" DF="3" EFFECT_SIZE="0.30487805894523573" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="59" I2="73.19032468311674" ID="CMP-001.06.02" LOG_CI_END="0.05997136250248052" LOG_CI_START="-1.0917190209667589" LOG_EFFECT_SIZE="-0.5158738292321392" MODIFIED="2011-07-11 02:39:14 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.010741676062889116" P_Z="0.07911510810471406" STUDIES="4" TAU2="1.1045150590709159" TOTAL_1="807" TOTAL_2="521" WEIGHT="27.36158621318294" Z="1.7558436544656004">
<NAME>Symptom of sore throat at 1 week (6 to 8 days): unblinded studies</NAME>
<DICH_DATA CI_END="1.1403397977957725" CI_START="0.003820678133937854" EFFECT_SIZE="0.066006600660066" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.057034281440619186" LOG_CI_START="-2.417859547117267" LOG_EFFECT_SIZE="-1.1804126328383238" ORDER="16707" O_E="0.0" SE="1.453764885816934" STUDY_ID="STD-Bennike-1951" TOTAL_1="100" TOTAL_2="99" VAR="2.1134323432343236" WEIGHT="1.8615413084811074"/>
<DICH_DATA CI_END="0.5656613172102819" CI_START="0.06423205642886788" EFFECT_SIZE="0.19061371841155234" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.24744351950341473" LOG_CI_START="-1.192248173557858" LOG_EFFECT_SIZE="-0.7198458465306363" ORDER="16708" O_E="0.0" SE="0.5549829306500449" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.30800605331291253" WEIGHT="7.981030439468995"/>
<DICH_DATA CI_END="3.853594541260966" CI_START="0.009436800535005082" EFFECT_SIZE="0.19069767441860466" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5858660181148893" LOG_CI_START="-2.025175224506629" LOG_EFFECT_SIZE="-0.7196546031958698" ORDER="16709" O_E="0.0" SE="1.5337385507784802" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="2.3523539421440725" WEIGHT="1.690053839397227"/>
<DICH_DATA CI_END="1.2951384689399066" CI_START="0.6174585006199147" EFFECT_SIZE="0.8942562592047129" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="35" LOG_CI_END="0.1123162032293819" LOG_CI_START="-0.2093922260155373" LOG_EFFECT_SIZE="-0.04853801139307772" ORDER="16710" O_E="0.0" SE="0.18897312382087353" STUDY_ID="STD-Little-1997" TOTAL_1="388" TOTAL_2="184" VAR="0.0357108415266192" WEIGHT="15.828960625835611"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="33.793240991174876" CI_END="0.7981383839356948" CI_START="0.2922212703718183" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.48294203843339084" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="142" I2="64.48994044953011" I2_Q="46.23884763575924" ID="CMP-001.07" LOG_CI_END="-0.09792180267278161" LOG_CI_START="-0.5342881755717958" LOG_EFFECT_SIZE="-0.3161049891222887" METHOD="MH" MODIFIED="2013-09-11 21:11:12 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="7.270743950883451E-4" P_Q="0.15566039713928526" P_Z="0.0045169214802995945" Q="3.720158352353884" RANDOM="YES" SCALE="192.96" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.41662833113873937" TOTALS="YES" TOTAL_1="1505" TOTAL_2="1019" WEIGHT="100.0" Z="2.83960649807675">
<NAME>Symptom of sore throat at one week (6 to 8 days): GABHS-positive throat swab, GABHS-negative swab</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="14.898587942851925" CI_END="0.700797299183237" CI_START="0.1177228218400089" DF="6" EFFECT_SIZE="0.2872278461391019" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="57" I2="59.72772706370007" ID="CMP-001.07.01" LOG_CI_END="-0.15440758057296233" LOG_CI_START="-0.9291393363205008" LOG_EFFECT_SIZE="-0.5417734584467316" MODIFIED="2013-09-11 21:10:47 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.021060333944435072" P_Z="0.0061210846078644104" STUDIES="7" TAU2="0.7676997367817053" TOTAL_1="650" TOTAL_2="467" WEIGHT="44.63009426312876" Z="2.7412235485576977">
<NAME>Symptom of sore throat at 1 week (6 to 8 days): GABHS-positive throat swab</NAME>
<DICH_DATA CI_END="0.5656613172102819" CI_START="0.06423205642886788" EFFECT_SIZE="0.19061371841155234" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" LOG_CI_END="-0.24744351950341473" LOG_CI_START="-1.192248173557858" LOG_EFFECT_SIZE="-0.7198458465306363" ORDER="16711" O_E="0.0" SE="0.5549829306500449" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.30800605331291253" WEIGHT="9.066899831093199"/>
<DICH_DATA CI_END="3.853594541260966" CI_START="0.009436800535005082" EFFECT_SIZE="0.19069767441860466" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5858660181148893" LOG_CI_START="-2.025175224506629" LOG_EFFECT_SIZE="-0.7196546031958698" ORDER="16712" O_E="0.0" SE="1.5337385507784802" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="42" TOTAL_2="40" VAR="2.3523539421440725" WEIGHT="2.3727805849040755"/>
<DICH_DATA CI_END="0.9176000611710073" CI_START="0.01662981097828244" EFFECT_SIZE="0.12352941176470589" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="10" LOG_CI_END="-0.03734656615492512" LOG_CI_START="-1.7791126871337841" LOG_EFFECT_SIZE="-0.9082296266443547" ORDER="16713" O_E="0.0" SE="1.0231220413443325" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="34" TOTAL_2="42" VAR="1.0467787114845941" WEIGHT="4.489651331874934"/>
<DICH_DATA CI_END="1.1940423123914907" CI_START="0.09925655614140866" EFFECT_SIZE="0.3442622950819672" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.07701971683736007" LOG_CI_START="-1.0032407973910558" LOG_EFFECT_SIZE="-0.4631105402768478" ORDER="16714" O_E="0.0" SE="0.6345503734335582" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="61" TOTAL_2="70" VAR="0.4026541764246682" WEIGHT="8.01944056822245"/>
<DICH_DATA CI_END="0.2886844122510116" CI_START="0.049406023985461955" EFFECT_SIZE="0.11942675159235669" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.5395766655690013" LOG_CI_START="-1.306220095121991" LOG_EFFECT_SIZE="-0.9228983803454961" ORDER="16715" O_E="0.0" SE="0.4503301454656065" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.2027972399150743" WEIGHT="10.606903694355573"/>
<DICH_DATA CI_END="7.2316313777687125" CI_START="0.013172666573584721" EFFECT_SIZE="0.30864197530864196" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8592362804815378" LOG_CI_START="-1.8803263008947622" LOG_EFFECT_SIZE="-0.5105450102066121" ORDER="16716" O_E="0.0" SE="1.6092326213539263" STUDY_ID="STD-MacDonald-1951" TOTAL_1="26" TOTAL_2="24" VAR="2.5896296296296293" WEIGHT="2.1855035275514862"/>
<DICH_DATA CI_END="7.661399417302844" CI_START="0.6109624683371604" EFFECT_SIZE="2.1635220125786163" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.8843081043196833" LOG_CI_START="-0.21398546781752595" LOG_EFFECT_SIZE="0.33516131825107864" ORDER="16717" O_E="0.0" SE="0.6451430809142598" STUDY_ID="STD-Zwart-2003" TOTAL_1="53" TOTAL_2="43" VAR="0.4162095948515431" WEIGHT="7.8889147251270435"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5337712102969892" CI_END="1.0701239067107169" CI_START="0.49553385757969276" DF="3" EFFECT_SIZE="0.7282050724765743" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="43" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.02943406636300677" LOG_CI_START="-0.3049266667938714" LOG_EFFECT_SIZE="-0.13774630021543233" MODIFIED="2013-09-11 21:10:58 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9114118713844909" P_Z="0.10633466687547793" STUDIES="5" TAU2="0.0" TOTAL_1="315" TOTAL_2="226" WEIGHT="38.24814245788314" Z="1.614889313567923">
<NAME>Symptom of sore throat at 1 week (6 to 8 days): GABHS-negative throat swab</NAME>
<DICH_DATA CI_END="4.215114279748114" CI_START="0.2406427601660404" EFFECT_SIZE="1.0071428571428571" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.6248093536680439" LOG_CI_START="-0.6186271997137602" LOG_EFFECT_SIZE="0.0030910769771418647" ORDER="16718" O_E="0.0" SE="0.7304007865666793" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="35" TOTAL_2="47" VAR="0.5334853090172238" WEIGHT="6.9151595138772"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16719" O_E="0.0" SE="0.0" STUDY_ID="STD-MacDonald-1951" TOTAL_1="15" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0575221452956358" CI_START="0.41644165890132645" EFFECT_SIZE="0.663623595505618" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" LOG_CI_END="0.024289470589864283" LOG_CI_START="-0.3804458321730134" LOG_EFFECT_SIZE="-0.17807818079157461" ORDER="16720" O_E="0.0" SE="0.2377435203149746" STUDY_ID="STD-Petersen-1997" TOTAL_1="89" TOTAL_2="90" VAR="0.05652198145175673" WEIGHT="13.88604678715577"/>
<DICH_DATA CI_END="3.532864908484046" CI_START="0.23684136916078635" EFFECT_SIZE="0.9147286821705426" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.5481270309752831" LOG_CI_START="-0.6255424369615302" LOG_EFFECT_SIZE="-0.0387077029931236" ORDER="16721" O_E="0.0" SE="0.6894192552236491" STUDY_ID="STD-Taylor-1977" TOTAL_1="129" TOTAL_2="59" VAR="0.47529890947313097" WEIGHT="7.366281775945981"/>
<DICH_DATA CI_END="2.1464428861652247" CI_START="0.32078508038484527" EFFECT_SIZE="0.8297872340425532" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="4" LOG_CI_END="0.33171933700214146" LOG_CI_START="-0.493785838820578" LOG_EFFECT_SIZE="-0.08103325090921827" ORDER="16722" O_E="0.0" SE="0.484905826594789" STUDY_ID="STD-Zwart-2003" TOTAL_1="47" TOTAL_2="13" VAR="0.23513366066557556" WEIGHT="10.080654380904187"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.4035509967745106" CI_END="4.466156256815557" CI_START="0.02770898854879083" DF="1" EFFECT_SIZE="0.3517849806020899" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="42" I2="70.618921210592" ID="CMP-001.07.03" LOG_CI_END="0.6499339136045665" LOG_CI_START="-1.5573793268231806" LOG_EFFECT_SIZE="-0.453722706609307" MODIFIED="2013-09-11 21:11:12 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.06505632140388073" P_Z="0.42038240011346983" STUDIES="3" TAU2="2.582787621971658" TOTAL_1="540" TOTAL_2="326" WEIGHT="17.121763278988105" Z="0.805758011717399">
<NAME>Symptom of sore throat at 1 week (6 to 8 days): GABHS untested</NAME>
<DICH_DATA CI_END="1.1403397977957725" CI_START="0.003820678133937854" EFFECT_SIZE="0.066006600660066" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.057034281440619186" LOG_CI_START="-2.417859547117267" LOG_EFFECT_SIZE="-1.1804126328383238" ORDER="16723" O_E="0.0" SE="1.453764885816934" STUDY_ID="STD-Bennike-1951" TOTAL_1="100" TOTAL_2="99" VAR="2.1134323432343236" WEIGHT="2.5968497295493"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16724" O_E="0.0" SE="0.0" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2951384689399066" CI_START="0.6174585006199147" EFFECT_SIZE="0.8942562592047129" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="35" LOG_CI_END="0.1123162032293819" LOG_CI_START="-0.2093922260155373" LOG_EFFECT_SIZE="-0.04853801139307772" ORDER="16725" O_E="0.0" SE="0.18897312382087353" STUDY_ID="STD-Little-1997" TOTAL_1="388" TOTAL_2="184" VAR="0.0357108415266192" WEIGHT="14.524913549438807"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-08-21 10:57:04 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Antibiotics versus control for the treatment of sore throat: symptom of fever</NAME>
<DICH_OUTCOME CHI2="11.38134974801449" CI_END="1.0970976775482868" CI_START="0.4545685975571122" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7061913003331955" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="114" I2="56.06847948001717" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.04024529569845868" LOG_CI_START="-0.3424005694441311" LOG_EFFECT_SIZE="-0.15107763687283624" METHOD="MH" MODIFIED="2011-07-11 02:40:02 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.044321874617291535" P_Q="1.0" P_Z="0.1216992956322425" Q="0.0" RANDOM="YES" SCALE="73.96" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1385416661645487" TOTALS="YES" TOTAL_1="712" TOTAL_2="622" WEIGHT="100.0" Z="1.5476802658240556">
<NAME>Symptom of fever on day 3</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9240006161695375" CI_START="0.3995180755008319" EFFECT_SIZE="0.6075812274368231" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="40" LOG_CI_END="-0.034327739170649955" LOG_CI_START="-0.3984635670065995" LOG_EFFECT_SIZE="-0.21639565308862474" ORDER="16726" O_E="0.0" SE="0.21389518777225494" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.045751151352128205" WEIGHT="27.41327001256631"/>
<DICH_DATA CI_END="0.7001302899087831" CI_START="0.12898436682876635" EFFECT_SIZE="0.300509337860781" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.15482113295271155" LOG_CI_START="-0.8894629238978785" LOG_EFFECT_SIZE="-0.522142028425295" ORDER="16727" O_E="0.0" SE="0.43153222453670553" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.18622006081359765" WEIGHT="15.556231994976535"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16728" O_E="0.0" SE="0.0" STUDY_ID="STD-Krober-1985" TOTAL_1="15" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.5552900827140284" CI_START="0.02973360070952835" EFFECT_SIZE="0.27564102564102566" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.40744020942997816" LOG_CI_START="-1.526752494979728" LOG_EFFECT_SIZE="-0.5596561427748751" ORDER="16729" O_E="0.0" SE="1.1361543689785625" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="1.2908467501490757" WEIGHT="3.5344268291962933"/>
<DICH_DATA CI_END="45.54285901227169" CI_START="0.08273890071218523" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.6584202905364642" LOG_CI_START="-1.0822902535372372" LOG_EFFECT_SIZE="0.2880650184996135" ORDER="16730" O_E="0.0" SE="1.609906940324887" STUDY_ID="STD-Middleton-1988" TOTAL_1="33" TOTAL_2="21" VAR="2.591800356506239" WEIGHT="1.8503428237241142"/>
<DICH_DATA CI_END="2.125803133157957" CI_START="0.7594280196913527" EFFECT_SIZE="1.2705882352941176" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.32752304281100136" LOG_CI_START="-0.1195133832656874" LOG_EFFECT_SIZE="0.10400482977265695" ORDER="16731" O_E="0.0" SE="0.2625914095434447" STUDY_ID="STD-Nelson-1984" TOTAL_1="17" TOTAL_2="18" VAR="0.06895424836601309" WEIGHT="24.347798747705767"/>
<DICH_DATA CI_END="1.2741024713736526" CI_START="0.5469943220898557" EFFECT_SIZE="0.8348214285714286" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="42" LOG_CI_END="0.10520435811117315" LOG_CI_START="-0.2620171817065008" LOG_EFFECT_SIZE="-0.07840641179766382" ORDER="16732" O_E="0.0" SE="0.21570775026484054" STUDY_ID="STD-Whitfield-1981" TOTAL_1="256" TOTAL_2="272" VAR="0.04652983352431882" WEIGHT="27.29792959183098"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.38134974801449" CI_END="1.0970976775482868" CI_START="0.45456859755711226" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7061913003331957" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="114" I2="56.06847948001717" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.04024529569845868" LOG_CI_START="-0.34240056944413105" LOG_EFFECT_SIZE="-0.15107763687283618" METHOD="MH" MODIFIED="2011-07-11 02:40:05 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.044321874617291535" P_Q="0.6012865073414311" P_Z="0.12169929563224258" Q="0.2730599888702696" RANDOM="YES" SCALE="216.06" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1385416661645487" TOTALS="YES" TOTAL_1="712" TOTAL_2="622" WEIGHT="100.0" Z="1.5476802658240552">
<NAME>Symptom of fever on day 3: blinded versus unblinded studies</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2149939979242848" CI_END="1.2309001739942222" CI_START="0.5401716046822717" DF="2" EFFECT_SIZE="0.8154123632801666" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="45" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.09022283307639169" LOG_CI_START="-0.2674682492006287" LOG_EFFECT_SIZE="-0.0886227080621185" NO="1" P_CHI2="0.5447128489496189" P_Z="0.33144167308125505" STUDIES="4" TAU2="0.0" TOTAL_1="356" TOTAL_2="347" WEIGHT="32.68269924475138" Z="0.9712141264938593">
<NAME>Symptom of fever on day 3: blinded studies.</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16733" O_E="0.0" SE="0.0" STUDY_ID="STD-Krober-1985" TOTAL_1="15" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.5552900827140284" CI_START="0.02973360070952835" EFFECT_SIZE="0.27564102564102566" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.40744020942997816" LOG_CI_START="-1.526752494979728" LOG_EFFECT_SIZE="-0.5596561427748751" ORDER="16734" O_E="0.0" SE="1.1361543689785625" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="1.2908467501490757" WEIGHT="3.5344268291962933"/>
<DICH_DATA CI_END="45.54285901227169" CI_START="0.08273890071218523" EFFECT_SIZE="1.9411764705882353" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.6584202905364642" LOG_CI_START="-1.0822902535372372" LOG_EFFECT_SIZE="0.2880650184996135" ORDER="16735" O_E="0.0" SE="1.609906940324887" STUDY_ID="STD-Middleton-1988" TOTAL_1="33" TOTAL_2="21" VAR="2.591800356506239" WEIGHT="1.8503428237241142"/>
<DICH_DATA CI_END="1.2741024713736526" CI_START="0.5469943220898557" EFFECT_SIZE="0.8348214285714286" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="42" LOG_CI_END="0.10520435811117315" LOG_CI_START="-0.2620171817065008" LOG_EFFECT_SIZE="-0.07840641179766382" ORDER="16736" O_E="0.0" SE="0.21570775026484054" STUDY_ID="STD-Whitfield-1981" TOTAL_1="256" TOTAL_2="272" VAR="0.04652983352431882" WEIGHT="27.29792959183098"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.420982795174867" CI_END="1.3706901789949009" CI_START="0.30784824833464036" DF="2" EFFECT_SIZE="0.6495880006689432" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="69" I2="80.80795219308834" ID="CMP-002.02.02" LOG_CI_END="0.13693930106339447" LOG_CI_START="-0.5116633132135231" LOG_EFFECT_SIZE="-0.18736200607506434" NO="2" P_CHI2="0.005458998770228707" P_Z="0.2574870779564631" STUDIES="3" TAU2="0.3430117410402156" TOTAL_1="356" TOTAL_2="275" WEIGHT="67.31730075524861" Z="1.1323506131337209">
<NAME>Symptom of fever on day 3: unblinded studies.</NAME>
<DICH_DATA CI_END="0.9240006161695375" CI_START="0.3995180755008319" EFFECT_SIZE="0.6075812274368231" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="40" LOG_CI_END="-0.034327739170649955" LOG_CI_START="-0.3984635670065995" LOG_EFFECT_SIZE="-0.21639565308862474" ORDER="16737" O_E="0.0" SE="0.21389518777225494" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.045751151352128205" WEIGHT="27.41327001256631"/>
<DICH_DATA CI_END="0.7001302899087831" CI_START="0.12898436682876635" EFFECT_SIZE="0.300509337860781" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="19" LOG_CI_END="-0.15482113295271155" LOG_CI_START="-0.8894629238978785" LOG_EFFECT_SIZE="-0.522142028425295" ORDER="16738" O_E="0.0" SE="0.43153222453670553" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.18622006081359765" WEIGHT="15.556231994976535"/>
<DICH_DATA CI_END="2.125803133157957" CI_START="0.7594280196913527" EFFECT_SIZE="1.2705882352941176" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.32752304281100136" LOG_CI_START="-0.1195133832656874" LOG_EFFECT_SIZE="0.10400482977265695" ORDER="16739" O_E="0.0" SE="0.2625914095434447" STUDY_ID="STD-Nelson-1984" TOTAL_1="17" TOTAL_2="18" VAR="0.06895424836601309" WEIGHT="24.347798747705767"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.667105010117744" CI_END="1.4618481624981823" CI_START="0.1791112846618017" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.511696689812963" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="74" I2="88.67952616540953" I2_Q="64.33312218336735" ID="CMP-002.03" LOG_CI_END="0.16490226618294343" LOG_CI_START="-0.7468770511584437" LOG_EFFECT_SIZE="-0.29098739248775013" METHOD="MH" MODIFIED="2011-07-11 02:40:09 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.4576093112206312E-4" P_Q="0.09404587371989259" P_Z="0.2109290228760643" Q="2.8037217194650745" RANDOM="YES" SCALE="32.46" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.7269538301917312" TOTALS="YES" TOTAL_1="371" TOTAL_2="286" WEIGHT="100.0" Z="1.2510150173052699">
<NAME>Symptom of fever on day 3: children compared with adults</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.125803133157957" CI_START="0.7594280196913527" DF="0" EFFECT_SIZE="1.2705882352941176" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.32752304281100136" LOG_CI_START="-0.1195133832656874" LOG_EFFECT_SIZE="0.10400482977265695" NO="1" P_CHI2="1.0" P_Z="0.3617755336887868" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="29" WEIGHT="36.0405793971931" Z="0.9119870716649708">
<NAME>Symptom of fever on day 3: children</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16740" O_E="0.0" SE="0.0" STUDY_ID="STD-Krober-1985" TOTAL_1="15" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.125803133157957" CI_START="0.7594280196913527" EFFECT_SIZE="1.2705882352941176" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.32752304281100136" LOG_CI_START="-0.1195133832656874" LOG_EFFECT_SIZE="0.10400482977265695" ORDER="16741" O_E="0.0" SE="0.2625914095434447" STUDY_ID="STD-Nelson-1984" TOTAL_1="17" TOTAL_2="18" VAR="0.06895424836601309" WEIGHT="36.0405793971931"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.296651377529381" CI_END="1.5081283561328633" CI_START="0.056844642991206604" DF="1" EFFECT_SIZE="0.29279518095297935" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="64" I2="86.29508320652978" ID="CMP-002.03.02" LOG_CI_END="0.1784383057167558" LOG_CI_START="-1.2453104567278737" LOG_EFFECT_SIZE="-0.5334360755055588" NO="2" P_CHI2="0.006908353254673982" P_Z="0.14191966950140802" STUDIES="2" TAU2="1.2205207594343024" TOTAL_1="339" TOTAL_2="257" WEIGHT="63.9594206028069" Z="1.4686797609573976">
<NAME>Symptom of fever on day 3: adults</NAME>
<DICH_DATA CI_END="0.9240006161695375" CI_START="0.3995180755008319" EFFECT_SIZE="0.6075812274368231" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="40" LOG_CI_END="-0.034327739170649955" LOG_CI_START="-0.3984635670065995" LOG_EFFECT_SIZE="-0.21639565308862474" ORDER="16742" O_E="0.0" SE="0.21389518777225494" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.045751151352128205" WEIGHT="37.122820459647315"/>
<DICH_DATA CI_END="0.3741989936840754" CI_START="0.03781273186486666" EFFECT_SIZE="0.11895161290322581" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="24" LOG_CI_END="-0.42689738476236044" LOG_CI_START="-1.4223619449337461" LOG_EFFECT_SIZE="-0.9246296648480532" ORDER="16743" O_E="0.0" SE="0.5847408102737166" STUDY_ID="STD-Catanzaro-1954" TOTAL_1="62" TOTAL_2="59" VAR="0.3419218151995626" WEIGHT="26.836600143159583"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-07-11 02:40:18 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="7.87" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="YES" TOTAL_1="486" TOTAL_2="291" WEIGHT="0.0" Z="0.0">
<NAME>Symptom of fever at 1 week (6 to 8 days)</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16744" O_E="0.0" SE="0.0" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16745" O_E="0.0" SE="0.0" STUDY_ID="STD-Denny-1950" TOTAL_1="157" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16746" O_E="0.0" SE="0.0" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-08-21 10:57:12 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Antibiotics versus control for the treatment of sore throat: symptom of headache</NAME>
<DICH_OUTCOME CHI2="8.706450340067734" CI_END="0.7061515590859719" CI_START="0.2726347745572424" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4387726872933742" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="147" I2="77.02852572654265" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.15110207768657014" LOG_CI_START="-0.5644187507202564" LOG_EFFECT_SIZE="-0.3577604142034133" METHOD="MH" MODIFIED="2011-07-11 02:40:29 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.012865292699995368" P_Q="1.0" P_Z="6.912456638296815E-4" Q="0.0" RANDOM="YES" SCALE="40.77" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1266475539714208" TOTALS="YES" TOTAL_1="552" TOTAL_2="359" WEIGHT="100.0" Z="3.3930280227319694">
<NAME>Symptom of headache on day 3</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.720281079697233" CI_START="0.41242836978122943" EFFECT_SIZE="0.5450361010830325" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="80" LOG_CI_END="-0.14249799309643024" LOG_CI_START="-0.3846514684717578" LOG_EFFECT_SIZE="-0.263574730784094" ORDER="16747" O_E="0.0" SE="0.14224215011450253" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.020232829269196673" WEIGHT="40.130748199989426"/>
<DICH_DATA CI_END="0.7838302034852151" CI_START="0.41924097260407667" EFFECT_SIZE="0.5732484076433121" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="30" LOG_CI_END="-0.10577800577978919" LOG_CI_START="-0.37753628016002855" LOG_EFFECT_SIZE="-0.24165714296990887" ORDER="16748" O_E="0.0" SE="0.1596321555961063" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.025482425100259495" WEIGHT="38.74594416771626"/>
<DICH_DATA CI_END="0.38250203545220796" CI_START="0.0828019995110384" EFFECT_SIZE="0.17796610169491525" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="37" LOG_CI_END="-0.4173662494428863" LOG_CI_START="-1.0819591757015259" LOG_EFFECT_SIZE="-0.7496627125722061" ORDER="16749" O_E="0.0" SE="0.39038517467236694" STUDY_ID="STD-El_x002d_Daher-1991" TOTAL_1="118" TOTAL_2="111" VAR="0.15240058460397443" WEIGHT="21.123307632294313"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.70645034006773" CI_END="0.7061515590859719" CI_START="0.2726347745572424" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.43877268729337426" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="147" I2="77.02852572654263" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.15110207768657014" LOG_CI_START="-0.5644187507202564" LOG_EFFECT_SIZE="-0.35776041420341326" METHOD="MH" MODIFIED="2011-07-11 02:40:44 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.012865292699995479" P_Q="0.463660716268829" P_Z="6.912456638296815E-4" Q="0.5370433828035113" RANDOM="YES" SCALE="67.06" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.12664755397142075" TOTALS="YES" TOTAL_1="552" TOTAL_2="359" WEIGHT="99.99999999999999" Z="3.3930280227319694">
<NAME>Symptom of headache on day 3: blinded versus unblinded studies</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.708914883486266" CI_END="1.2045007561857157" CI_START="0.09230082178819615" DF="1" EFFECT_SIZE="0.3334312667409061" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="67" I2="89.7001877964665" ID="CMP-003.02.01" LOG_CI_END="0.08080707698457434" LOG_CI_START="-1.0347944322732203" LOG_EFFECT_SIZE="-0.47699367764432293" MODIFIED="2011-07-11 02:40:41 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.001833786081687383" P_Z="0.09373244634263844" STUDIES="2" TAU2="0.7745839953662671" TOTAL_1="275" TOTAL_2="161" WEIGHT="59.86925180001056" Z="1.6760293371387789">
<NAME>Symptom headache on day 3: blinded studies</NAME>
<DICH_DATA CI_END="0.7838302034852151" CI_START="0.41924097260407667" EFFECT_SIZE="0.5732484076433121" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="30" LOG_CI_END="-0.10577800577978919" LOG_CI_START="-0.37753628016002855" LOG_EFFECT_SIZE="-0.24165714296990887" ORDER="16750" O_E="0.0" SE="0.1596321555961063" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="0.025482425100259495" WEIGHT="38.74594416771625"/>
<DICH_DATA CI_END="0.38250203545220796" CI_START="0.0828019995110384" EFFECT_SIZE="0.17796610169491525" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="37" LOG_CI_END="-0.4173662494428863" LOG_CI_START="-1.0819591757015259" LOG_EFFECT_SIZE="-0.7496627125722061" ORDER="16751" O_E="0.0" SE="0.39038517467236694" STUDY_ID="STD-El_x002d_Daher-1991" TOTAL_1="118" TOTAL_2="111" VAR="0.15240058460397443" WEIGHT="21.12330763229431"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.720281079697233" CI_START="0.41242836978122943" DF="0" EFFECT_SIZE="0.5450361010830325" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="80" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="-0.14249799309643024" LOG_CI_START="-0.3846514684717578" LOG_EFFECT_SIZE="-0.263574730784094" MODIFIED="2011-07-11 02:40:44 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.9839399503572413E-5" STUDIES="1" TAU2="0.0" TOTAL_1="277" TOTAL_2="198" WEIGHT="40.130748199989426" Z="4.26669060826785">
<NAME>Symptom of headache on day 3: unblinded studies</NAME>
<DICH_DATA CI_END="0.720281079697233" CI_START="0.41242836978122943" EFFECT_SIZE="0.5450361010830325" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="80" LOG_CI_END="-0.14249799309643024" LOG_CI_START="-0.3846514684717578" LOG_EFFECT_SIZE="-0.263574730784094" ORDER="16752" O_E="0.0" SE="0.14224215011450253" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.020232829269196673" WEIGHT="40.130748199989426"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-08-21 10:57:12 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Antibiotics versus placebo for the treatment of sore throat: incidence of complications</NAME>
<DICH_OUTCOME CHI2="12.195290766294914" CI_END="0.6005442877816402" CI_START="0.12006602298627175" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.26852367541999833" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="74" I2="50.80068105811242" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.2214549595684009" LOG_CI_START="-0.9205798745059393" LOG_EFFECT_SIZE="-0.57101741703717" METHOD="MH" MODIFIED="2011-07-11 02:37:29 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05775128059786405" P_Q="1.0" P_Z="0.001366470778324367" Q="0.0" RANDOM="YES" SCALE="103.31" SORT_BY="EFFECT_SIZE" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.5084481786426333" TOTALS="YES" TOTAL_1="5656" TOTAL_2="4445" WEIGHT="100.00000000000001" Z="3.2016412175438824">
<NAME>Incidence of acute rheumatic fever within 2 months. Rheumatic fever defined by clinical diagnosis</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16546" O_E="0.0" SE="0.0" STUDY_ID="STD-Leelarasamee-2000" TOTAL_1="369" TOTAL_2="386" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16536" O_E="0.0" SE="0.0" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16538" O_E="0.0" SE="0.0" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16541" O_E="0.0" SE="0.0" STUDY_ID="STD-Chapple-1956" TOTAL_1="186" TOTAL_2="97" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16543" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16542" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16548" O_E="0.0" SE="0.0" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16551" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16547" O_E="0.0" SE="0.0" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.7616174209568431" CI_START="0.004127569106590067" EFFECT_SIZE="0.08527131782945736" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.2459115964664688" LOG_CI_START="-2.3843056467485164" LOG_EFFECT_SIZE="-1.0691970251410239" ORDER="16540" O_E="0.0" SE="1.5450026284498168" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.3870331219168426" WEIGHT="5.824571736435628"/>
<DICH_DATA CI_END="0.5113550248173269" CI_START="0.027475520940970815" EFFECT_SIZE="0.11853162317558602" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" LOG_CI_END="-0.29127747211062527" LOG_CI_START="-1.5610540645225168" LOG_EFFECT_SIZE="-0.9261657683165709" ORDER="16544" O_E="0.0" SE="0.7458730558782487" STUDY_ID="STD-Denny-1950" TOTAL_1="798" TOTAL_2="804" VAR="0.5563266154851572" WEIGHT="15.838972372023042"/>
<DICH_DATA CI_END="0.3697997267214913" CI_START="0.05723718960229482" EFFECT_SIZE="0.14548641542506574" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="35" LOG_CI_END="-0.4320334141162514" LOG_CI_START="-1.2423216986400676" LOG_EFFECT_SIZE="-0.8371775563781595" ORDER="16550" O_E="0.0" SE="0.4759673493209865" STUDY_ID="STD-Wannamaker-1951" TOTAL_1="978" TOTAL_2="996" VAR="0.22654491761964599" WEIGHT="22.945710146641176"/>
<DICH_DATA CI_END="4.177780968288562" CI_START="0.00966949205969468" EFFECT_SIZE="0.200990099009901" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6209456671528651" LOG_CI_START="-2.0145963388917245" LOG_EFFECT_SIZE="-0.6968253358694296" ORDER="16549" O_E="0.0" SE="1.5481304204939272" STUDY_ID="STD-Siegel-1961" TOTAL_1="605" TOTAL_2="608" VAR="2.3967077988587038" WEIGHT="5.805174894988521"/>
<DICH_DATA CI_END="1.4587888568615863" CI_START="0.05604003370364619" EFFECT_SIZE="0.28592057761732853" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.16399243724250645" LOG_CI_START="-1.2515016121924165" LOG_EFFECT_SIZE="-0.5437545874749551" ORDER="16537" O_E="0.0" SE="0.8314682114466228" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.6913393866462457" WEIGHT="14.056603881001166"/>
<DICH_DATA CI_END="6.877031673466728" CI_START="0.05899288976729276" EFFECT_SIZE="0.6369426751592356" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8374010245717951" LOG_CI_START="-1.2292003293902627" LOG_EFFECT_SIZE="-0.19589965240923377" ORDER="16545" O_E="0.0" SE="1.2139318651589996" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="1.4736305732484076" WEIGHT="8.508712648539454"/>
<DICH_DATA CI_END="1.4283966013287788" CI_START="0.37649051900396924" EFFECT_SIZE="0.7333333333333333" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="12" LOG_CI_END="0.15484880817860405" LOG_CI_START="-0.42424595597351655" LOG_EFFECT_SIZE="-0.13469857389745624" ORDER="16539" O_E="0.0" SE="0.34016313102826956" STUDY_ID="STD-Catanzaro-1954" TOTAL_1="650" TOTAL_2="220" VAR="0.1157109557109557" WEIGHT="27.02025432037102"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.610286255669067" CI_END="0.49593502022410596" CI_START="0.1421362272881341" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2655001558468825" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="74" I2="21.15933884181465" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-0.3045752231203034" LOG_CI_START="-0.8472952161884404" LOG_EFFECT_SIZE="-0.5759352196543719" METHOD="MH" MODIFIED="2011-07-11 02:37:32 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.26806710805638245" P_Q="1.0" P_Z="3.1848027340476946E-5" Q="0.0" RANDOM="YES" SCALE="70.42" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14592346333438866" TOTALS="YES" TOTAL_1="4332" TOTAL_2="3843" WEIGHT="100.0" Z="4.159833071817625">
<NAME>Incidence of acute rheumatic fever within 2 months. Penicillin versus placebo</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16552" O_E="0.0" SE="0.0" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.0476473714233494" CI_START="0.07893375123711573" EFFECT_SIZE="0.4020304568527919" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3112551682066818" LOG_CI_START="-1.1027372573508807" LOG_EFFECT_SIZE="-0.3957410445720994" ORDER="16553" O_E="0.0" SE="0.8305861501479032" STUDY_ID="STD-Brink-1951" TOTAL_1="197" TOTAL_2="198" VAR="0.6898733528175152" WEIGHT="12.159791631474613"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16554" O_E="0.0" SE="0.0" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1465091664905167" CI_START="0.23931463022963068" EFFECT_SIZE="0.5238095238095238" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0593775313209386" LOG_CI_START="-0.621030750472327" LOG_EFFECT_SIZE="-0.2808266095756942" ORDER="16555" O_E="0.0" SE="0.39967519280067876" STUDY_ID="STD-Catanzaro-1954" TOTAL_1="420" TOTAL_2="220" VAR="0.15974025974025974" WEIGHT="33.2493337070786"/>
<DICH_DATA CI_END="1.7616174209568431" CI_START="0.004127569106590067" EFFECT_SIZE="0.08527131782945736" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.2459115964664688" LOG_CI_START="-2.3843056467485164" LOG_EFFECT_SIZE="-1.0691970251410239" ORDER="16556" O_E="0.0" SE="1.5450026284498168" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.3870331219168426" WEIGHT="4.0123526750653005"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16557" O_E="0.0" SE="0.0" STUDY_ID="STD-Chapple-1956" TOTAL_1="99" TOTAL_2="97" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16558" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16559" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.5113550248173269" CI_START="0.027475520940970815" EFFECT_SIZE="0.11853162317558602" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" LOG_CI_END="-0.29127747211062527" LOG_CI_START="-1.5610540645225168" LOG_EFFECT_SIZE="-0.9261657683165709" ORDER="16560" O_E="0.0" SE="0.7458730558782487" STUDY_ID="STD-Denny-1950" TOTAL_1="798" TOTAL_2="804" VAR="0.5563266154851572" WEIGHT="14.47221643284232"/>
<DICH_DATA CI_END="14.679808734372685" CI_START="0.06062725040349599" EFFECT_SIZE="0.9433962264150944" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.166720397123127" LOG_CI_START="-1.2173321276526672" LOG_EFFECT_SIZE="-0.025305865264770234" ORDER="16561" O_E="0.0" SE="1.4004042543036272" STUDY_ID="STD-Denny-1953" TOTAL_1="53" TOTAL_2="50" VAR="1.961132075471698" WEIGHT="4.823373159122201"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16562" O_E="0.0" SE="0.0" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.177780968288562" CI_START="0.00966949205969468" EFFECT_SIZE="0.200990099009901" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6209456671528651" LOG_CI_START="-2.0145963388917245" LOG_EFFECT_SIZE="-0.6968253358694296" ORDER="16563" O_E="0.0" SE="1.5481304204939272" STUDY_ID="STD-Siegel-1961" TOTAL_1="605" TOTAL_2="608" VAR="2.3967077988587038" WEIGHT="3.9970857283848025"/>
<DICH_DATA CI_END="0.3697997267214913" CI_START="0.05723718960229482" EFFECT_SIZE="0.14548641542506574" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="35" LOG_CI_END="-0.4320334141162514" LOG_CI_START="-1.2423216986400676" LOG_EFFECT_SIZE="-0.8371775563781595" ORDER="16564" O_E="0.0" SE="0.4759673493209865" STUDY_ID="STD-Wannamaker-1951" TOTAL_1="978" TOTAL_2="996" VAR="0.22654491761964599" WEIGHT="27.285846666032167"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16565" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.195290766294914" CI_END="0.60054428778164" CI_START="0.12006602298627181" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.26852367541999833" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="74" I2="50.80068105811242" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-0.22145495956840097" LOG_CI_START="-0.9205798745059391" LOG_EFFECT_SIZE="-0.57101741703717" METHOD="MH" MODIFIED="2011-07-11 02:37:35 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.05775128059786405" P_Q="1.0" P_Z="0.0013664707783243627" Q="0.0" RANDOM="YES" SCALE="145.34" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.508448178642633" TOTALS="YES" TOTAL_1="5656" TOTAL_2="4445" WEIGHT="99.99999999999999" Z="3.2016412175438833">
<NAME>Incidence of acute rheumatic fever within 2 months: early (pre-1975) versus late studies (post-1975)</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="12.195290766294914" CI_END="0.60054428778164" CI_START="0.12006602298627181" DF="6" EFFECT_SIZE="0.26852367541999833" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="74" I2="50.80068105811242" ID="CMP-004.03.01" LOG_CI_END="-0.22145495956840097" LOG_CI_START="-0.9205798745059391" LOG_EFFECT_SIZE="-0.57101741703717" NO="1" P_CHI2="0.05775128059786405" P_Z="0.0013664707783243627" STUDIES="10" TAU2="0.508448178642633" TOTAL_1="4208" TOTAL_2="3409" WEIGHT="99.99999999999999" Z="3.2016412175438833">
<NAME>Incidence of acute rheumatic fever within 2 months: early (pre-1975) studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16566" O_E="0.0" SE="0.0" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4587888568615863" CI_START="0.05604003370364619" EFFECT_SIZE="0.28592057761732853" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.16399243724250645" LOG_CI_START="-1.2515016121924165" LOG_EFFECT_SIZE="-0.5437545874749551" ORDER="16567" O_E="0.0" SE="0.8314682114466228" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.6913393866462457" WEIGHT="14.056603881001163"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16568" O_E="0.0" SE="0.0" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4283966013287788" CI_START="0.37649051900396924" EFFECT_SIZE="0.7333333333333333" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="12" LOG_CI_END="0.15484880817860405" LOG_CI_START="-0.42424595597351655" LOG_EFFECT_SIZE="-0.13469857389745624" ORDER="16569" O_E="0.0" SE="0.34016313102826956" STUDY_ID="STD-Catanzaro-1954" TOTAL_1="650" TOTAL_2="220" VAR="0.1157109557109557" WEIGHT="27.020254320371013"/>
<DICH_DATA CI_END="1.7616174209568431" CI_START="0.004127569106590067" EFFECT_SIZE="0.08527131782945736" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.2459115964664688" LOG_CI_START="-2.3843056467485164" LOG_EFFECT_SIZE="-1.0691970251410239" ORDER="16570" O_E="0.0" SE="1.5450026284498168" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.3870331219168426" WEIGHT="5.824571736435626"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16571" O_E="0.0" SE="0.0" STUDY_ID="STD-Chapple-1956" TOTAL_1="186" TOTAL_2="97" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.5113550248173269" CI_START="0.027475520940970815" EFFECT_SIZE="0.11853162317558602" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="17" LOG_CI_END="-0.29127747211062527" LOG_CI_START="-1.5610540645225168" LOG_EFFECT_SIZE="-0.9261657683165709" ORDER="16572" O_E="0.0" SE="0.7458730558782487" STUDY_ID="STD-Denny-1950" TOTAL_1="798" TOTAL_2="804" VAR="0.5563266154851572" WEIGHT="15.838972372023042"/>
<DICH_DATA CI_END="6.877031673466728" CI_START="0.05899288976729276" EFFECT_SIZE="0.6369426751592356" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8374010245717951" LOG_CI_START="-1.2292003293902627" LOG_EFFECT_SIZE="-0.19589965240923377" ORDER="16573" O_E="0.0" SE="1.2139318651589996" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="1.4736305732484076" WEIGHT="8.508712648539452"/>
<DICH_DATA CI_END="4.177780968288562" CI_START="0.00966949205969468" EFFECT_SIZE="0.200990099009901" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6209456671528651" LOG_CI_START="-2.0145963388917245" LOG_EFFECT_SIZE="-0.6968253358694296" ORDER="16574" O_E="0.0" SE="1.5481304204939272" STUDY_ID="STD-Siegel-1961" TOTAL_1="605" TOTAL_2="608" VAR="2.3967077988587038" WEIGHT="5.805174894988518"/>
<DICH_DATA CI_END="0.3697997267214913" CI_START="0.05723718960229482" EFFECT_SIZE="0.14548641542506574" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="35" LOG_CI_END="-0.4320334141162514" LOG_CI_START="-1.2423216986400676" LOG_EFFECT_SIZE="-0.8371775563781595" ORDER="16575" O_E="0.0" SE="0.4759673493209865" STUDY_ID="STD-Wannamaker-1951" TOTAL_1="978" TOTAL_2="996" VAR="0.22654491761964599" WEIGHT="22.945710146641172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-01-07 14:13:20 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="6" TAU2="0.0" TOTAL_1="1448" TOTAL_2="1036" WEIGHT="0.0" Z="0.0">
<NAME>Incidence of acute rheumatic fever within 2 months: late (post-1975) studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16577" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16578" O_E="0.0" SE="0.0" STUDY_ID="STD-Leelarasamee-2000" TOTAL_1="369" TOTAL_2="386" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16579" O_E="0.0" SE="0.0" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16580" O_E="0.0" SE="0.0" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16581" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.409726622413537" CI_END="0.576163623406991" CI_START="0.15319188848398543" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.29709189410936937" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-0.23945416475105682" LOG_CI_START="-0.8147642300030832" LOG_EFFECT_SIZE="-0.5271091973770701" METHOD="MH" MODIFIED="2009-04-07 13:21:55 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6100937660121961" P_Q="1.0" P_Z="3.287714340006172E-4" Q="0.0" RANDOM="YES" SCALE="291.06" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2325" TOTAL_2="1435" WEIGHT="100.00000000000001" Z="3.5915069287942836">
<NAME>Incidence of otitis media within 14 days. Otitis media defined by clinical diagnosis</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.6653861202910365" CI_START="0.010861283667605897" EFFECT_SIZE="0.22510460251046024" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6688875929854803" LOG_CI_START="-1.9641188435489776" LOG_EFFECT_SIZE="-0.6476156252817485" ORDER="16582" O_E="0.0" SE="1.5466410144124043" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="2.392098427462631" WEIGHT="4.774194442807268"/>
<DICH_DATA CI_END="0.7587241538259132" CI_START="0.09961855468721384" EFFECT_SIZE="0.27492363232435435" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="-0.11991609004119481" LOG_CI_START="-1.001659763506276" LOG_EFFECT_SIZE="-0.5607879267737355" ORDER="16583" O_E="0.0" SE="0.5179405984949653" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.2682624635693228" WEIGHT="42.571528148547394"/>
<DICH_DATA CI_END="3.4615801970219753" CI_START="0.00583484133972799" EFFECT_SIZE="0.1421188630490956" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.539274397689662" LOG_CI_START="-2.2339709487389974" LOG_EFFECT_SIZE="-0.8473482755246676" ORDER="16584" O_E="0.0" SE="1.6290180442780582" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.653699788583509" WEIGHT="4.303555009564983"/>
<DICH_DATA CI_END="1.7577008704625239" CI_START="0.15472931835336737" EFFECT_SIZE="0.521505376344086" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.24494496780197997" LOG_CI_START="-0.8104273877053229" LOG_EFFECT_SIZE="-0.28274120995167146" ORDER="16585" O_E="0.0" SE="0.6199309458024039" STUDY_ID="STD-Chapple-1956" TOTAL_1="186" TOTAL_2="97" VAR="0.38431437756346304" WEIGHT="29.716148251971706"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16586" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16587" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.3227384604784156" CI_START="0.0031507372549149214" EFFECT_SIZE="0.06455696202531645" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.12147398145156511" LOG_CI_START="-2.501587811836575" LOG_EFFECT_SIZE="-1.1900569151925051" ORDER="16588" O_E="0.0" SE="1.5407994817427395" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="2.3740630429386944" WEIGHT="4.81046324907346"/>
<DICH_DATA CI_END="3.8864975790251113" CI_START="0.006502730619903738" EFFECT_SIZE="0.15897435897435896" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5895584015111156" LOG_CI_START="-2.1869042365676066" LOG_EFFECT_SIZE="-0.7986729175282453" ORDER="16589" O_E="0.0" SE="1.6309078973191555" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="2.659860569537989" WEIGHT="4.2935870961927085"/>
<DICH_DATA CI_END="67.31893081255978" CI_START="0.11646055433989873" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8281372097117954" LOG_CI_START="-0.9338211470273569" LOG_EFFECT_SIZE="0.4471580313422192" ORDER="16590" O_E="0.0" SE="1.6223880106629416" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="55" VAR="2.632142857142857" WEIGHT="4.338800604248612"/>
<DICH_DATA CI_END="1.0320821071974957" CI_START="0.003081785980679751" EFFECT_SIZE="0.0563973063973064" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.013714248923311634" LOG_CI_START="-2.511197524812008" LOG_EFFECT_SIZE="-1.2487416379443483" ORDER="16591" O_E="0.0" SE="1.4831456744069802" STUDY_ID="STD-Taylor-1977" TOTAL_1="131" TOTAL_2="66" VAR="2.1997210915121364" WEIGHT="5.191723197593884"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16592" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.409726622413538" CI_END="0.5761636234069911" CI_START="0.15319188848398543" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2970918941093694" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-0.23945416475105674" LOG_CI_START="-0.8147642300030832" LOG_EFFECT_SIZE="-0.52710919737707" METHOD="MH" MODIFIED="2009-04-07 13:22:24 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.610093766012196" P_Q="0.9404536354594929" P_Z="3.287714340006181E-4" Q="0.005580047247840837" RANDOM="YES" SCALE="641.89" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2325" TOTAL_2="1435" WEIGHT="100.0" Z="3.5915069287942827">
<NAME>Incidence of otitis media within 14 days: early (pre-1975) versus late studies (post-1975)</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0776595789366605" CI_END="0.6176086564240045" CI_START="0.14824293513230694" DF="4" EFFECT_SIZE="0.3025824185100895" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="23" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="-0.20928662554338268" LOG_CI_START="-0.8290259948012395" LOG_EFFECT_SIZE="-0.5191563101723111" NO="1" P_CHI2="0.7214778793121608" P_Z="0.0010244384729816984" STUDIES="5" TAU2="0.0" TOTAL_1="1115" TOTAL_2="722" WEIGHT="86.1758891019648" Z="3.2837277112245853">
<NAME>Incidence of otitis media within 14 days: early (pre-1975) studies</NAME>
<DICH_DATA CI_END="4.6653861202910365" CI_START="0.010861283667605897" EFFECT_SIZE="0.22510460251046024" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6688875929854803" LOG_CI_START="-1.9641188435489776" LOG_EFFECT_SIZE="-0.6476156252817485" ORDER="16593" O_E="0.0" SE="1.5466410144124043" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="2.392098427462631" WEIGHT="4.774194442807267"/>
<DICH_DATA CI_END="0.7587241538259132" CI_START="0.09961855468721384" EFFECT_SIZE="0.27492363232435435" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="-0.11991609004119481" LOG_CI_START="-1.001659763506276" LOG_EFFECT_SIZE="-0.5607879267737355" ORDER="16594" O_E="0.0" SE="0.5179405984949653" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.2682624635693228" WEIGHT="42.57152814854739"/>
<DICH_DATA CI_END="3.4615801970219753" CI_START="0.00583484133972799" EFFECT_SIZE="0.1421188630490956" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.539274397689662" LOG_CI_START="-2.2339709487389974" LOG_EFFECT_SIZE="-0.8473482755246676" ORDER="16595" O_E="0.0" SE="1.6290180442780582" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.653699788583509" WEIGHT="4.303555009564982"/>
<DICH_DATA CI_END="1.7577008704625239" CI_START="0.15472931835336737" EFFECT_SIZE="0.521505376344086" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.24494496780197997" LOG_CI_START="-0.8104273877053229" LOG_EFFECT_SIZE="-0.28274120995167146" ORDER="16596" O_E="0.0" SE="0.6199309458024039" STUDY_ID="STD-Chapple-1956" TOTAL_1="186" TOTAL_2="97" VAR="0.38431437756346304" WEIGHT="29.716148251971703"/>
<DICH_DATA CI_END="1.3227384604784156" CI_START="0.0031507372549149214" EFFECT_SIZE="0.06455696202531645" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.12147398145156511" LOG_CI_START="-2.501587811836575" LOG_EFFECT_SIZE="-1.1900569151925051" ORDER="16597" O_E="0.0" SE="1.5407994817427395" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="2.3740630429386944" WEIGHT="4.810463249073459"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3040420525266425" CI_END="2.736600132841242" CI_START="0.027858431686647426" DF="2" EFFECT_SIZE="0.27611118748509267" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="39.46808278452222" ID="CMP-004.05.02" LOG_CI_END="0.4372113437062954" LOG_CI_START="-1.555043336189384" LOG_EFFECT_SIZE="-0.5589159962415444" NO="2" P_CHI2="0.19166235180433844" P_Z="0.2714567521053307" STUDIES="6" TAU2="1.6224592925275536" TOTAL_1="1210" TOTAL_2="713" WEIGHT="13.824110898035201" Z="1.099714041654667">
<NAME>Incidence of otitis media within 14 days: late (post-1975) studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16598" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16599" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.8864975790251113" CI_START="0.006502730619903738" EFFECT_SIZE="0.15897435897435896" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5895584015111156" LOG_CI_START="-2.1869042365676066" LOG_EFFECT_SIZE="-0.7986729175282453" ORDER="16600" O_E="0.0" SE="1.6309078973191555" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="2.659860569537989" WEIGHT="4.293587096192708"/>
<DICH_DATA CI_END="67.31893081255978" CI_START="0.11646055433989873" EFFECT_SIZE="2.8" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8281372097117954" LOG_CI_START="-0.9338211470273569" LOG_EFFECT_SIZE="0.4471580313422192" ORDER="16601" O_E="0.0" SE="1.6223880106629416" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="55" VAR="2.632142857142857" WEIGHT="4.338800604248611"/>
<DICH_DATA CI_END="1.0320821071974957" CI_START="0.003081785980679751" EFFECT_SIZE="0.0563973063973064" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.013714248923311634" LOG_CI_START="-2.511197524812008" LOG_EFFECT_SIZE="-1.2487416379443483" ORDER="16602" O_E="0.0" SE="1.4831456744069802" STUDY_ID="STD-Taylor-1977" TOTAL_1="131" TOTAL_2="66" VAR="2.1997210915121364" WEIGHT="5.191723197593883"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16603" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.451233836190737" CI_END="2.7612484013955125" CI_START="0.08418611889262348" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4821397994481986" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="32.60295660927734" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="0.44110547744796264" LOG_CI_START="-1.074759511651366" LOG_EFFECT_SIZE="-0.3168270171017016" METHOD="MH" MODIFIED="2009-04-07 13:22:58 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.2166818532544632" P_Q="1.0" P_Z="0.4126187044756364" Q="0.0" RANDOM="YES" SCALE="431.01" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.0367216272954682" TOTALS="YES" TOTAL_1="1545" TOTAL_2="842" WEIGHT="100.00000000000003" Z="0.8192939969113586">
<NAME>Incidence of sinusitis within 14 days. Sinusitis defined by clinical diagnosis</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3440873675243865" CI_START="0.014870197627405322" EFFECT_SIZE="0.14137483787289234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.12842749937296324" LOG_CI_START="-1.8276832595936299" LOG_EFFECT_SIZE="-0.8496278801103333" ORDER="16604" O_E="0.0" SE="1.1490291427213977" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="1.3202679708230702" WEIGHT="33.63865192715988"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16605" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16606" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.6002898824619307" CI_START="0.004452069164851369" EFFECT_SIZE="0.10759493670886076" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.41502176617695374" LOG_CI_START="-2.3514380973292512" LOG_EFFECT_SIZE="-0.9682081655761486" ORDER="16607" O_E="0.0" SE="1.6250322180207262" STUDY_ID="STD-Denny-1953" TOTAL_1="157" TOTAL_2="50" VAR="2.640729709605361" WEIGHT="21.560027699473018"/>
<DICH_DATA CI_END="84.20646227237991" CI_START="0.20462005662868604" EFFECT_SIZE="4.150943396226415" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9253454219217563" LOG_CI_START="-0.6890517994789218" LOG_EFFECT_SIZE="0.6181468112214172" ORDER="16608" O_E="0.0" SE="1.5357098693257216" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="2.358404802744425" WEIGHT="23.35287192415817"/>
<DICH_DATA CI_END="34.978478211226005" CI_START="0.05852457557913368" EFFECT_SIZE="1.4307692307692308" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5438009109504405" LOG_CI_START="-1.2326617271282814" LOG_EFFECT_SIZE="0.15556959191107955" ORDER="16609" O_E="0.0" SE="1.6309078973191555" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="2.659860569537989" WEIGHT="21.448448449208946"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16610" O_E="0.0" SE="0.0" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16611" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.8451124956711085" CI_END="0.47213548770808195" CI_START="0.04882217857953299" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.15182451414254183" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="-0.32593335492447306" LOG_CI_START="-1.3113828450753346" LOG_EFFECT_SIZE="-0.8186580999999038" METHOD="MH" MODIFIED="2011-07-11 02:37:47 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.7238502289867397" P_Q="1.0" P_Z="0.0011280923689052354" Q="0.0" RANDOM="YES" SCALE="711.65" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1438" TOTAL_2="995" WEIGHT="100.0" Z="3.2564639947323206">
<NAME>Incidence of quinsy within 2 months. Quinsy defined by clinical diagnosis</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5640382560427271" CI_START="0.009991359708721824" EFFECT_SIZE="0.07507002801120448" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="15" LOG_CI_END="-0.24869143888047782" LOG_CI_START="-2.0003754052863307" LOG_EFFECT_SIZE="-1.1245334220834045" ORDER="16612" O_E="0.0" SE="1.0289478328422756" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="1.0587336427108156" WEIGHT="31.648798601892423"/>
<DICH_DATA CI_END="4.0209116498044075" CI_START="0.009464762533041488" EFFECT_SIZE="0.19508196721311474" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6043245305950863" LOG_CI_START="-2.023890277831559" LOG_EFFECT_SIZE="-0.7097828736182363" ORDER="16613" O_E="0.0" SE="1.5438263883429337" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="2.383399917343987" WEIGHT="14.0587601717058"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16614" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Meyere-1992" TOTAL_1="87" TOTAL_2="94" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="35.882494130456436" CI_START="0.06270467130349894" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5548826224837677" LOG_CI_START="-1.202700104372405" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="16615" O_E="0.0" SE="1.6198177440099624" STUDY_ID="STD-Howe-1997" TOTAL_1="69" TOTAL_2="34" VAR="2.623809523809524" WEIGHT="12.770609881220565"/>
<DICH_DATA CI_END="3.3682584908951956" CI_START="0.00818480226514744" EFFECT_SIZE="0.1660377358490566" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5274054132497186" LOG_CI_START="-2.0869918081509593" LOG_EFFECT_SIZE="-0.7797931974506205" ORDER="16616" O_E="0.0" SE="1.5357098693257216" STUDY_ID="STD-Landsman-1951" TOTAL_1="52" TOTAL_2="43" VAR="2.358404802744425" WEIGHT="14.207759326223558"/>
<DICH_DATA CI_END="3.8864975790251113" CI_START="0.006502730619903738" EFFECT_SIZE="0.15897435897435896" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5895584015111156" LOG_CI_START="-2.1869042365676066" LOG_EFFECT_SIZE="-0.7986729175282453" ORDER="16617" O_E="0.0" SE="1.6309078973191555" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="2.659860569537989" WEIGHT="12.597520417027999"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16618" O_E="0.0" SE="0.0" STUDY_ID="STD-Pichichero-1987" TOTAL_1="59" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2638471528593342" CI_START="0.003411052131453395" EFFECT_SIZE="0.06565857540787903" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10169455441822019" LOG_CI_START="-2.4671116431755595" LOG_EFFECT_SIZE="-1.1827085443786696" ORDER="16619" O_E="0.0" SE="1.508929476262342" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="2.2768681643333455" WEIGHT="14.716551601929657"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.13695680294609308" CI_END="2.083578472404624" CI_START="0.02270113267570175" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.21748469220221764" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.08" LOG_CI_END="0.3188098616402051" LOG_CI_START="-1.6439524730916888" LOG_EFFECT_SIZE="-0.6625713057257419" METHOD="MH" MODIFIED="2011-07-11 02:37:57 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.7113254069249084" P_Q="1.0" P_Z="0.18575114672901402" Q="0.0" RANDOM="YES" SCALE="370.25" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2927" TOTAL_2="2220" WEIGHT="100.00000000000001" Z="1.3232533286711126">
<NAME>Incidence of acute glomerulonephritis within 1 month. Acute glomerulonephritis defined by clinical diagnosis</NAME>
<GROUP_LABEL_1>Antibiotics</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotics</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16620" O_E="0.0" SE="0.0" STUDY_ID="STD-Bennike-1951" TOTAL_1="238" TOTAL_2="268" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16621" O_E="0.0" SE="0.0" STUDY_ID="STD-Brink-1951" TOTAL_1="277" TOTAL_2="198" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16622" O_E="0.0" SE="0.0" STUDY_ID="STD-Brumfitt-1957" TOTAL_1="62" TOTAL_2="59" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.4615801970219753" CI_START="0.00583484133972799" EFFECT_SIZE="0.1421188630490956" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.539274397689662" LOG_CI_START="-2.2339709487389974" LOG_EFFECT_SIZE="-0.8473482755246676" ORDER="16623" O_E="0.0" SE="1.6290180442780582" STUDY_ID="STD-Chamovitz-1954" TOTAL_1="257" TOTAL_2="109" VAR="2.653699788583509" WEIGHT="50.09090114569301"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16624" O_E="0.0" SE="0.0" STUDY_ID="STD-Chapple-1956" TOTAL_1="186" TOTAL_2="97" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16625" O_E="0.0" SE="0.0" STUDY_ID="STD-Dagnelie-1996" TOTAL_1="121" TOTAL_2="118" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16626" O_E="0.0" SE="0.0" STUDY_ID="STD-Leelarasamee-2000" TOTAL_1="369" TOTAL_2="386" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16627" O_E="0.0" SE="0.0" STUDY_ID="STD-Little-1997" TOTAL_1="454" TOTAL_2="216" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.166286757118161" CI_START="0.013606075125179848" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9120246259969091" LOG_CI_START="-1.8662671354362343" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16628" O_E="0.0" SE="1.6319823334318493" STUDY_ID="STD-Siegel-1961" TOTAL_1="605" TOTAL_2="605" VAR="2.6633663366336635" WEIGHT="49.909098854307004"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16629" O_E="0.0" SE="0.0" STUDY_ID="STD-Zwart-2000" TOTAL_1="358" TOTAL_2="164" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-10-25 10:46:39 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-10-25 10:46:39 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-10-25 10:46:39 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAT0AAARECAIAAACI7FFkAAA3oklEQVR42u3dv24kRfv28ZGQVgQO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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2011-07-11 02:42:17 +1000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of findings.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1MAAACRCAIAAACpEnXpAAAW90lEQVR42u2da5LkqA5Ga//buhG9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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2014-01-28 07:40:28 +1000" MODIFIED_BY="Liz Dooley">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2009-01-12 08:48:14 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]">Antibiotics for sore throat</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2009-01-12 08:48:05 +1000" MODIFIED_BY="[Empty name]">
<P>1. The objectives as they are stated in the abstract include an assessment of the harms associated with the use of antibiotics in the management of sore throat, but the objectives as stated in the text of the review no longer refer to any assessment of harm. Indeed, the review does not address any adverse effects of antibiotics [which are not unimportant] and does not provide a reasonable explanation as to why this is not done other than to state in the discussion that this was not possible because of inconsistencies in the way these data were recorded. In the absence of RCT data on harmful effects the authors might have considered whether usable information could be provided by other study designs.</P>
<P>2. Reviews on this subject should treat adults and children separately, but this review does not attempt to do this.</P>
<P>3. All clinically important outcomes have not been addressed by the review and others such as resource use, re-attendance and time off school or work are probably at least as important as those that were selected. It may have been more helpful to have collected data on all available outcomes provided that they are free from detection bias.</P>
<P>4. The question addressed by the review is not sufficiently well defined to allow the review to be executed systematically. Clear definitions are not given for the key elements of the question.</P>
<P>Most importantly, clear definitions of what is meant by primary care and sore throat are not given, leading to confusion around inclusion and exclusion decisions. Many of the control groups of the included studies do not involve a placebo but instead simply compare treatment with antibiotics to no treatment, so that some excluded studies would be eligible for inclusion, such as Catanzaro 1958 which was excluded because it compared antibiotics with sulfadiazine.</P>
<P>Apparent errors in inclusion and exclusion decisions have arisen probably as a result of the general lack of clarity discussed above. Specifically, the lack of a clear definition of what is meant by primary care appears to have led to the inclusion of an odd assortment of studies. For example, a couple of the included trials studied only people with sore throat who were admitted to hospital (Siegal 1961 and Bennike 1951). In addition, there appears to be an issue around the definition of a sore throat particularly in relation to positive or negative Streptococcus throat swabs. Streptococcal sore throats are a small sub-set of the total population of sore throats and the failure of the reviewers to address this in the inclusion criteria means that the results of pragmatic trials of sore throat are mixed in with those of<BR/>streptococcal sore throat.</P>
<P>There is a failure to always faithfully report the detailed results of the included studies, and there are several numerical errors in the data abstracted. For example, in Bennike 1951 the baseline numbers include patients in the "ulcerative tonsillitis" group even though most outcomes are not reported for this group.</P>
<P>5. The search strategy is restricted to a Medline search, a search of the Cochrane Library and citation checking. No attempt appears to have been made to search other databases. The reviewers are not explicit about the details of their searching activities nor about how they used the work of the Cochrane Acute Respiratory Infections Group.</P>
<P>6. References to the included and excluded studies were incomplete. Specifically they were not provided for Dagnelie 1996, Howie 1997, Little 1997 and Peterson 1997 (included) and Herx 1988, Howie 1970, Marlow 1989, McDonald 1985, Schalen 1993 and Todd 1984 (excluded).</P>
<P>7. Given the nature of the data presented, it is possible that a formal meta-analysis was inappropriate. A descriptive analysis may have been more appropriate and more informative.</P>
<P>8. There is considerable uncertainty around the effectiveness of antibiotics on sore throat on the basis of the existing research examined by this review and this is not emphasised by the authors. Particular problems exist around the relevance of the trials to the present day with regard to the outcomes examined (rheumatic fever and glomerulonephritis), the poor quality of the majority of the included trials and the generalisability of the trials with regard to the study populations (e.g. United States air force recruits).</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2009-01-12 08:48:14 +1000" MODIFIED_BY="[Empty name]">
<P>1. This is valid criticism: we need to describe the inadequacies of the information in the trials (after checking again) in the text.</P>
<P>2. A subgroup analysis on the basis of age is a good idea, and we will attempt this at the next major review.</P>
<P>3. This is a good idea, and we will attempt this at the next major review.</P>
<P>4. Certainly the issue of definitions is particularly difficult in this group of illnesses. One of us has written a paper on these difficulties (Del Mar C. Managing sore throat: a literature review. I. Making the diagnosis. Med J Aust 1992;156:572-5.). There is a particular difficulty in the fact that primary care doctors use the terms 'sore throat' tonsillitis and pharyngitis in slightly different ways, including interchangeably. Moreover the notion that patients with positive swabs for Streptococcus have a different illness can be challenged. Nevertheless a subgroup analysis for this with swab-positive and swab-negative is a good idea which we will incorporate with our next review.</P>
<P>Thank for pointing numerical errors out to us, and we will check on this. Please could you detail other numerical errors for us?</P>
<P>5. We are explicit about our search method. At the time we undertook the search the Cochrane Acute Respiratory Infections Group had no material to assist us. This will be reviewed at the next major update.</P>
<P>6. Thank you for drawing our attention to this.</P>
<P>7. As is often the case, there is considerable variation in the population groups, treatments, outcomes measures, etc in these trials. This does not make a synthesis inappropriate, but rather allows us to examine whether these factors appear to make a difference. We also felt it important to specifically attempt to calculate the SIZE of the benefits, as this is what clinicians are interested in, and what will persuade them to modify their practice. It is then important to recognise that the size of the effect will vary in different populations: as we point out, in groups at high risk of rheumatic fever - such as Australian aboriginals - the prevention of RF is important; we are also interested in trying to better predict which sub-groups will experience the most or least symptom relief, and plan to detail this in the next update.</P>
<P>8. We think we have discussed this in the Review. However we will reconsider what we have written in the overhaul.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2008-07-14 09:04:56 +1000" MODIFIED_BY="Liz Dooley">
<P>Jackie Young (on behalf of an interdepartmental critical appraisal workshop based in the Department of Public Health and Epidemiology, The University of Birmingham, UK) Email: j.m.young.20@bham.ac.uk</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
<FEEDBACK_ITEM ID="FBK-02" MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]">Antibiotics for sore throat</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]">
<P>I noticed that trials with no events in either groups are not (cannot) be part of the pooled estimates. Although I see there is a statistical/technical problem here it does not seem right. It appears to imply that no events is no evidence. I wonder whether it is defensible to add one event in both groups and add the evidence as one would normally do?</P>
<P>I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of my criticisms.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]">
<P>Many thanks for this. We have gone back and checked with statisticians about your point. The issue seems to be:</P>
<P>1. Whether empty cells are a problem. The concern is that because one cannot divide anything by zero, this might represent a problem. We think not, because in no forest plots are there totals with zero--except for acute glomerulonephritis (there were no cases in the intervention arms of any trials, and only two in the control arms).</P>
<P>2. Whether the empty cells represent no evidence or evidence of no effect. We only recoded a zero where the study declared the outcome. Thus we assume that "no events" implies no events, rather than no reporting of events that might have occurred.</P>
<P>We have reported in Peto Odds ratios, the best measure for rare events.</P>
<P>Chris Del Mar</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]">
<P>Gerben ter Riet</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
<FEEDBACK_ITEM ID="FBK-03" MODIFIED="2009-01-28 10:01:05 +1000" MODIFIED_BY="Liz Dooley" NO="3">
<TITLE MODIFIED="2009-01-28 09:58:33 +1000" MODIFIED_BY="Liz Dooley">Typographical error in the Abstract</TITLE>
<DATE_SUBMITTED>
<DATE DAY="26" MONTH="8" YEAR="2008"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2009-01-28 09:59:48 +1000" MODIFIED_BY="Liz Dooley">
<P>Feedback: There seems to be a printing error in the abstract: the total number of cases according to the full text is 12835, but the number given in the abstract is 2835. </P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2009-01-28 10:01:05 +1000" MODIFIED_BY="Liz Dooley">
<P>Many thanks. We will correct the typing error.<BR/>Chris Del Mar (Feedback reply submitted 28 August 2008)</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2009-01-28 09:59:21 +1000" MODIFIED_BY="Liz Dooley">
<P>Martti Teikari (Feedback comment submitted 27 August 2008)</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
<FEEDBACK_ITEM ID="FBK-04" MODIFIED="2014-01-28 07:40:28 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2014-01-28 07:36:19 +1000" MODIFIED_BY="[Empty name]">Antibiotics for sore throat</TITLE>
<DATE_SUBMITTED>
<DATE DAY="30" MONTH="12" YEAR="2013"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2014-01-28 07:37:38 +1000" MODIFIED_BY="[Empty name]">
<P>Comment: This work is important and useful. I have 2 concerns. First is a value judgment about the size of the treatment effect, especially concerning quinsy. Second, is the exclusion of other causes of adolescent and young adult pharyngitis - group C (see Zwart 2000) strep and Fusobacterium necrophorum. Adolescents and young adults have a significant risk of suppurative complications, and most are not due to group A strep. A complete review in 2014 should acknowledge that sore throat in those age groups include other bacterial causes.</P>
<P>I agree with the conflict of interest statement below:<BR/>I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of my feedback.</P>
<P>Robert Centor<BR/>Professor Internal Medicine<BR/>University of Alabama at Birmingham</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2014-01-28 07:40:28 +1000" MODIFIED_BY="[Empty name]">
<P>We thank Dr Centor for commenting on the review with his thoughtful points.</P>
<P>1. Our comment on the size of the reduction of the complication of quinsy</P>
<P>The comments we made in the review are these:</P>
<P>&#8220;Antibiotics are effective at reducing the relative complication rate of people suffering sore throat. However, the relative benefit exaggerates the absolute benefit because complication rates are low and the illness is short-lived. Interpretation of these data is aided by estimating the absolute benefit, which we attempt below.</P>
<P>In these trials, conducted mostly in the 1950s, for every 100 participants treated with antibiotics rather than placebo, there was one fewer case of acute rheumatic fever, two fewer cases of acute otitis media and three fewer cases of quinsy. These figures need to be adapted to current circumstances and individuals. For example, the complication rate of acute otitis media among those with sore throats before 1975 was 3%. A NNTB of about 50 to prevent one case of acute otitis media can be estimated from the data. After 1975, this complication rate fell to 0.7% and applying the odds of reducing the complication with antibiotics from the data table yields a NNTB of nearly 200 to prevent one case of acute otitis media. Clinicians will have to exercise judgement in applying these data to their patients&#8230;.&#8221;</P>
<P>In other words we think that it is important to keep in mind the incidence of complications (and the absolute risk reduction we can expect from antibiotics) rather than simply focus on the relative risk reduction. In clinical settings (such as low-income countries, and in Australia for example among indigenous communities) where complications are much more common, then clinicians will interpret the finding of this review by increasing the threshold for using antibiotics.</P>
<P>We also, incidentally, mention under &#8220;Agreements and disagreements with other studies or reviews&#8221; that &#8220;A recent review analysing the risk-benefit profile of antimicrobial prescribing for children concluded that antibiotics show little benefit in preventing quinsy following sore throat (<A HREF="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000023.pub4/full#CD000023-bbs2-0073">Keith 2010</A>).&#8221;</P>
<P>2. Exclusion of the other aetiological agents of sore throat such as Group C Streptococcus and Fusobacterium necrophorum.</P>
<P>It is certainly true that there are many aetiological agents other than Group A beta haemolytic Streptococcus (GABHS), including a huge range of viruses and bacteria, and even non-infective causes. However two factors influence the review:</P>
<P>a) The enormous focus on acute rheumatic fever as a complication, which for decades was the over-riding indication, and the single reason proposed by researchers and clinicians for using penicillin for sore throat. This was the motivation for an enormous search to find the best way of identifying GABHS, (and incidentally the reason why your own work on predictors of GABHS was so important).</P>
<P>b) The availability of randomised controlled trials that addressed these agents.</P>
<P>In future updates, any new RCTs that address other aetiological agents will be eligible for inclusion, as can be seen from our inclusion and exclusion criteria.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2014-01-28 07:38:53 +1000" MODIFIED_BY="[Empty name]">
<P>Anneliese Spinks (Feedback reply submitted 24 January 2014)</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2013-09-11 21:16:01 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-09-11 21:15:36 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-07-11 16:31:26 +1000" MODIFIED_BY="[Empty name]">Details of previous searches</TITLE>
<APPENDIX_BODY MODIFIED="2013-09-11 21:15:36 +1000" MODIFIED_BY="[Empty name]">
<P>For the 2011 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2011, Issue 2, part of <I>The Cochrane Library</I>,<I> </I>
<A HREF="http://www.thecochranelibrary.com">www.thecochranelibrary.com</A> (accessed 18 May 2011), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (November 2008 to May week 1, 2011) and EMBASE (November 2008 to May 2011).</P>
<P>In the previous update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) and the Database of Abstracts of Reviews of Effects (DARE) (<I>The Cochrane Library</I> 2008, Issue 4) which contains the Acute Respiratory Infections Group's Specialised Register, MEDLINE (January 1966 to November 2008) and EMBASE (January 1990 to November 2008).</P>
<P>MEDLINE and CENTRAL were searched using the search strategy shown below. We combined the MEDLINE search string with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity and precision-maximising version (2008 revision) (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search string for EMBASE.</P>
<SUBSECTION>
<HEADING LEVEL="5">MEDLINE (Ovid)</HEADING>
<P># 1 explode Pharyngitis/<BR/># 2 pharyngit$.mp.<BR/># 3 explode Nasopharyngitis/<BR/># 4 nasopharyngit$.mp.<BR/># 5 explode Tonsillitis/<BR/># 6 tonsillit$.mp.<BR/># 7 sore throat*.mp.<BR/># 8 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7<BR/># 9 explode Anti-Bacterial Agents/<BR/># 10 antibiot$.mp.<BR/># 11 #9 OR #10<BR/># 12 #8 AND #11</P>
<P>(Embase.com used in 2011 update)<BR/>#1. 'pharyngitis'/exp AND [embase]/lim<BR/>#2. pharyngit*:ti,ab AND [2004-2008]/py<BR/>#3. 'rhinopharyngitis'/exp AND [embase]/lim<BR/>#4. rhinopharyngit*:ti,ab OR nasopharyngit*:ti,ab [embase]/lim<BR/>#5. 'tonsillitis'/exp AND [embase]/lim<BR/>#6. tonsillit*:ti,ab AND [embase]/lim<BR/>#7. 'sore throat'/exp AND [embase]/lim<BR/>#8. 'sore throat':ti,ab OR 'sore throats':ti,ab embase]/lim<BR/>#9. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8<BR/>#10. 'antibiotic agent'/exp AND [embase]/lim<BR/>#11. antibiotic*:ti,ab AND [embase]/lim<BR/>#12. #10 OR #11 619,306<BR/>#13. random*:ti,ab OR factorial*:ti,ab OR crossover*:ti,ab OR 'cross over':ti,ab OR placebo*:ti,ab OR assign*:ti,ab OR allocat*:ti,ab OR volunteer*:ti,ab AND [embase]/lim<BR/>#14. 'double blind':ti,ab OR 'double blinded':ti,ab OR 'single blind':ti,ab OR 'single blinded':ti,ab AND [embase]/lim<BR/>#15. 'crossover procedure'/exp AND [embase]/lim<BR/>#16. 'double blind procedure'/exp AND [embase]/lim<BR/>#17. 'single blind procedure'/exp AND [embase]/lim<BR/>#18. 'randomized controlled trial'/exp AND [embase]/lim<BR/>#19. #13 OR #14 OR #15 OR #16 OR #17 OR #18<BR/>#20. #9 AND #12 AND #19</P>
<P>(EMBASE search used in earlier versions of the review)<BR/>EMBASE (WebSPIRS)<BR/>#1 explode 'pharyngitis-' / all subheadings in DEM,DER,DRM,DRR<BR/>#2 (pharyngit* in ti) or (pharyngit* in ab)<BR/>#3 explode 'rhinopharyngitis-' / all subheadings in DEM,DER,DRM,DRR<BR/>#4 (nasopharyngit* in ti) or (nasopharyngit* in ab)<BR/>#5 explode 'tonsillitis-' / all subheadings in DEM,DER,DRM,DRR<BR/>#6 (tonsillit* in ti) or (tonsillit* in ab)<BR/>#7 explode 'sore-throat' / all subheadings in DEM,DER,DRM,DRR<BR/>#8 (sore throat in ti) or (sore throat in ab)<BR/>#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8<BR/>#10 'antibiotic-agent' / all subheadings in DEM,DER,DRM,DRR<BR/>#11 (antibiotic* in ti) or (antibiotic* in ab)<BR/>#12 #10 or #11<BR/>#13 #9 and #12<BR/>#14 explode 'randomized-controlled-trial' / all subheadings<BR/>#15 explode 'controlled-study' / all subheadings<BR/>#16 explode 'single-blind-procedure' / all subheadings<BR/>#17 explode 'double-blind-procedure' / all subheadings<BR/>#18 explode 'crossover-procedure' / all subheadings<BR/>#19 explode 'phase-3-clinical-trial' / all subheadings<BR/>#20 (randomi?ed controlled trial in ti) or (randomi?ed controlled trial in ab)<BR/>#21 ((random* or placebo* or double-blind*)in ti) or ((random* or placebo* or double-blind*)in ab)<BR/>#22 (controlled clinical trial* in ti) or (controlled clinical trial* in ab)<BR/>#23 (explode 'randomized-controlled-trial' / all subheadings) or (explode 'controlled-study' / all subheadings) or (explode 'single-blind-procedure' / all subheadings) or (explode 'double-blind-procedure' / all subheadings) or (explode 'crossover-procedure' / all subheadings) or (explode 'phase-3-clinical-trial' / all subheadings) or ((randomi?ed controlled trial in ti) or (randomi?ed controlled trial in ab)) or (((random* or placebo* or double-blind*)in ti) or ((random* or placebo* or double-blind*)in ab)) or ((controlled clinical trial* in ti) or (controlled clinical trial* in ab))<BR/>#24 (nonhuman in der) not ((human in der)and (nonhuman in der))<BR/>#25 ((explode 'randomized-controlled-trial' / all subheadings) or (explode 'controlled-study' / all subheadings) or (explode 'single-blind-procedure' / all subheadings) or (explode 'double-blind-procedure' / all subheadings) or (explode 'crossover-procedure' / all subheadings) or (explode 'phase-3-clinical-trial' / all subheadings) or ((randomi?ed controlled trial in ti) or (randomi?ed controlled trial in ab)) or (((random* or placebo* or double-blind*)in ti) or ((random* or placebo* or double-blind*)in ab)) or ((controlled clinical trial* in ti) or (controlled clinical trial* in ab))) not ((nonhuman in der) not ((human in der)and (nonhuman in der)))<BR/>#26 #13 and #25</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-09-11 21:16:01 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-09-11 21:16:01 +1000" MODIFIED_BY="[Empty name]">EMBASE (Elsevier) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-07-11 16:48:30 +1000" MODIFIED_BY="[Empty name]">
<P>#16 #11 AND #15 <BR/>#15 #12 OR #13 OR #14 <BR/>#14 azithromycin*:ab,ti OR clarithromycin*:ab,ti OR erythromycin*:ab,ti OR roxithromycin*:ab,ti OR macrolide*:ab,ti OR cefamandole*:ab,ti OR cefoperazone*:ab,ti OR cefazolin*:ab,ti OR cefonicid*:ab,ti OR<BR/>cefsulodin*:ab,ti OR cephacetrile*:ab,ti OR cefotaxime*:ab,ti OR cephalothin*:ab,ti OR cephapirin*:ab,ti OR cephalexin*:ab,ti OR cephaclor*:ab,ti OR cephadroxil*:ab,ti OR cephaloglycin*:ab,ti OR<BR/>cephradine*:ab,ti OR cephaloridine*:ab,ti OR ceftazidime*:ab,ti OR cephamycin*:ab,ti OR cefmetazole*:ab,ti OR cefotetan*:ab,ti OR cefoxitin*:ab,ti OR cephalosporin*:ab,ti OR cefpodoxime*:ab,ti OR<BR/>cefuroxime*:ab,ti OR cefixime*:ab,ti OR amoxicillin*:ab,ti OR amoxycillin*:ab,ti OR ampicillin*:ab,ti OR sulbactum*:ab,ti OR tetracyclin*:ab,ti OR clindamycin*:ab,ti OR lincomycin*:ab,ti OR doxycyclin*:ab,ti OR fluoroquinolone*:ab,ti OR ciprofloxacin*:ab,ti OR fleroxacin*:ab,ti OR enoxacin*:ab,ti OR norfloxacin*:ab,ti OR ofloxacin*:ab,ti OR pefloxacin*:ab,ti OR moxifloxacin*:ab,ti OR esparfloxacin*:ab,ti OR clindamicin*:ab,ti OR penicillin*:ab,ti OR ticarcillin*:ab,ti OR 'beta-lactam':ab,ti OR 'beta-lactams':ab,ti OR levofloxacin*:ab,ti OR trimethoprim*:ab,ti OR 'co-trimoxazole':ab,ti <BR/>#13 antibiot*:ab,ti <BR/>#12 'antibiotic agent'/exp <BR/>#11 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10<BR/>#10 (sore* NEAR/2 throat*):ab,ti <BR/>#9 ((throat* OR pharyn*) NEAR/3 (infect* OR inflam* OR strep*)):ab,ti <BR/>#8 'sore throat'/de <BR/>#7 (tonsil* NEAR/2 (infect* OR inflam*)):ab,ti <BR/>#6 tonsillit*:ab,ti <BR/>#5 'tonsillitis'/exp<BR/>#4 rhinopharyngit*:ab,ti OR nasopharyngit*:ab,ti <BR/>#3 'rhinopharyngitis'/de <BR/>#2 pharyngit*:ab,ti <BR/>#1 'pharyngitis'/exp </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2008-07-12 19:39:08 +1000" MODIFIED_BY="[Empty name]"/>
</COCHRANE_REVIEW>